The synthesis of novel indolequinones by Claire L. Norton (7166690)
LOUGHBOROUGH 
UNIVERSITY OF TECHNOLOGY 
LIBRARY 
j AUTHOR/FILING TITLE . NOa:Tc..l c. L. ----------------------~----------------------! 
--~-------------------------- ----- ----- - ------ - .. -
ACCESSION/COPY NO. 
(5\+.0 \ '2.\ ~ 3'" . 
--------------... __ ... ___ ... _______ L __________________ _ 
VOL. NO. CLASS MARK 
11 NOIJ 1997 
26 JUih:jj) 
,~ '"""""" 1111' 
'] 
, , 
The Synthesis of Novel Indolequinones 
by 
Claire Louise Norton 
A Doctoral Thesis 
Submitted in partial fulfilment of the requirements 
for the award 
of 
Doctor of Philosophy 
of the 
Loughborough University of Technology 
October 1995 
• © by Claire Louise Norton (1995) 
~~----~-~-------------------------------------, 
Abstract 
Mitomycin C (MMC), obtained from Streptomyces caespitosus, a clinically useful 
antitumour antibiotic, is the archetypical quinone bioreductive alkylating agent. The 
reductive activation mechanism of MMC, involves quinone reduction sequentially 
activating electrophiIic sites in the drug molecule (C-l and C-lO for MMC). This 
research project was designed to investigate the role of the C-lO in alkylation processes 
by preparing compounds in which the electrophilicity at C-l is much reduced by 
substituting a cyclopropane for the aziridine ring. The resulting pyrrolo[I,2-a]indole, 
cyclopropamitosenes, could on reductive activation, by either 1- or 2-electron processes, 
followed by elimination of the carbamate, generate a powerful electrophile capable of 
alkylating DNA (or other nucleophiles) at C-lO .. 
A range of compounds was prepared utilising the azidocinnamate decomposition route 
to substituted indoles and an intramolecular [3 + 2] cycloaddition strategy was 
employed to synthesise the pyrrolo[I,2-a]indole nucleus. 
The rapid ring opening of cyclopropylcarbinyl radicals is briefly outlined. The 
reduction-initiated ring opening of the cyclopropane ring is investigated, thereby 
establishing its relevance to the potent bioreductive anticancer action of the 
cyclopropamitosenes, novel analogues of MMC. 
The design and synthesis of fused [I,2-a]indoles without the cyclopropane ring, is 
examined for comparative purposes. The key step in the synthesis is the formation of 
the [I,2-a ]indole nucleus via a radical cyclisation. 
Biological data were r~corded for the cyclopropamitosenes and correlated with their 
structures. 
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Chapter One 
Mitomycins: Chemical and Biological Perspectives 
1 
Mitomycins: Chemical and Biological Perspectives 
1. 11ntroduction 
The Mitomycins, exemplified by Mitomycin C (MMC) 1, are among the most potent 
antitumour agents in clinical chemotherapy. The first mitomycins A and B were isolated 
. from Streptomyces caespitosus by Hata in 1956, followed by the isolation of MMC by 
Wakaki in 1958.1,2 
Over the last thirty years, developments in isolation and structural elucidation 
techniques, coupled with continued research into the mitomycins has led to the 
discovery of a large family of closely related structures, most of which possess some 
antitumour or antibacterial activity.3,4 These fall broadly into three main categories 
based on similarities in chemical structure. They are designated the A, B and G types 
after the first member of each type to be isolated, as illustrated below. 5 
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Me 
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o 
Type A 
10 
TypeB 
o 
o 
NZ 
NMe 
x 
MeO 
NH2 
MeO 
MeNH 
NH2 
x 
MeO 
NH2 
MeO 
MeNH 
2 
Z Name 
H Mitomycin A 
H Mitomycin C 1 
Me MitomycinF 
H Mitomycin M 
Me Porfiromycin 
y Name 
H MitomycinB 
H MitomycinD 
Me MitomycinJ 
H MitomycinL 
TypeG x y Name 
o NH2 Me MitomycinG 
MeO· Me Mitomycin K 
Me NMe 
MeO 
H Mitomycin H 
o 
All members of the mitomycins in. groups A, Band G are characterised by the 
azirino[2' ,3' :3.4jpyrrolo[1,2"ajindole ring system. Mitomycins in groups A and B 
possess three carcinostatic functional groups namely (i) the aziridine ring (ii) the 
carbamate and (Hi) the quinone moiety on the same pyrrolo[l,2-ajindole nucleus. There 
is some confusiori about the nomenclature and numbering of the mitomycin structures. 
In the initial structure elucidation of the mitomycins, the name mitosane was proposed 
for structures of types A and B, the numbering system as illustrated in Figure 1. 
However, Chemical Abstracts uses the systematic numbering for 
azirino[2' ,3':3,4jpyrrolo[l,2-ajindole, where the aziridine nitrogen is the starting point. 
The trivial name for mitomycin C is 7 -arnino-9a-methoxymitosane, but it is known in 
Chemical Abstracts as 6-amino-l,l a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-
methoxy-5-methyl-azirino[2' ,3' ,3.4]pyrrolo[l,2-ajindole-4,7-dione carbamate. 
Figure 1 Mitomycin C numbering; Bottom left, Mitosane: bottom right, Chemical 
Abstracts 
o 
o 2 ·la 
3 
1.2 Mode of Action of Mitomycin C 
Mitomycin C 1 is the archetypical quinone bioreductive alkylating agent, whereby 
reductive activation is necessary before covalent binding to DNA (alkylation). It is only 
recently that the details of this activation process and the formation of a powerful 
electrophile that can alkylate DNA, have begun to emerge.· Therefore, the understanding 
of the reductive activation mechanism of MMC and related mitosenes, such as 
aziridinomitosenes 2 and the indolequinone E09 4, in which the quinone reduction 
sequentially activates eiectrophilic sites in the drug molecule (C-l and C-1O for MMC), 
has increased markedly in recent years due to the efforts of several research groups.6-8 
0 10 
OCONH2 ~N 0 OH 
Z 
OH 
0 0 
Z = NR aziridinomitosene 2 E094 
Z = CR2 cyclopropamitosene 3 
In 1964 Iyer and Szybalski achieved the first covalent binding to DNA with MMC in 
vitro.9 They perceived that mitomycins and porfiromycin behave as bifunctional 
alkylating agents upon chemical reduction with sodium dithionite, sodium borohydride, 
catalytic hydrogenation utilising 5% palladium on carbon, or enzymatic reduction using 
the cell lysate Sarcina lutea. A high content of guanine and cytosine favoured this 
cross-linking reaction. Iyer and co-workers discovered that in their natural oxidised 
form MMC and related compounds exhibit hardly any alkylating function when reacted 
with thiosulfate at acid or neutral pH or with y-(4-nitrobenzyl)pyridine, although they all 
contain the aziridine ring. The authors related this lack of reactivity to the partial 
withdrawal of electrons from the nitrogen into the quinone ring. 
From these observations, it was concluded that the Col aziridine and the C-IO carbamate 
groups were two masked alkylating functions which became 'allylic' under reductive 
activation conditions, affording the hydroquinone 5, as shown in Scheme 1. Consequent 
spontaneous elimination of the tertiary 9a-methoxy or hydroxyl group probably caused 
by the regaining of electrons by the nitrogen coupled with the high driving force for the 
formation of the aromatic indole system led to the subsequent bond breakage of the 
4 
aziridine ring, to afford the intennediate 7. This intennediate can then react further to 
give the mono-DNA adduct 8 or cross-linked DNA 9. 
It took many years to provide the experimental evidence to confirm this postulated 
mechanism. Moore amended this hypothesis by speculating that both displacements 
were SN 1 types taking place sequentially.tO 
Scheme 1 Iyer and Szybalski mechanism for the mode of action of MMC in vitro 
o 
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Iyer and Szybalski made the assumption that under reductive activation conditions 
the reactive species was the hydroquinone, but recently the hypothesis is that a 
semiquinone radical anion is the reactive species. 
5 
o 
Semiquinone radical anion 10 . 
In 1974 Tomasz et al. provided experimental evidence, supporting the theory that the 
initial binding to DNA is via a semiquinone radical anion 10.11 In earlier efforts to 
prepare extensively substituted DNA-mitomycin complexes Tomasz and also Iyer-
Szybalski only achieved incorporation of 1 unit of MMC per 150 nucIeotides with native 
DNA and 50 nucIeotides with denatured DNA. Tomasz hypothesized the inabilty to 
produce the substituted DNA-MMC complexes may be due to an imperfection in the 
activation mechanism originally developed by Iyer and Szybalski (1964).9 Iyer et al. 
previously noted that after the addition of the reducing agent MMC lost its ability to 
cross-link, thus indicating that not the fully reduced drug, but the semiquinone radical 
anion form, is the active species. 
Tomasz and co-workers tested this theory by adding the required (stoichiometric) 
amount of sodium dithionite in five portions at five minute intervals to a solution of 
polynucleotide and MMC in a sodium phosphate buffer (pH 7.5) under anaerobic 
conditions. This allowed temporary build up of the semiquinone radical anion before 
the reduction was completed. Using this technique, resulted in approximately 5 and 2-3 
binding ratios in native and denatured DNA respectively, which was a vast 
enhancement. During the course of the reaction, non reduced MMC was kept in excess 
maximising the concentration of the semiquinone at the expense of the hydroquinone. 
This is due to the disproportionation eqUilibrium being reversed by excess quinone and 
because the excess quinone competes effectively for the available reducing agent with 
the semiquinone. Although Tomasz and co-workers provided experimental evidence 
suggesting a semiquinone radical anion, the participation of'the hydroquinone and the 
existence of oxygen radicals cannot be ruled out in the reductive activation of MMC. 
In 1987 Tomasz and Nakanishi isolated and characterised a covalent cross-link adduct 
between MMC and DNA providing experimental evidence that MMC was a 
bisalkylating agent. 12 The cross-linked adduct was achieved by exposing MMC to 
6 
Microccocus luteus DNA in neutral buffer at room temperature under reductive 
conditions (sodium dithionite), the resulting complex was digested by a mixture of 
deoxyribonuclease I, snake venom diesterase and alkaline phosphatase. The digest was 
analysed by HPLC which allowed them to fully characterise both a mono C-l 11 and bis 
C-I and C-IO adduct 13. Isolated was the decarbamoyl adduct 12 which resulted from 
nucleophilic attack of water at the iminium intermediate, linked through C-l. All three 
are linked through the N-2 position of2'-deoxyguanosine.13-15 
o 
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During their experimental studies into the isolation and structure of a covalent cross-link 
adduct between MMC and DNA, Tomasz et al. discovered that the reducing conditions 
influence how MMC reacts with DNA. When the authors activated MMC by catalytic 
hydrogenation using hydrogen/platinum oxide conditions, they obtained the C-I mono 
adduct 11 as the major component and the minor components being the IO-decarbamoyl 
adduct 12, and a bifunctional adduct 13.· Alternatively, when sodium dithionite was 
used to activate MMC, no mono adduct was isolated, instead the predominant adducts 
were 12 and 13. More surprisingly, when poly (dG-dC) was treated with MMC 
7 
activated with sodium dithionite the bifunctional adduct 13 was the sole product of 
alkylation. 
In an attempt to rationalise these observations in the binding of MMC to DNA the 
authors suggest that the activated semiquinone radical anion 21 can react further by two 
pathways. The first pathway results in quenching of 21 via electron transfer to unreacted 
MMC resulting in a C-l cross-link/quinone. This reaction is thermodynamically 
favourable due to difference in reduction potentials between mitosenes and mitosanes 
(MMC). Therefore, C-l cross-link/quinone is the favourable pathway. However in the 
absence of MMC activated mitosene, 21 undergoes a retro Michael-type elimination of 
carbamate to produce an iminium species, which when attacked by the appropriate 
nucleophiIe forms a ClIClO reduced cross-link. Therefore, due to the rapid kinetics of 
MMC reduction by sodium dithionite, the second pathway, is presumably operative in 
alkylation reactions. Thus, efficient bifunctional DNA alkylation in sodium dithionite 
occurs because the MMC-reducing reaction in this case is much faster than in 
hydrogen/platinum oxide. 
Tomasz et al. also predicted that 02 inhibits the formation of the bis-adduct due to its 
activation of the active intermediate 10.12 This may be attributed to the greater toxicity 
of MMC under hypoxic conditions for example, to cells in solid tumours. In the 
presence of oxygen, the active form of MMC may be reoxidised to the quinone under 
concomitant formation of superoxide anion radicals (02··),16 This process is generally 
known as redox cycling. The 02-' radicals can dismutate either spontaneously or 
enzymatically to form hydrogen peroxide. In the presence of ferrous ions (Fe2+), 
hydrogen peroxide can be converted into hydroxyl radicals. These hydroxyl radicals are 
capable of damaging DNA, proteins and cell membranes. However, in the absence of 
oxygen, reoxidation of activated MMC occurs to a lesser extent and so relatively more 
of the alkylating agent will bind to DNA. In vivo a significant difference between 
normal tissue and solid tumours is the presence of hypoxic cells, located in poorly 
vascularised regions of the tumour. 17 The existence of hypoxic cells in solid tumours is 
an obstacle to effective cancer treatment. Residual malignant cells, protected from 
radiotherapy by hypoxia, may be capable of proliferating and causing the tumour to 
recur. Hence, the need to develop bioreductive alkylating agents which exploit the 
metabolic characteristics unique to cells in hypoxia, causing death of solid tumour cells. 
Since the isolation of a covalent cross-link adduct between MMC and DNA, research 
into the characteristics of the cross-link has increased markedly. In 1993 Hopkins and 
8 
I 
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co-workers demonstrated that DNA interstrand cross-linking reactions are not limited to 
MMC, but can be extended to pyrrole-derived bifunctional electrophiles, thus providing 
evidence for a common target site in DNA.18,19 They suggested that MMC, 
pyrrolizidine alkaloids and simple bifunctional pyrroles share a common bifunctional 
electrophilic substructure, and subsequently preferentially cross-link a common target in 
DNA, the exocyclic amino groups of deoxyguanosine residues at the duplex sequence 
S'-d(CG). 
In 1987 scientists at Fujisawa Pharmaceutical Co. isolated and characterised a family of 
antitumour agents similar in structure to the mitomycins. The initial reports described 
FR900482 14.20 Other members of this family include FR66972 16, a dihydro 
derivative of FR900482 isolated from the same fermentation broth and FK973 15, a 
synthetic triacetate ofFR900482.21•22 
HO 
OHC 
R = H FR900482 14 FR6697916 
R = COCH3 FK973 15 
In 1994 Hopkins et al. reported the DNA-DNA interstrand cross-linking reactions of 
FR900482 and FR66979 despite the lack of the pyrrole functional group as seen in 
reductively activated MMC. Fukuyama and Goto recognised that reductive scission of 
the N-O bond of FR900482 would in principle permit formation of the required pyrrole, 
Scheme 2.23 A related mechanism in which an attacking nUcleophile at C-S cleaves the 
key N-O bond by an SN2 reaction was proposed by Danishefsky and McClure.24 
Finally, Williams and Rajski have noted that FR900482 at approximately millimolar 
concentrations possess DNA interstrand cross-linking activity in the absence of added 
reductant or nucleophiles, and they suggested that the analogy to the mitomycins might 
not pertain i.e. that a mitosene analog might not be involved in this reaction.25 
9 
\' , 
.! 
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On the basis of these studies and the efforts of several other research groups, a proposed 
mechanism of action of MMC, in vivo has been suggested, illustrated in Scheme 3. 
The initial step is a single electron reduction of MMC to the semiquinone radical anion 
10. The radical anion 10 then readily loses methanol. The activated mitosene 
semiquinone formed 19 is now rendered electrophilic both at C-I and C-lO by opening 
of the aziridine ring which is assisted by the radical anion , and by elimination of the 
carbamate group assisted by the indole nitrogen, respectively. However, the first 
alkylation of DNA is thought to occur at C-l. Evidence for this comes from the 
isolation, after oxidation, of a mono DNA adduct 8. However since it is still a radical it 
can readily lose the carbamoyloxy substituent to afford an iminium compound 22 which 
can cross link to give a bis C-l/C-IO DNA adduct 9. In both the opening ofthe aziridine 
ring and elimination of the carbamate group, the products formed are attacked by 
nucIeophiles, apparently by an SN I type mechanism. 
10 
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1.3 Chemical Reduction 
It is generally accepted that MMC must be activated by reduction before alkylation can 
occur. Reductive activation can be brought about in a variety of ways, and as previously 
discussed, chemical reduction has been performed using sodium borohydride, sodium 
dithionite and catalytically using hydrogen over platinum oxide.26,27 MMC has been 
activated electrochemically by reduction on a mercury or platinum electrode.27 ,28 
Finally, MMC can be activated enzymatically. At least six different enzymes have been 
shown to be capable of reductively activating MMC, e.g. NADH cytochrome h5 
reductase, NADPH cytochrome P450 reductase, xanthine dehydrogenase, xanthine 
oxidase, carbonyl reductase and DT-diaphorase,30-35 
Several chemical methods have been used in the reductive activation of 
MMC.26,27,36,37,38 Initial studies were undertaken to gain information on the mutual 
binding sites between MMC and DNA. Szybalski & Iyer introduced sodium dithionite 
as an efficient reducing agent for in vitro studies and illustrated that reduced MMC can 
react in the presence of DNA by monofunctional and bifunctional alkylation.9 This has 
emerged as the method of choice for generating high yields of MMC-DNA adducts. 
More recently, Kohn et al. examined the use of sodium dithionite for the reductive 
activation of MMC in the absence of DNA and discovered contrasting results with an 
increase in the number of MMC products,36,37 This was attributed to HSOr. a 
byproduct in the reductive activation process and a contaminant in commercial sodium 
dithionite. Previously Hornemann et al. observed that sodium dithionite reduction of 
aqueous solutions of MMC at O'C followed by quenching by oxygen furnished 7-
aminomitosane-9a-sulfonate 24,38 
o 
Where X = OCH3 1 
X=S03- 24 
Kohn et al. utilised two procedures, noting significant differences between product 
profiles for the incremental addition of sodium dithionite versus a protocol in which the 
12 
equivalent amount of sodium dithionite was added in a single administration. These 
differences include higher amounts of C-l electrophilic versus C-l nucleophilic products 
in the single administration and an increase in the number of C-l sulfonato adducts from 
the nucleophilic product pool of the single technique. The authors observed greater 
amounts of C-I/C-lO mitosene adducts using the incremental protocol. Finally, on the 
basis of their studies The authors, proposed a mechanism for the sodium dithionite 
mediated MMC reductive process as shown in Scheme 4. 
Scheme 4 illustrates the reaction of the iminium species 25 with HS03- in a reversible 
process to give 26. The authors demonstrated that 24 is more efficiently converted to 
mitosene products than 1 at near neutral pH values. This can be attributed to the 
necessity of acid for the removal of the C-9a methoxy group in MMC and the enhanced 
leaving group ability of the sulfonate group over methoxide ion. Kohn supported this 
theory by demonstrating the relative reactivity of 5 versus 26 increased over 20-fold in 
reducing the pH from 7.4 to 5.5. 
13 
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• 
o 1 OH 5 
. 
NH • NH Me Me 
OH 26 OH 25 
[Red] It [Ox] 
o OCONH2 
OH 
j 
o 24 OH 6 
J 
14 
1.4 Enzymology 
Reductive activation of MMC leads to ring opening of the aziridine ring and elimination 
of the carbamate group leading to DNA adduct formation. The most important of these 
DNA adducts is considered to be the DNA interstrand cross-link, which would render 
the cell unable to replicate, subsequently resulting in cell death. 
Various ways of reduction can be used for activation of MMC. As described, MMC can 
be activated chemically, electrochemicaIIy or cataIytically.26-29 However, in vivo, 
MMC is reductiv~ly activated by severai redu~ing enzymes, e.g; xanthine 
dehydrogenase, NADPH cytochrome P450 reductase, NADH cytochrome c reductase, 
NADH cytochrome b5 reductase, and DT-diaphorase. Also xanthine oxidase, a· 
. degradation product of xanthine dehydrogenase, has been used frequently for in vitro 
activation ofbioreductive alkylating drugs.30-35 . 
These reducing enzymes activate MMC via one electron reduction generating the 
semiquinone radical anion. However, DT -diaphorase reductively activates MMC via a 
two electron process yielding the hydroquinone.35 In 1984 Pan et al. investigated the 
reductive activation of MMC catalysed by purified microsomal NADPH-cytochrome P-
450 reductase and bovine milk xanthine oxidase.32 MMC was dissolved in DMSO and 
added to the reaction mixture of 0.1 M phosphate buffer at pH 7.8 (xanthine oxidase) 
and pH 7.4 (NADPH-cytochrome P-450 reductase). The metabolites were isolated by 
reversed phase HPLC, as shown in Scheme 5 
The authors suggested that one electron reduction activates MMC shown by the fact that 
NADPH-cytochrome P-450reductase and xanthine oxidase favour one electron transfer. 
to suitable receptors. MMC thus receives one electron to form a semiquinone radical 
anion which then undergoes subsequent conversion to metabolites. Pan et al. obtained . 
EPR (Electron Paramagnetic Resonance) evidence which also confirmed the concept. 
15 
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Where: R = OH; cis 28 and trans 2,7-Diamino-1-hydroxymitosene 29 
R = OP(O)(OHh; cis 30 and trans 2,7-Diaminomitosene-1-phosphate 31 
In 1986 Tomasz et al. studied the formation of a covalent complex with calf thymus 
DNA,39 Reductive activation of MMC, under anaerobic conditions, in the presence of 
either NADPH-cytochrome P-450 reductaselNADPH, xanthine oxidaselNADH, or via 
hydrogenation resulted in the formation of a C-1 mono adduct. More recently, 
Maliepaard et al. presented extensive investigations in vitro reductive activation of 
several mitosenes. These are structurally related to MMC and related mitosenes, such as 
aziridinomitosenes and E09. The group reductively activated the mitosenes by purified 
reducing enzyme xanthine oxidase, which is mainly a one electron reducing enzyme 
when using NADH as a cofactor .. 
MaIiepaard et al. concluded that xanthine oxidase-mediated activation of mitosenes 
results in formation of DNA cross-linked species.40 However, the cross-links are 
dependent on several other factors, e.g. the presence of oxygen, pH. Therefore, these 
results implicate that the relative importance of certain reducing enzymes for antitumour 
activity of mitosenes and related bioreductive alkylating agents (MMC) should be 
judged for each compound separately. 
In 1958 Emster & N avazio published the first report highlighting the discovery of DT-
diaphorase (DID).41 They described the activity of the two electron reducing enzyme 
16 
in the soluble fraction of rat liver homogenates, which catalysed the oxidation of NADH 
and NADPH with equal facility. Subsequently, Emster and co-workers partially 
purified and characterised DID. However, since the discovery in 1958, the role ofDTD 
in the reductive activation of MMC has been the subject of much controversy. Early 
studies by SatoreIli et al. relied on the use of dicoumarol as a specific inhibitor of 
DTD.42,43 The authors, discovered that dicoumarol inhibits the cytotoxicity of MMC in 
EMT-6 mouse mammary tumour cells, which suggest a role for DID in the bioreductive 
activation of this drug. This data indirectly implicated a role for DTD in the reductive 
activation of MMC. 
Ross et al. implicated DT -diaphorase (DID) involvement in the reductive activation of 
MMC under aerobic conditions.35 They observed an association between elevated DTD 
levels in human colon carcinoma cells, human fibroblasts and aerobic MMC activity .44 
The data supported a role for DTD in the reductive activation of MMC. However, the 
authors discovered MMC was not acting as a substrate for purified DTD isolated from 
either human kidney or rat liver at pH 7.8, but found that reductive activation by either 
rat hepatic or human kidney DTD was pH-dependent. At pH 7.8, two-electron reduction 
of MMC by DTD leads to inhibition of the enzyme. 2,7-Diaminomitosene was the 
major metabolite detected during activation of MMC by DID at pH values between 5.8-
7.0, under either aerobic or anaerobic conditions. 
In 1992 Ross et al. studied the reductive activation of MMC in a cell free system, in 
order to confirm the role of individual reducing enzymes in the process.35 ,45 
Glutathione conjugates and also binding to DNA with interstrand cross-linking were 
'observed during DID-mediated activation as shown in Scheme 6. The major metabolite, 
2,7-diaminomitosene 27 was prepared from MMC 1 either enzymatically using DTD at 
pH 5.8 or via sodium borohydride mediated reduction of MMC. Enzymatic preparation 
was performed by the addition of 110 J.1L of purified DTD (3.5 mgl mL) to 5 mg (15 
J.1mol) ofMMC and 21 mg (30 J.1mol) ofNADH in 10 mL of 0.1 M potassium phosphate 
buffer (pH 5.8) under aerobic conditions. The reaction mixture was stirred at 22 'C for 
4-6 h. The metabolite 2,7-diaminomitosene was then isolated by HPLC. Preparation of 
the glutathione conjugate was performed by sodium borohydride (10 mM) mediated 
reduction of MMC (0.1 mM) under aerobic conditions in potassium phosphate buffer, 
(100 mM), pH 5.8 (100 mL), containing GSH(l mM) and the metabolite isolated by 
HPLC. 
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Since DTD is a two-electron reductase, reductive activation occurs via the 
hydroquinone.46 However, this does not rule out the participation of radicals following 
enzymatic reduction even though Ross and co-workers failed to observe any oxygen 
uptake during DTD-mediated activation of MMC under aerobic conditions. In 1986, 
Peterson and Fisher illustrated the ambivalent behaviour of the quinone methide of 
MMC, which at pH 7.8 can function as an electrophiIe leading to enzyme alkylation and 
inhibition.47 At lower pH values the quinone rriethide is covalently trapped by a proton 
leading to 2,7-diaminomitosene formation and maintenance of enzyme integrity. Ross 
et al. discovered increasing amounts of DNA cross-linking were observed during DTD-
mediated reductive activation of MMC, as the pH was lowered from 7.8 to 5.8. This 
mechanism was not consistent with formation of the major metabolite 2,7-
diaminomitosene, since Iow pH values would be expected to favour protonation of the 
quinone methide to form the non cross-linking 2,7-diaminomitosene. In an attempt to 
rationalise these observations, the authors, suggest that the precursor to DNA cross-
linking could be the protonated leucomitomycin C 32 or the leucoaziridinomitosene 33. 
The pKa of the aziridine ring in leucomitomycin C has been reported to be 5.1, which 
would allow significant protonation at pH 5.8. 
The authors did not observe any differences under aerobic or anaerobic conditions 
suggesting that the mechanism for reductive activation of MMC should be the same in 
each case. They supported this theory with the observation that little difference occurs 
in glutathione conjugate formation. Again, the authors illustrated the pH-dependence in 
the reductive activation of MMC confirming earlier evidence that metabolism and 
bioactivation increases as the pH is decreased from pH 7.8 to 5.8. Finally, in 1993 Ross 
et al. demonstrated that the reductive activation process of MMC by DTD results 
predominantly in monoalkylation of DNA at the guanine N-7 position, within 5'-GG-3' 
and S' -GTC-3' sequences.48 The preferential sequence for DNA interstrand cross-
linking was also determined using singly end-labelled oligonucleotide duplexes, 
, 
isolating cross-linking of DNA at 5'-CG-3'sequences. Overall, the authors postulate 
that attempts to modulate pH in combination with MMC treatment could be a viable 
approach for the therapy of tumours high in DTD activity such as certain human colon 
and non-small-cell lung cancers.49,50 
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As described, the use of reductants (enzymatic, chemical and electrochemical) 
demonstrate that MMC reductive activation leads first to the formation of C-I adducts. 
However, the C-I product profile is dependant on pH. In the absence of DNA, under 
slightly acidic conditions, the electrophilic product 2,7-diaminomitosene 27 dominated 
whereas in moderate base, trans - 29 and cis-l-hydroxy-2,7-diaminomitosene 28 were 
generated in high yields. 
In 1993 Kohn et al. reported that the proton transfer process of MMC to quinone 
methide to 2,7-diaminomitosene is the major pathway for reductively activated MMC at 
all operational pH values (pH 5.5-8.5) in the absence of external nucleophiles. The 
authors proposed the formation of 28 and 29 were attributed to the hydrolysis of the 7-
aminoaziridinomitosene 35.51 
1.5 Cyclopropylcarhinyl Radicals 
Much research has gone into establishing the molecular basis for the antitumour action 
of MMC, and although the exact details are stilI the subject of some uncertainty, the 
generally accepted overall mechanism is shown in Scheme 3 
Our own work was designed to investigate the role of C-lO in alkylation processes by 
preparing compounds in which the electrophilicity at C-l is much reduced by 
substituting a cyclopropane for the aziridine ring.52,53 This led to the design of the 
cyclopropamitosene 3 system, which on reductive activation, by 1- or 2-electron 
processes, followed by elimination of the .carbamate, generates a powerful electrophile 
capable of alkylating suitable nucleophiles, illustrated in Scheme 7.54 
Ionic ring opening of the cyclopropane, analogous to that proposed for the natural 
aziridine is extremely unlikely, although results suggest that the cyclopropane ring is 
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necessary for the potent biological activity of cyclopropamitosenes.55 In vitro toxicity 
experiments under aerobic and anaerobic conditions were performed. Chinese hamster 
V79 cells were exposed to the cyclopropamitosenes and related mitosenes for 3 hours at 
37'C under these conditions. Toxicity was measured using the MTT assay and values of 
ICso, the concentration required to kill 50% of the cells, were determined. The results 
illustrate that the cyclopropamitosene 36 is clearly more potent than the dimethyl 
compound 38, with the cyclopentane 37 having intermediate potency. Under anaerobic 
conditions 36 is even more potent, by a factor of 25, indicating that oxygen inhibits 
activity, suggesting that initial I-electron processes (which are revers'ed by 02) are 
important in the reductive activation of the cyclopropilInitosene 36. 
o 
·MeO 
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o • 
MeoVS' OCONH2 
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The above results, indicating the' importance of the cyclopropane ring for antitumour 
activity and the involvement of I-electron reductive activation processes, strongly 
suggest that radical induced ring opening of the cyclopropane maybe responsible for the 
enhanced biological activity of CPMs. The resulting highly reactive radical would be 
capable of abstracting hydrogen from DNA, as indicated in Scheme 7, and hence causing 
damage, e.g. strand cleavage. 
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The rapid ring opening of cyclopropy1carbinyl radicals is one of the most studied radical 
processes, and the demonstration that single electron transfer to nitro- or to acyl-
cyclopropanes can initiate ring opening is highly relevant. 
• k = 108s-1 t • • • X~ 
X k= 10\-1 
46 47 
The rates involved have been accurately determined and used as a radical clock by 
Ingold and co-workers.56 'Radical clocks' can be used to 'time' competing processes 
and a variety of unimolecular radical rearrangements have been calibrated for clock 
purposes. The above cyclopropylcarbinyl radical ring opening is the archetypical fast 
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radical reaction with a rate constant at 25·C of 1 x 108s- l . The addition of radical 
stabilising groups (X) or the incorporation of cyclopropylcarbinyl radical into a more 
highly strained system results in rate accelerations over that of the parent that can 
amount to several orders of magnitude. 
In 1991 Ingold et al. reported that at 25·C polymethyl-sustituted cyciopropylcarbinyl 
radicals rearrange with rate constants of up to 4 x I 09s-l, and Newcombe et al. 
determined the bicyclo[2.1.0]pent-2-yl radical ring opens with a rate constant of 1.5 x 
109s-1 and phenyl-substituted cyciopropylcarbinyl radicals ring open with rates of 3-5 x 
1011s-I.57-59 More recently, Newcombe and Choi established rate constants for ring 
openings of the (trans-2-ethoxycarbonylcyciopropyl)methyl radical and the (trans-2-
tert-butoxycarbonylcyclopropyl)methyl radical determined by the PTOC-thiol method 
with PhSeH trapping. At 25·C, these radicals rearrange with rate constants of7 and 12 x 
1010s-1, respectively.60 
Pereyre et al. in 1979 showed that the methylcyciopropyl carbinyl radical trans- 49 was 
generated by treating the corresponding chloride or bromide with tributyltin hydride at 
25 and 45·C, and the regioselectivity of ring-opening being determined by GC analysis 
of the alkenes which were formed. 61 The intermediate radical 51 was also prepared 
from the corresponding acyclic bromide 50, Scheme 8. Hence, they established through 
studies of the equilibria involved that the manifold may be approached from either the 
homoallylic halide or the cyciopropyl derivative. 
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The authors demonstrated that the ring-opening was regioselective in favour of the 
primary alkyl radical 51 but that, when the concentration of tin hydride was low, the 
acyclic radicals 51 and 52 can equilibrate through the cyclic radical 49, prior to 
hydrogen atom capture and pent-l-ene is formed as the major thermodynamic product. 
Also the radicals, cis- and trans- 49, 51 and 52 were generated photolytically at low 
temperature. Ring opening of 49 was irreversible and whereas cis- 49 gave principally 
the secondary alkyl radical 52, the trans- 49 compounds gave the primary alkyl radicals 
51. Pereyre et al. extended the reaction to the ring-opening of cis- and trans-2-
methylcyclobutyIcarbinylradicals SS, Scheme 9. 
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Ring opening was relatively slow and irreversible and both eis- and trans- 55 gave 
principally the secondary alkyl radical 57. 
The rapid ring opening of cyclopropylcarbinyl radicals has been extended to regio- and 
stereospecific construction of bicyclic systems. In 1992, Motherwell et al. generated a 
bicyclic system via a tandem free radical cycIopropylcarbinyl rearrangement-cycIisation 
strategy.62 This reaction was specifically targeted towards regiospecific generation of 
spirocyclic quaternary carbon centres. Thus, construction of the spiro[ 4.5]decane 67 
was achieved via a suitable bicycIo[ 4.1.0] precursor 63, Scheme 10. 1,2 Addition of 4-
lithio-I-trimethylsilylbut-I-yne to the enol ether of dirnedone 60 gave, after acidic work 
up, enone 61 in 80% yield. Subsequent reaction with diisobutylalurninium hydride 
followed by hydroxyl directed Simmons-Smith cycIopropanation furnished the alcohol 
63. Finally, Motherwell achieved quantitative conversion to the thiocarbonylimidazole 
derivative thus establishing a suitable precursor for carbon centred radical generation. 
Slow addition of tri-n-butyltin hydride to a refluxing solution of 64 using 
azobisisobutyronitrile (AIBN) as initiator led to their desired spirocyclic system 67. 
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(i) 4-lithio-l-trimethylsilylbut-l-yne, pentane, 1HF, (ii) H30+, (iii) DIBAL, toluene, (iv) Zn.Ag, CH2CI2, 
(v) thiocarbonyldiimidazole, CH2CI2, (vi) BU3SnH, AIBN, benzene. 
Clive et al. utilised a hydroxyl directed Sjrnmons-Smith cyc1opropanation to achieve a 
general method for the attachment of alkyl and also substituted alkyl groups to existing 
cyclic structures.63,64 The route also enables the use of stereo and regiocontrol in the 
preparation of the alkyl-substituted cyc1oalkenes, Scheme 11. 
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The authors also examined the use of the pheny Iseleno group as a low temperature 
radical trigger for cyc1opropyl ring opening of variously substituted bicyclic derivatives, 
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Table 1 
Substrate (0.1-0.2 M) , 
SePh 
6= :.' ·n CU2Et ~ 
'SePh 
75 
SePh fr: 
'~ 
77 
SePh 
MeO 
79 
SePh 
81 
Conditions 
Ph3SnH, AIBN, 
benzene, reflux Ih 
Ph3SnH, sunlamp, 
Pyrex, toluene, 
-20 to -lO·C, 2.5 h 
nBu3SnH, sunlamp, 
Pyrex, hexane, 
O·C, 2.5 h 
Pyrex, hexane, 
lO-30·C, 2.5 h 
Product 
UvCU2B 
76 
~CHC\2 
"'~ 
78 
{'>;Z, 
H 
80 
82 OSiPh2Bu 
The ~ddition of arenesulfonyl radicals to vinylcyc1opropanes has also been studied by 
Motherwell and coworkers as a novel route to 1,5-difunctionalised derivatives.65 The 
authors used p-toluenesulfonyl iodide in a thermal reaction for the preparation of 
substituted l-iodo-5-paratoluene sulfonyl pent-3-enes under mild conditions. 
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More recently the necessity for processes which lead to concomitant incorporation or 
retention of useful functionality for further manipulation has increased. The case of 
radical ring opening reactions of cyclopropyl ketones has been studied by Motherwell 
and co-workers.66 The ring opening is mediated by samarium (IT) iodide acting as a 
single electron reducing agent, generating useful metal enones. 
The authors recognised the synthetic potential of intermediate 85 which results from 
stereochemical controlled ring opening of the exocyclic cyclopropyl carbon-carbon bond 
in a bicyclic system, Scheme 12. The generation of the new carbon-centred radical 
offers possibilities for either simple hydrogen atom abstraction from solvent, or 
intramolecular carbon-carbon bond formation by introduction of a pendant chain 
possessing an unsaturated radicophilic acceptor. The authors report the use of samarium 
(IT) iodideffHFIDMPU as an effective reagent for the formation of intermediate 85. 
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As the process involved results in the formation of a samarium enolate, the authors 
decided to examine whether such a species could be effectively quenched or used further 
in situ carbon-carbon bond formation. They discovered that direct formation of both 
enolic derivatives and carbon alkylated products is possible under the reaction 
conditions, with the overall outcome suggesting that both tri- and tetrasubstituted 
samarium enolates can be usefully employed. 
In 1990 Murphy et al. went on to demonstrate radical-induced carbon-nitrogen bond -"\ 
cleavage of a series of fused aziridines to afford allylic amines or pyrrolidines.67 They 
synthesised the aziridine 87 from isophorol 86 using the aziridination procedure used by 
Atkinson, Scheme 13. Reaction of 87 with thiocarbonyldiimidazole in dichloromethane 
generated the imidazolide 88 in situ. They then reacted this with tri-n-butyltin hydride 
in THF and a catalytic amount of AmN whiCh afforded the allylic amine 89. The 
authors saw no evidence for carbon-carbon bong cleavage of the aziridine. 
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(i) QNH2, Pb(OAc)4, CH2CI2, room temperature, (ii) thiocarbonyldiimidazole (2 equivalents), CH2Cl2, 
heat, (iii) BU3SnH, AIBN, THF, heat. 
More recently, Schwan et al. reported the rapid ring opening of 2-aziridinylmethyl 
radicals to produce aminyl radicals by carbon-nitrogen cleavage and also, a-aminyl 
carbon radicals via carbon-carbon bond homolysis, Scheme 14.68 The authors prepared 
a series of radical precursors, 2-aziridinylmethyl seIenides, 2-aziridinylmethyl xanthates 
and in one case 2-aziridinyl sulfide from 2-carboalkoxy aziridines. They discovered 
when the nitrogen has a phenyl or benzyl group attached the products are obtained via 
carbon-nitrogen bond homolysis as in the case of Murphy's compounds. However, 
when the functionality at the carbon three position is a phenyl group then that group 
increases the rate of carbon-carbon homolysis to a level competitive with carbon-
nitrogen homolysis. 
30 
Scheme 14 
BU3SnH,AIBN 
, 
benzene, reflux 
1n Summary: Bioreductive activation provides a novel, exploitable pathway for the 
design and development of new anticancer agents, targeting the hypoxic fractions of 
solid tumours. Single electron reduction leads to the formation of C-l mono and 
ClIClO bis DNA adducts. This process proceeds via a semiquinone radical anion as 
opposed to the hydroquinone first postulated by Iyer in 1964.9 However, DT-diaphorase 
reductively activates bioreductive agents via a two electron process yielding the 
hydroquinone. Also, in the presence of oxygen, the toxicity of the semiquinone radical 
anion is limited, by redox cycling and oxygen radical generation which is relatively non 
toxic. Therefore, cyctotoxic events are induced with greater efficiency in the order of 
semiquinone> hydroquinone > oxygen radicals.. Furthermore, various reductases have 
been implicated in the bioreductive activation creating an enzyme-directed approach to 
drug development. 
Finally, the rapid ring opening of cyclopropylcarbinyl radicals is highly relevant in 
understanding the single electron transfer which can initiate ring opening of the 
cyclopropane of cyclopropamitosenes and related mitosenes . 
• 
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Chapter Two 
Cyclopropamitosenes: Novel Bioreductive Anticancer Agents 
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2.11ntroduction 
As described in Chapter I, MMC is a clinically useful antitumour antibiotic, showing 
remarkable antitumour activities against several tumour lines, especially solid tumours 
e.g. stomach and lung cancers,3,4 Unfortunately, this drug has strong side effects such 
as myelosuppression and gastrointestinal toxicities . .To c'ontrol its toxicities, studies for 
the schedule of dosage were developed and these studies showed MMC to be a practical 
antitumour agent. Simultaneously, in order to find a more effective yet less toxic 
derivative, several research groups have been modifying the mitomycins. However, 
despite the efforts of different research groups only one analogue, E09, has proved 
superior to MMC. 
Our first objective was to design and synthesise novel MMC analogues, which may 
enhance the antitumour activity, but decrease cumulative myelosuppression. As 
described in Chapter I, our own work in the field was designed to investigate the role of 
the C-IO in alkylation processes by preparing compounds in which the electrophilicity at 
C-I is much reduced by substituting a cyclopropane for the aziridine ring. The resulting 
cyclopropamitosene could on reductive activation, by either 1- or 2- electron processes, 
followed by elimination of the carbamate, generate a powerful electrophile capable of 
alkylating DNA at C-lO. 
Several approaches have been attempted in the synthesis of the pyrrolo[I,2-alindole 
nucleus. In 1965 Weiss et al. published the first synthesis of 7-methoxymitosene.69 
Starting with 2,5-xylenol 94, this was converted to phenylpyruvic acid via a sequence, 
nitration para to the phenol, then methylation of the hydroxyl group, followed by 
condensation with ethyl oxalate and ester hydrolysis to give 95, as shown in Scheme 15.· 
Reductive cyclisation of 95 then gave indole acid 96 via a Reissert type synthesis. Next, 
the methyl ester of 96 was subjected to a process involving base catalysed 1,4-addition 
to methyl acrylate followed by Dieckmann ring closure. Decarboxymethylation 
followed by Wolff-Kishner reduction afforded the required pyrrolo[I,2-alindole nucleus 
99. Weisset at. completed the synthesis by formylation, oxidation to the quinone and 
elaboration of the side chain. The methodology established by Weiss and co-workers is 
extremely logical and future workers frequently utilised various parts of the synthetic 
route. 
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In 1983 Rapoport et al. proposed an alternative route to the pyrrolo[1,2-ajindole nucleus 
using palladium catalysis, Scheme 16.70 
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More recently, Michael et al. optimised reaction conditions whilst synthesising the 
pyrrolo[1,2-ajindoles by means of an intramolecular Heck reaction on N-(2-bromoaryl) 
vinylogous urethanes and related enaminones, Scheme 17.71 The authors then oxidised 
the tricyclic product of the Heck reaction to the quinone. 
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Edstrom et al. developed a route illustrating the viability of 4-oxotetrahydroindoles 111 
as precursors to pyrrolo[ 1 ,2~a jindoles. 72 Oxidation of the simple hexahydro-8-oxo-1H-
pyrrolo[l,2-ajindoles 111, Scheme 18, by 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) 
gives either the phenolic product 113 or C-1 substituted ethers 115. Thus, two 
mechanistic pathways are possible in the oxidation leading to the carbocationic 
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intermediates 112 and 114 via hydride abstraction at the C-5 or C-l positions, 
respectively. 
Scheme 18 
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The authors treated the C-9 substitued 8-oxopyrrolo[1,2-aJindole system 116 with DDQ 
affording a good yield of the 8-hydroxy-2,3-dihydro-1H-pyrrolo[I,2-aJindole 117 
(82%). 
DDQ (3.1 eq) 
.. 
116 117 
. In 1985 Verboom and Reinhoudt reacted aniline 118 with an acid chloride to give a 
Madelung type indole precursor 119, Scheme 19.73,74 Reaction of 119 with potassium t-
butoxide in THF then forms the five membered lactam derived from attack at the amide, 
which spontaneously gives pyrrolo[I,2-aJindole 120 in 85% yield by attack of the alpha 
cyano anion at the lactam carbonyl. Thus the pyrrolo[I,2-aJindole nucleus is set up in 
one efficient process. 
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More recently, Zorgdrager and Gen provided a new route for the construction of the· 
pyrrolo[1,2-a]indole nucleus using 2-(diphenylphosphinyl)pyrrolidine and 2-methoxy-3-
methyl-l A-benzoquinone as starting materials.75 Oxidative addition of 121 to 122 gave 
the substituted pyrrolidinylbenzoquinone 123. Subsequent protection of the quinone and 
addition of an aldehyde to the anion of this compound, followed by treatment with a 
catalytic amount of para-toluenesulfonic acid in toluene afforded pyrrolidine ketone 
125. In situ addition of an equivalent amount of para-toluenesulfonic acid induced 
conversion of the amino-ketone into the benzylated pyrrolo[I,2-a]indole 126. 
Debenzylation, by hydrogenolysis using PdlC followed by air oxidation gave the 
pyrrolo[l,2-a]indole quinone 127, Scheme 20. 
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In 1965 Weiss tried novel approaches to introduction of the aziridine function but, all 
attempts proved to be fruitless.76 In 1968 Hirata et al. incorporated the aziridine ring by 
introducing functionality on the C-ring of the pyrrolo[I,2-a]indole nucleus, as shown in 
Scheme 21.77 Cyclisation of the iodo-amine 130 or its hydrochloride with sodium 
methoxide in boiling methanol afforded a crystalline mixture which was treated with 
methyl chloroformate and triethylamine to give 131. 
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Frank's group reported another interesting approach for the incorporation of an aziridine 
by effecting an intermolecular 1,3-dipolar cycloaddition, followed by photolysis, 
Scheme 22. 78 
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Alternatively, a route was described by Cory in 1983 which was effectively a one step· 
. bicycloannulation forming the pyrrolo[1,2-aJindole 135 incorporating an aziridine ring, 
in a single operation.79 The authors formed the sodium salt of the imine in THF at O'C, 
and in the presence of methyl 2-bromopropenoate, they obtained the aziridine directly, 
in 60% yield. It was presumed that 133 formed initially, which then closed by attack of 
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the carbanion on the imine double bond to give 134. Subsequent ring closure to the 
aziridine could then be effected via displacement of the bromine, Scheme 23. However 
the route as published is limited to N-phenyl aziridine. 
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Finally, the extensive research described above, has contributed in part, to the total 
synthesis of a mitomycin, first reported in 1977 by Kishi' s group at Harvard 
University.80,81 They describe the synthesis of MMF and porfiromycin and also a route 
to MMC 1 and MMA. In 1987 Fukuyama published a total synthesis of MMA and 
MMC and so two entirely different synthetic routes to the mitomycins were available, 
giving access to all of the A-type mitomycin family.82 Also, extensive research has 
been carried out into the synthesis of MMH and MMK.83 Recently, Danishefsky 
published the total synthesis of FR900482 14, a novel compound related to the 
mitomycins by structure and mechanism of action.84 
Hence, our own work in the design and synthesis of cyclopropapyrrolo[I,2-a]indoles 
was based on Padwa's research into the intramolecular 1,3-dipolar cycloaddition of a 
diazo compound to an alkene double bond.85 In 1989, Moody and Jones reported the 
initial studies on the synthesis of a ring system in which the electrophilicity at the C-I is 
much reduced, the previously unknown cycl0l'ropapyrrolo[l,2-a]indole.52,53,86 In this 
Chapter we report the details of the synthesis of cyclopropamitosenes 3, novel 
bioreductive anticancer agents. 
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2.2 Synthesis of 9.Hydroxymethyl.7.methoxy.1,2.dihydro.3H .1,2. 
cyclopropapyrrolo[1,2·ajindole·5,8.dione carbamate. 
o 10 
n 
Where X = OMe, Y = OCONH2, n = 1136 
X = OMe, Y = OCOOPh, n = 2 137 
The key intermediate is 4-benzyloxy-5-methoxyindole-2-carboxaldehyde 143, prepared. 
from Q.vanillin 138. The indole ring system was established by azidocinnamate 
decomposition, developed in the Hofmann Laboratory at Imperial College. a-Vanillin 
138 was chosen as the ideal starting material due to its commercial availability and 
relative cheapness. Thus, protection of the phenolic group of a-vanillin 138 to prevent 
the functional hydroxyl group from participating in any side reactions, during the course 
of the synthetic route, gave 2-benzyloxy-3-methoxybenzaldehyde 139 as a colourless 
solid (95%). The phenol was protected as the benzyl ether by treatment of a-vanillin 
138 with benzyl chloride in refluxing ethanol using potassium hydroxide as the base. 
OH OBn 
Me0'(jrCHO 1. KOH, EtOH Me0'(jrCHO 
'?' I 2. PhCH2Cl, reflux (15 h) '?' I 
:::,.... ---..:;..------- :::,.... 
95% 
138 139 
2-Benzyloxy-3-methoxybenzaldehyde 139 was then condensed with methyl azidoacetate 
using sodium methoxide as the base, to afford the azidocinnamate 140 in 72% yield, 
thermolysis of which in boiling xylene gave the indole-2-ester 141 (84%), Scheme 24. It 
was very important that this thermolysis reaction was carried out in dilute solution, as 
the reaction was considerably less clean when carried out in more concentrated solution. 
Finally, the indole-2-carboxylate 141. was converted into the desired indole-2-
carboxaldehyde 143 by reduction (94%) and reoxidation (66%). The indole-2-
carboxylate 141 was reduced to the corresponding alcohol 142 with lithium aluminium 
hydride in refluxing THF. The indole-2-methanol 142 was oxidised to the indole-2-
carboxaldehyde 143 using standard conditions, manganese (IV) oxide, which is specific 
for allylic and benzylic hydroxyl groups under mild conditions. The alcohol 142 was 
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stirred with a ten fold excess of manganese (IV) oxide in refluxing dichloromethane for 
15 hours furnishing indole-2-carboxaldehyde 143. 
Scheme 24 
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The construction of the tetracyclic cyclopropapyrrolo[I,2-a]indole ring system relies on 
the previously developed intramolecular cycloaddition reaction. Alkylation of the 
indole nitrogen 143, followed by reaction of the aldehyde with tosyl hydrazide gave the 
tosylhydrazone 145, decomposition of which gave the desired tetracycle 146 in 94% 
yield. The C-lD carbon was introduced by Vilsmeier-Haack formylation and the 0-
benzyl group was hydrogenolysed over PdlC in ethyl acetate in the presence of a small 
amount of dilute sulfuric acid. In the absence of acid, hydrogenolysis was considerably 
slower, and a certain amount of reductive c1eayage of the cyclopropane was observed. 
Oxidation of the phenol 148 with Fremy's salt gave the corresponding indolequinone 
149 (82%). Finally, elaboration of the C-I0 side chain by reduction of the formyl group 
in the quinone aldehyde 149 with sodium borohydride gave the quinone alcohol 150 as 
an orange solid (74%), treatment of which with phenyl chloroformate afforded the 
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phenyl carbonate 151 (92%). Finally the phenyl carbonate 151 was treated with 
ammonia yielding the required carbamate 136 (81%). The desired novel 
cyclopropamitosene urethane 136 was synthesised in 14 steps from the commercially 
available o-vanillin 138 in an overall yield of 18.2 %. Despite the extensive synthetic 
route it was possible to furnish hundreds of milligrams of the final urethane enabling its 
biological evaluation. 
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2.3 Synthesis of lO-Hydroxymethyl-8-methoxy-l,2,-dihydro-3,H4-H-l,2-
cyclopropapyrido[1,2-a]indole-6,8-dione carbamate 
x 
Where X = OMe, Y= OCOOPh 137 
From the outset of this project one of the main objectives was to design and synthesise 
novel MMC analogues, in order to' find less toxic derivatives but simultaneously 
enhance the potency. As described, our own work in the area was designed to 
investigate the' role of, the' C-IO. Hence, the synthesis of the parent 
cyc1opropapyrrolo[1,2-ajindole-5,8-dione carbamate 136. In order to investigate the 
mechanistic possibilities, and' to evaluate the biological activities of 
cyc1opropamitosenes, a range of compounds was required. Therefore, structurally 
modified analogues of the parent cyc1opropapyrrolo[1,2-ajindole-5,8-dione carbamate 
136 were synthesised. Initially, the homologue of 136 was prepared by introducing a 
carbon into the Coring of the tetracyclic cyc1opropapyrrolo[ 1 ,2-a jindole. 
This synthetic route was again started from o-vanillin 138 and followed the route to the 
key intermediate, 4-benzyloxy-5-methoxyindole-2-carboxaldehyde 143, Scheme 24. 
The key difference between the two synthetic routes was in the alkylation of the indole 
nitrogen. Treatment of the indole aldehyde 143 with sodium hydride in DMF, and then, 
quenching with 4-bromo-l-butene gave the alkylated indole nitrogen 152 in 35% yield. 
This yield was considerably worse than the corresponding analogous allyl compound 
144, which was obtained in 99%. Thus, addition of a catalytic amount of sodium iodide 
to the reaction mixture instigated an in situ Finkelstein reaction and in so doing 
improved the yield to 70%. ,The N-alkylated indole 152 was converted into the 
precursor 153 for the key intramolecular cyc1oaddition reaction by condensation with 
\ toluene-p-sulfonyl hydrazide in methanol at 40'C, in 89% yield. ' 
45 
-------_._------------------
OBn OBn 
MeO 1. NaH, DMF M 0 
~ 2. CH2=CH(CH2hBr e ~ CHO • CHO 
N 70% N I ~ 143 H 152 
TsNHNH2 
89% 
OBn 
MeO 
~ 
..-:NNHTs 
N 
153 ~ 
To effect the intramolecular cycloaddition, the tosylhydrazone 153 was converted into 
its sodium salt which was heated in boiling chlorobenzene to give the 
cyclopropapyrido[I,2-alindole homologue 154, in 76% yield. 
OBn OBn 
MeO 
..-:NNHTs 
MeO 1. NaH, THF 
2. d,PhCl 
76% 
153 
Thus the tetracyclic ring system of the cyclopropamitosene was established directly from 
an indole in excellent yield, and it remained only to introduce the side chain at C-9 and 
oxidise the benzene ring to the quinone level. 
In 1980 Padwa et al. predicted that tricyclic cyclopropanes were formed via pyrazolines, 
derived from a 1,3-dipolar concerted pericyclic addition of a diazoalkane to a C=C 
bond.85 The authors examined the thermolysis of the sodium salt of 155, which gave 
the cycloadduct 158 via the diazoalkene 156, Scheme 26. 
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The diazo moiety was generated by a variation of the Bamford-Stevens reaction, namely 
the thermolysis of the sodium salt of tosylhydrazones.87 In 1989, Moody and Jones 
applied the intramolecular cycloaddition to the synthesis of cyclopropapyrrolo[1,2-
ajindoles.52,53 They isolated the pyrazoline 161 by using tosylhydrazone 160 as the 
diazo precursor to generate the parent tetracyclic system 162, as shown in Scheme 27 . 
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Scheme 27 
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The tosylhydrazone 160 was converted into its sodium salt by reaction with sodium 
hydride in THF. The salt was collected by filtration, thermolysis of which in boiling 
benzene gave a 29% yield of pyrazoline 161. When the temperature was raised, the 
thermolysis of the pyrazoline was achieved in refluxing xylene and the desired 
cyclopropapyrrolo[I,2-a]indole was isolated in 89% yield. Moody and Jones 
investigated different diazo precursors, notably the imine 163 derived from N-amino-
2,3-diphenyl aziridine, for the formation of pyrazoline 164. Thus, condensation of 
allylic indole with amine in dry THF gave 164 in 52% yield, thermolysis of which in 
boiling benzene gave an increased yield (40%) ofpyrazoline 161.88 
The C-IO carbon was introduced by a variation of the Vilsmeier Haack reaction, which 
involves formylation of active aromatic rings (phenol and amine) and heterocycles using 
disubstituted formamides and phosphorus oxychloride.89 The cyclopropapyrido[1,2-
a]indole 154 behaves as a simple indole and so "it was possible to formylate successfully 
at the C-9 position. The tetracycle 154 was stirred with a mixture of DMF and 
phosphorus oxychloride and hydrolysed with an aqueous solution of sodium acetate to 
afford the C-9 formylated cyclopropapyrido[1,2-a]indole 165 in 57% yield. 
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Confinnation of the structure of was achieved using X-ray crystallography, as shown in 
Figure 2. 
OBn OBn 
MeO MeO 
.. 
57% 
The O-benzyl group should have been easily removed by hydrogenolysis over 
palladium-carbon (10%) to give the corresponding phenol 167 but proved to be 
extremely difficult. Previously, Q'Sullivan and Moody found hydrogenolysis of 147 
resulted in removal of the O-benzyl group and reductive cleavage of the cyclopropane 
166. 
Therefore, they modified the procedure by the introduction of a small amount of dilute 
sulfuric acid to the reaction mixture. Unfortunately this proved unsuccessful in 
debenzylation of the cyclopropapyrido[I,2-a]indole 165 and at this stage it was 
proposed that new reaction conditions were required. The O-benzyl group was 
hydrogenolysed over PdlC in ethanol under an atmosphere of hydrogen (60psi) for 12 h 
to afford the phenol 167 in 69% yield. 
OBn 
MeO H2/ Pd-C/ EtOH MeO 
.. 
60 psi (12 h) 69% 
OH 
The next step involved fonnation of the quinone moiety via oxidation ofthe pheno1.l67. 
Ortho and para diols are easily oxidised to ortho- and para-quinones, respectively. 
Literature precedent has shown that either or both groups can be replaced by NH2 
groups to give the same products, though for the preparation of ortho-quinones only OH 
groups are nonnally satisfactory.90 
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The reaction has been successfully carried out with other groups para to OH or NH2 e.g. 
halogen, OR, Me, t-Bu. Also several oxidising agents have been used such as acid 
dichromate, silver oxide, lead tetraacetate and atmospheric oxygen, to name a few. 
However, when there is only one OH or NH2 present, as· is the case for 
cyclopropapyrido[1,2-a]indole 167, a particularly effective reagent is dipotassium 
nitrosodisulfonate ( (KS03hN-O") more commonly known as Fremy's salt. 
OH 0 
CHO CHO 
Fremy's salt MeO 
• 
89% 
167 0 168 
The phenol 167 was oxidised with Fremy's salt in a mixture of water and acetone which 
was buffered with sodium dihydrogen phosphate to give the indolequinone 168 directly, 
isolated as an orange solid (89%.). The precise mechanism for the oxidation of phenols 
and aromatic amines to quinones is equivocal. Fremy's salt is a stable free radical, thus 
the sequence, as shown in Scheme 28, is a likely mechanism, for the formation of the 
quinone. Initially, (KS03hN-O" abstracts a hydrogen atom from the phenol 167 
generating a phenoxide radical which leads to radical 169. Radical 169 combines with 
the Fremy's salt to generate intermediate 170. The nitrogen-oxygen bond of (KS03hN-
OR is very labile and HN(S03Kh is eliminated, generating the desired tetracyclic 
quinone 168. 
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During the oxidation of the phenol 167, not only was the desired cyclopropapyrido[1,2-
a]indole-6,9-dione 168 formed but also the cyclopropane ring opened unexpectedly 
giving 172. Previously, compound 171 had not been isolated in the comparative 
oxidation of the cyclopropapyrrolo[1 ,2-a]indole 148 to the relevant quinone 149. 
o o CHO 
MeO MeO 
o 
172 
Unfortunately, the indolequino~e 168 and suspected ring opened product 172 were 
unable to be separated at this stage of the synt!J.etic route. Therefore, the mixture was 
reacted further with sodium borohydricte in methanol. The quinone aldehyde was 
initially reduced to the hydroquinone, accompanied by disappearance of the orange 
colour, which upon reoxidation by blowing air rapidly through the solution gave a red 
crystalline quinone alcohol. Purification of the resulting residue by column 
J 
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chromatography (ethyl acetate) isolated the quinone alcohols 173 and 174 in 36 and 
30% yields, respectively. 
MeO MeO 
168/172 
NaBH4, MeOH . 
• 
+ 
174 
The structure of 174 was proved by considering the 'H NMR, where noticeable 
differences occur between the spectra of 173 and 174. The spectrum for 174 product 
shows an intense signal at 1.14 ppm appearing as a doublet. This can be assigned to the 
methyl protons attached to the C-2 position, generated as a result of cyclopropane ring-
opening. 
13C NMR data illustrate a marked difference in chemical shifts between the two quinone 
alcohols. The characteristic cyclopropane chemical shifts, 12.47 (C-2), 9.80 (C-la) and 
8.43 (C-l) as seen in the quinone 173 are absent in compound 174. In the quinone 
alcohol 174 the methyl carbon appears at 21.20 ppm. C-l and C-2 are now further 
downfield at 29.97 and 26.30, respectively. All signals were assigned using the DEPT 
spectra. 
Other signals in the 'H NMR were assigned via the three dimensional contour plot of a 
COSY spectrum (COrrelated Spectroscop Y). Therefore, the possibility of an alternative 
reaction product 175 could be eliminated. Initially, the two C-l protons, as seen in the 
'H NMR spectrum appear further downfield (2.95 and 2.27 ppm) than the C-2 proton 
(2.03 ppm). This can be attributed to the deshielding effect of the C-l protons due to the 
indole ring. Further evidence appears in the coupling of the C-l protons e.g. the proton 
at 2.27 ppm appears as a double doublet. A specific coupling pattern which would not 
be seen in the alternative product 175. 
MeO 
o 175 
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lH-13C correlated spectra confirmed the assigned 13C signals, thus the NMR data of the 
unexpected product 174 is fully assigned. Finally, the mass spectra data support the 
structure of quinone alcohol 174. Compound 174 had a molecular weight of 275' to 
correspond with the observed mass ion of 275 (M+). 
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The rationale for the formation of 172 can be explained in the mechanism for the 
formation of the quinone 168. In this, the key step is the abstraction of the hydrogen 
atom from the phenol 167 generating an alkoxide radical 176 which can lead to 
cyclopropane ring opening, as shown in Scheme 29. The radical 178 then abstracts a 
hydrogen atom from another phenol 167 forming intermediate 179. The intermediate 
undergoes nucleophilic conjugate addition to form the enolate 180, protonation of which 
gives 181. Generation of the stable cyclopropapyrido[I,2-a]indole system eventually 
leads to the formation of the hydroquinone 182, which upon reo xi dation regenerates the 
quinone 172. 
As stated, the comparative ring opened pyrrolo[I,2-a]indole-5,8-dione 171 was not 
isolated. It appears that the isolation of a ring-opened product is dependent on the 
quality of the Fremy's salt used in the oxidation. In the oxidation of the 
cyclopropapyrido[I,2-a]indole 167 to the corresponding quinone aldehyde 168 poor 
quality Fremy's salt was used. Therefore, the phenoxide radical 176, as shown in 
Scheme 29 , had the opportunity to form radical 177 before reacting with a second 
Fremy's salt, as shown in the previous Scheme 28. As described in Chapter I, rapid ring 
opening of cyclopropylcarbinyl radicals is one of the most studied radical processes. 
Thus, the formation of radical 177, illustrated in Scheme 29 , would then lead to the 
rapid ring-opening of the cyclopropane. 
Hence the isolation of compound 174 provides some evidence for the feasibility of 
cyclopropane ring-opening under radical conditions. 
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Transfonnation of the quinone alcohol 173 into the desired final quinone urethane 183 
proved to be fruitless. It was possible however to obtain the phenyl carbonate 137 by 
treatment of the quinone alcohol 173 with phenyl chlorofonnate in THF containing a 
few drops of pyridine and under nitrogen for 2 hours. 
MeD PhDCDCl,py MeD 
75% 
Direct ammoniolysis with ammonia in dichloromethane at -78·C did not afford the 
desired urethane 183 but recovery of the starting phenyl carbonate 137. Alternative 
reaction conditions were attempted for the conversion of the phenyl carbonate 137 to the 
final quinone urethane 183. 
MeD MeD 
Ammoniolysis of the phenyl carbonate 137 in dichloromethane with either (i) ammonia 
gas at room temperature, or (ii) 0.88 ammonia solution, again only starting material was 
recovered. Alternatively the ammoniolysis was carried out in methanol with either (i) 
ammonia gas at -78·C, or (ii) ammonia gas at room temperature and finally (iii) 0.88 
ammonia solution. In a last attempt to get this extremely difficult reaction to give the 
final urethane 183 the phenyl carbonate 137 in methanol was refluxed with ammonia gas 
bubbling through the reaction mixture. Unfortunately, this did not afford the desired 
urethane 183 but resulted in baseline material. 
It was likely that the desired final urethane 183 was not isolated due to cyclopropane 
ring sterically hindering the carbonyl group of the phenyl carbonate 137, thus preventing 
attack by the ammonia and subsequent substitution. 
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Chapter Three 
Mechanistic Issues: The Role of the Cyclopropane Ring 
60 
3.1 Introduction 
Continuing the research into the design and synthesis of the cyclopropamitosenes, this 
chapter addresses the mechanistic issues involved, and in particular the role of the 
cyclopropane ring. One of the main objectives of the investigation was to study the 
reduction-initiated ring opening of the cyclopropane ring, thereby establishing its 
relevance to the potent bioreductive anticancer action of these novel analogues of MMC. 
As described in Chapter I, much research has gone into establishing the molecular basis 
for the antitumour action of MMC. Our own work led to the design of the 
cyclopropamitosene system which on reductive activation, by 1- or 2-electron processes, 
followed by elimination of the carbamate, generates a powerful electrophile capable of 
alkylating suitable nucleophiles, Scheme 7. 
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Ionic ring opening of the cyclopropane, analogous to that proposed for the natural 
aziridine is extremely unlikely, although results suggest that the cyclopropane ring is 
necessary for the potent biological activity of cyclopropamitosenes.55 In 1994, Moody 
et al. published the chemistry, electrochemistry and biological studies of a range of 
cyclopropamitosenes, pyrrolo[ 1 ,2-a ]indolequinones and 1 ,2-dimethylindolequinones.55 
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The authors, displaced the methoxy group in the indolequinones by various nitrogen 
nudeophiles (ammonia, 2-methoxyethylamine, aziridine, 2-methylaziridine, pyrrolidine) 
in 22-88% yield, extending the range of compounds . 
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Table 2 Substitution Reactions o/the Methoxyindolequinones 
substrate R R' X Eroduct 
36 CH20CONH2 H NH2 190 
36 CH20CONH2 H MeOCH2CH2NH 191 
36 CH20 CONH2 H pyrrolidinyl 192 
36 CH20CONH2 H aziridinyl 193 
184 CH20CONH2 H 2-methylaziridinyl 194 
184 CH20CONH2 Me pyrrolidinyl 195 
184 CH20CONH2 Me aziridinyl 196 
186 H H aziridinyl 197 
186 H H 2-methylaziridinyl 198 
37 CH20CONH2 aziridinyl 199 
37 CH20CONH2 2-methylaziridinyl 200 
188 H aziridinyl 201 
188 H 2-methylaziridinyl 202 
38 CH20CONH2 pyrrolidinyl 203 
38 CH20CONH2 aziridinyl 204 
38 CH20CONH2 2-methylaziridinyl 205 
189 H pyrrolidinyl 206 
189 H aziridinyl 207 
189 H 2-methylaziridinyl . 208 
The resulting amino substituted quinones, together with their methoxy precursors, were 
studied by cyclic voltammetry to determine their reduction potentials, which, in DMF 
solution, lie in the range -1.355 to -1.597V (vs. ferrocene). Also, in vitro toxicity 
experiments under aerobic and anaerobic conditions were performed. Reductive 
activation of the novel cyclopropamitosenes and related indolequinones can occur via a 
I-electron reduction, by enzymes such as cytochrome P450 reductase. This involves a 
semiquinone radical anion, in a process that is potentially reversible by oxygen. Also, 
the cyclopropamitosime can undergo a 2-electron reduction to give a hydroquinone, 
generally carried out by the obligate 2-electron reductase DT -diaphorase, in a process 
that is oxygen independent. The subsequent level of the alkylating species is then 
governed by any disproportionation reaction between the semi- and hydroquinones. 
Moody and co-workers investigated the effect of oxygen on the cytoxicity of the 
cycloproparnitosenes and related indolequinones by performing experiments under air 
and under nitrogen. Chinese hamster V79 cells were exposed to the 
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cyclopropamitosenes for 3 h at 37'C under these conditions. Toxicity was measured 
using the MTT assay and the values for ICso, the concentration required to kill 50% of 
the cells, were determined, as illustrated in Tables 2, 3 and 4. 
Table 3 Biological Activity of Cyclopropamitosenes 
product ICso (air) (I1mol dm-3) ICso (N2) (1!ID01 dm-3) 
193 0.003 0.003 
194 1.2 0.06 
36 4.8 0.14 
184 3.0 0.12 
MMCl 0.8 0.4 
Table 4 Biological Activity of Pyrrolo[ l,2-aJindolequinones 
product 1CSO (air) (1!ID01 dm-3) ICso (N2) (1!ID01 dm-3) 
199 0.07 0.005 
200 0.2 0.07 
37 6 0.1 
187 11 0.45 
Table 5 Biological Activity of l,2-Dimethylindolequinones 
product 1Cso (air) (1!ID01 dm-3) ICSo (N2) (1!ID01 dm-3) 
204 0.5 0.025 
205 4 0.7 
38 25 0.3 
203 1000 1000 
Ratio 
1 
20 
34 
25 
2 
Ratio 
14 
3.5 
60 
24 
Ratio 
20 
6 
83 
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The activities of the indolequinones span a large range, with the 7-
aziridinylcyclopropamitosene 193 being the most active. However, in terms of 
structure/activity relationships, the main interest was the effect of the cyclopropane ring. 
To date there is no evidence to suggest that the compound is trifunctional, with 
involvement of the cyclopropane, but the cycl?propane ring does appear to have some 
effect, since, in general, the cyclopropamitosenes are clearly more potent than the 
simple 1,2-dimethylindolequinones, with the pyrrolo[I,2-aJindolequinones having 
intermediate potency. Under anaerobic conditions the 7-(2-methylaziridinyl) compound 
194 and 7-methoxycyclopropamitosenes 36 and 184 all become more toxic than MMC 
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1, indicating that oxygen inhibits activity, suggesting that initial I-electron processes 
(which are reversed by oxygen) are important in reductive activation of the 
cyclopropamitosenes. 
The above results, indicating the importance of the cyclopropane ring for anticancer 
activity and the involvement of I-electron reductive activation process, strongly 
suggests that radical induced ring opening of the cyclopropane is responsible for the 
enhanced biological activity of the cyclopropamitosenes. The resulting highly reactive 
radical would be capable of abstracting hydrogen from DNA. 
As discussed in Chapter I, the rapid ring opening of cyclopropyIcarbinyl radicals is one 
of the most studied radical processes, and the demonstration that single electron transfer 
to nitro- or acyl- cyclopropanes can initiate ring opening is highly relevant. Thus, just 
as Motherwell et al. demonstrated the reduction of the ketone 83 results in cyclopropane 
ring opening and the formation of the radical 85, reduction of the cyclopropamitosene 
209 can lead, via the semiquinone 210, to radical 211.66 Therefore, the relatively 
stabilised semiquinone radical is irreversibly transformed into a highly reactive CH2 
centred radical, which readily abstracts hydrogen. 
O· O· 
~ -----l.~ -j--)( -_.t\. 
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As described in Chapter 2, the cyclopropane ring of the cyclopropapyrido[J,2-a]indole 
homologue 137 ring opened via a radical mechanism during oxidation, using Fremy's 
salt, of the phenol 167 to the correspondin& indolequinone 168. Thus providing 
circumstantial evidence for the radical induced ring opening of the cyclopropane. 
Hence, in order to address the mechanistic issues the effect of substituents on the 
cyclopropane ring was studied by the preparation of cyclopropamitosenes, in which 
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such substituents can stabilise the developing radical centre. In this chapter we report 
the details of the synthesis of a cyclopropapyrrolo[ 1 ,2-a Jindole, where the cyclopropane 
substituent is a phenyl. 
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3.2 Synthesis of 9-Hydroxymethyl-7-methoxy-l,2-dihydro-la-phenyl-3H-l,2-
cyclopropapyrrolo[1,2-ajindole-5,8.dione carbamate 
o 
x 
o 
Cyclopropamitosene 
H 
Ph 
Where X = MeO, Y = OCONH2 212 
The synthesis of cyclopropamitosene was based on the previously described route. The 
key intermediate is 4-benzyloxy-5-methoxyindole-Z-carboxaldehyde 143, prepared from 
the commercially available o-vanillin 138. Thus, treatment of 4-benzyloxy-5-
methoxyindole-Z-carboxaldehyde 143 with sodium hydride in DMF, and then 
quenching with cinnamyl bromide gave the a1kylated indole nitrogen 213 as a yellow 
solid, in 66% yield. The N-alkylated indole 213 was converted into the tosylhydrazone 
214 by condensation with toluene-p-sulfonyl hydrazide in methanol at 40'C, in 61 % 
yield. Again, the previously developed intramolecular cycloaddition reaction was 
applied. Formation of the sodium salt by thermolysis in chlorobenzene furnished the 
tetracyclic cyclopropapyrrolo[1,Z-a]indole ring system 215,-in 84% yield. The initial 
intramolecular cycloaddition led to the formation of the exo adduct with no evidence of 
the alternative endo mode of addition, Scheme 30. 
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The cyclopropapyrrolo[1,2-a]indole 215 was then formylated via the ViIsmeier-Haack 
reaction to give the tetracycle 216 as a pale yellow solid, in 59% yield. Confirmation of 
the structure of 216 was achieved using X-ray crystallography, as shown in Figure 5. 
The IH NMR spectrum of compound 216 provides evidence for the formation of the exo 
adduct as the major diastereomer, as shown in Figure 6. However, repeating the 
intramolecular cycloaddition, in order to provide sufficient material for subsequent 
synthetic steps, the formation of the cyclopropapyrido[1 ,2-a ]indole tetracyclic system 
217 gave a ca. 1.4: I mixture of exo:endo adducts calculated from the I H NMR data. 
Formylation of the mixture of diastereomers using POCI3 and DMF gave the 
cyclopropapyrrolo[ 1 ,2-a ]indole-9-carboxaldehyde 218 in 59% yield, Scheme 31. The 
O-benzyl group was hydrogenolysed o~er PdiC in ethanol under an atmosphere of 
hydrogen (60 psi) for 12 hours, to afford the phenol 219 as a colourless solid 76% yield. 
69 
Figure 5 X -Ray Determination of Compound 216 
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OBn OBn 
MeO MeO 
CHO 
POCl3,DMF 
• 
Ph 59% Ph 
218 
H2,EtOH (60 psi) 76% 
o OH 
MeO MeO 
Fremy's salt 
.. 
Ph 43% Ph 
o 220 
Oxidation of the phenol 219 with Fremy's salt gave the corresponding indolequinone 
220 (43%), the side chain of which was elaborated in the usual way to give the desired 
cyclopropapyrrolo[l,2-a]indole 223, as shown in Scheme 32. 
Scheme 32 
o CHO 
MeO 
o 220 
MeO 
o 223 
Figure 7 clearly illustrates the exo:endo adducts of the final urethane in the 1 H NMR 
spectrum of the desired cyclopropapyrrolo[I,2-a]indole carbamate 223. In particular 
the signals representing the 6-H and MeO are doubled up, thus indicating two 
72 
diastereomers. Also, the two protons of the C-3 for the endo adduct have different 
chemical shift values of 4.32 and 3.89 ppm respectively. This can be attributed to the 
close proximity of the phenyl group to the C-3 protons in the endo adduct. 
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The O-benzyl group of diastereomer 216 was hydrogenolysed over Pd/C in ethanol 
under an atmosphere of hydrogen (60 psi) for 12 hours, to afford the phenol 224, in 87% 
yield .. 
OBn 
MeO 
216 
CHO 
H 
H 
Ph 
MeO 
H2, EtOH (60 psi) 
• 87% 
MeO 
OH 
o 
H. 
Fremy's salt 
94% 
Oxidation of the phenol 224 with Fremy's salt gave the corresponding indolequinone 
225, as orange crystals, in 94% yield. As previously described, oxidation of the phenol 
167 to the quinone 168 lead to the formation of the cyclopropane ring opened product 
172. However, the pyrrolo[I,2-aJindole 227 was not isolated in the oxidation of the 
cyclopropapyrrolo[1,2-aJindole to the indolequinone 225, Scheme 33. 
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Scheme 33 
o 227 
The C-lO side chain was elaborated in the usual way. The quinone aldehyde 225 was 
reduced to the alcohol 228 with sodium borohydride in methanol, in 78% yield. The 
alcohol 228 was then transformed to the final urethane 230 by ammonolysis of the 
phenyl carbonate 229 in DCM at -78'C, to afford 230 a single diastereomer of 
cyclopropamitosene 212, as an orange crystalline solid, in 89% yield. 
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Chapter Four 
1,2-Fused Iodoles via Radical CycIisatioo 
77 
4.11ntroduction 
In order to compare the properties of the cyclopropane containing indolequinones, the 
next logical extension to the work was the preparation offused [l,2-a]indoles. Initially, 
it was necessary to synthesise the pyrido[I,2-a]indole, thus providing a comparison to 
the cyclopropapyrido[I,2-a]indole homologue 137, as described in Chapter 2. 
Previously, pyrrolo[I,2-a]indoles were prepared from the key intermediate, 4-
benzyloxy-5-methoxyindole-2-carboxaldehyde 143 by reaction with 
vinyltriphenylphosphonium bromide in the prescence of sodium hydride.54 This reagent 
is known to be useful for the annulation of both pyrrole- and indole-2-carbaldehyde to 
give pyrrolo-pyrroles and -indoles respectively. Reaction of the sodium salt of the 
indole-2-carboxaldehyde 143 with the phosphonium salt gave the 9H-pyrrolo[I,2-
a]indole 231, as shown in Scheme 34. Prolonged hydrogenation of over PdlC at 3 
atmospheres pressure resulted in O-debenzylation and reduction of one double bond 
(followed by isomerisation) to give the pyrrolo[I,2-a]indole 232. 
Scheme 34 
OBn OBn 
MeO + - MeO 
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However, in this reaction two other products were isolated, firstly the corresponding 0-
benzyl compound 233 and secondly the debenzylated starting material 234. Therefore, a 
more direct approach to the formation of pyrrolotl,2-a]indoles was sought. Also it was 
necessary to be able to extend the viability of such an approach to the synthesis of 5,6 
and 7-membered fused [I,2-a]indoles. 
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Free radical cyclisations now constitute a major tactic in the synthesis of mono-, bi-, and 
polycyclic ring systems.91 ,92 Among such reactions, the intramolecular addition of 
radicals to an aromatic ring, often under oxidative conditions,93 has considerable 
synthetic potential, although it has not been widely used with heteroaromatic rings.94,95 
Muchowski and co-workers devised an efficient method of effecting oxidative radical 
cyclisation to aromatic systems.96 The authors successfully cyclised N-(ro-
iodoalkyl)indoles via addition of excess hydrogen peroxide to a sonicated solution of 
iron(II)sulfate heptahydrate in DMSO to afford the pyrrolo[I,2-a]indoles in 14-85% 
yields. 
R 
o V-l 
I 
CH2(CH2)nCH21 
235n= 1 
237n=2 
DMSO 
») 
Where R = CHO, CO2 Me, COMe, CN, Me and H 
236n= 1 
238n=2 
In view of our own work, oxidative radical cyclisation of precursors 235 and 237 where 
R = CHO gave the fused [I,2-a]indoles 236 and 238 in 60 and 45% yields, respectively. 
In 1990, Murphy et al. reported an intramolecular radical addition to pyridinium salts 
using tributyltin hydride.97,98 The use of tributyltin hydride as an approach to mild, 
non-oxidative radicals has led to reactions which avoid the aggressive hydrogen-atom 
abstraction processes involved in the chemistry of oxidative radicals. 
01 rU 
239 
. oxidation 
240 
The authors, treated the pyridium salt with tributyltin hydride under nitrogen and in the 
presence of AmN to afford the bicycle. However, in relation to our own work 
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concerning the preparation of fused [I,2-ajindoles, Ziegler et al. developed a method for 
the synthesis of the 3H-pyrrolo[I,2-ajindole nucleus.99-102 The authors, effected an 
intramolecular radical cycIisation onto the indole 2-position demonstrating that alkyl, 
vinyl, oxiranyl and aziridinyl radicals cycIise under photochemical or reductive 
conditions to give mainly l,2-fused 2,3-dihydroindoles (or their dimers). 
Recently, Caddick and co-workers discovered intramolecular free radical addition of 
alkyl radicals to tosyl substituted indoles provided access to fused [l,2-ajindoles.103.104 
Radical ipso-substitution of a SPh, SOPh or S02Ar group from the indole 2-position led 
to the formation of 5, 6 and 7 membered ring systems. Therefore, in this Chapter we 
report some new results in the synthesis of l,2-fused indoles. 
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4.2 Synthesis of IO-Formyl-8-methoxy-I,2,3,4-tetrahydropyrido[I,2_a]indole-6,9-
dione. 
x 
Mitosene 
Where X = MeO, Y = CHO 241 
Our first objective was to establish suitable methodology for the formation of the 
comparative pyrido[I,2-alindole 241, as shown above. In view of our own work on the 
synthesis of 1,2-fused indoles, we were interested in the recent report by Muchowski.96 
Thus, it was planned to form the tricyclic system of the desired mitosene via an 
intramolecular oxidative radical cyclisation. 
The synthetic route started from o-vanillin 138 and followed the route to the key 
intermediate, 4-benzyloxy-5-methoxyindole-2-carboxaldehyde 143, as described in 
chapter 2. Decarbonylation of the C-2 aldehyde, of 143 by heating with 
bis(triphenylphosphine)carbonyl rhodium chloride afforded 4-benzyloxy-5-
methoxyindole 242 as a brown solid, in 90% yield. Formylation of 242 proceeded 
without incident to give, 4-benzyloxy-5-methoxyindole-3-carboxaldehyde 243, in 57% 
yield. 
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Thus, alkylation of the indole-3-carboxaldehyde 243 with l-bromo-4-chlorobutane using 
potassium hydroxide in DMSO gave the chloroalkyindole 244 as a colourless solid, in 
84% yield. Mass spectral data supported the I-(co-chloroalkyl)indole structure. The 
isotopic chlorine consists of 35Cl and 37Cl in the ratio of approximately 3: I, thus the 
molecular ion 371 (M+) in the compound 244 gave rise to the characteristic isotope 
pattern of chlorine, as observed in the mass spectra. Reaction of the chloride 244 with 
sodium iodide in acetonitrile, afforded the corresponding iodide 245 as a colourless 
solid, in good yield (72%). 
OBn CHO OBn CHO 
Meo'Oj I. KOH,DMSO Meo'Od I '\::. 2. l-bromo-4-chlorobutane I '\:: 
~ . ~ ~ . . ·84% N. 
243 H .. . . 244 ~Cl. 
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To effect the intramolecular oxidative radical cyclisation, the iodide 245 was cyclised by 
addition of excess hydrogen peroxide (10 eq) to a sonicated solution of iron(II)sulfate 
heptahydrate in DMSO to afford the pyrido[1,2-ajindole 246, albeit in poor yield (33%). 
OBn CHO Meo'6j I ~ 
~ N -
OBn 
33% 
245 ~I 
_ The reaction mechanism proceeds under Fenton conditions in which methyl 
radicals are generated from DMSO, as shown in Equation 1. 
Equation 1 
MeSOMe + H20 2 +Fe(Il) ---...... Me· + MeS02H + Fe(III) + OH" 
The methyl radical abstracts the iodide from the 1-(0l-iodoalkyl)indole-3-
carboxaldehyde 245 on the basis of the favourable equilibrium in Equation 2. 
Equation 2 
Me· + RI .:;.;:::=~ .... R· + MeI 
Intramolecular cyclisation proceeds generating radical species 248. Oxidation of 248 
leads to the formation of re-aromatised 246, Scheme 35. 
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Unfortunately, the poor yield of the oxidative radical cyclisation hindered the continued 
progress of the synthetic route. Therefore, an alternative approach to the cyclisation was 
necessary. Caddick et al. used tributyltin hydride and azobisisobutyronitrile (AmN) in 
their radical ipso-substitutions of a tosyl group from the indole-2-position, to effect the 
formation of l,2-fused indoles.104 Therefore, regarding our own work the conditions 
utilised by Caddick were applied to the radical cyclisation of 1-(ro-iodoalkyl)indole-3-
carboxaldehyde 245. Treatment of the iodide 245 via slow addition of tributyltin 
hydride and AmN in boiling toluene gave the pyrido[ 1,2-a Jindole 246 as a colourless 
oil, increasing the yield to 73%. 
OBn CHO Meotx5 I ~ 
~ N 
BU3SnH, AIBN 
toluene, reflux 
73% 
245 ~I 
MeO 
• 
Oxidations during reductive cyclisations using tributlytin hydride are becoming 
increasingly common, and although disproportionation, or oxidation of an intermediate 
radical by AIBN as proposed by Curran, cann~t be ruled out, the preferred mechanism 
for the radical cyclisation is one proposed by Bowman involving a 'pseudo' SRN I 
mechanism, as shown in Scheme 36.105.106.107 
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Loss of H+ from the intermediate radical 248 yields a highly delocalised radical anion 
250. Radical anion 250 then undergoes a single electron transfer with the 
(iodoalkyl)indole 251 to generate, after loss of iodide, the initial radical 247 , thereby 
continuing the chain reaction i.e. single electron transfer between the starting material 
245 and radical anion 250 to yield the product 246 and the new intermediate radical 251. 
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Following the cyclisation the O-benzyl group was hydrogenolysed over PdlC in ethanol 
under an atmosphere of hydrogen (6Opsi) for 12 hours, to afford the phenol 166, in 69% 
yield. Oxidation of the phenol 166 with Fremy's salt gave the corresponding 
indolequinone 241, as an orange solid, in 53% yield. Unfortunately, the synthetic route 
could not be taken to the final urethane due to the small quantities of indolequinone 
produced. It was not considered useful at this stage to repeat the entire sequence again, 
due to lack of time. 
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4.3 Synthesis of Fused [I,2-aJindoles 
As the cyclisation of the iodide using tributyltin hydride and AIBN with oxidation was a 
new result in terms of the formation of 1,2 fused indoles, the applications of this radical 
cyclisation were explored further. Initially, for comparative purposes, the simpler indole 
derivative was prepared. Also, the viability of the radical cyclisation provided access to 
5,6 and 7 membered fused[I,2-a]indoles. 
Thus, alkylation of the indole-3-carboxaldehyde 252 with I-bromo-ro-chloroalkane 
using potassium hydroxide in DMSO gave the corresponding 1-(ro-chloroalkyl)indoles, 
in good yield (86-97%). 
CHO ~ l0l-rl 
I 
252 H 
BrCH2(CH2)nCH2CI 
• 
KOH,DMSO 
253n= 1 (91%) 
254 n = 2 (97%) 
255 n = 3 (86%) 
Reactions of the chlorides with sodium iodide in acetonitrile gave the corresponding 
iodides again in good yield (73-92%). 
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• 
235 n = 1 (79%) 
. 237n=2(73%) 
256 n = 3 (92%) 
The cyclisation reactions were carried out· by slow addition of tributyltin hydride and 
AmN to the iodoalkylindoles in boiling toluene. This resulted in the forination of the 
desired 1,2-fused indoles (43-75%). 
236 n = 1 (64%) 
238n=2(75%) 
257n=3(43%) 
4.4 Synthesis of Substituted Fused [l,2-aJindoles related to the mitomycins 
The synthesis of 1 0-forrnyl-8-methoxy-1 ,2,3,4-tetrahydropyrido[ 1 ,2-a Jindole-6,9-dione 
241 produced a 6,5,6-ring system .. The rationale for the formation of 241 was to 
compare the properties of the cyclopropane containing indolequinone 137 with the 
simpler derivative lacking a cyclopropane ring. As described in Section 4.3, the radical. 
cyclisation provided access to 5,6 and 7-membered fused [I ,2-aJindoles. Therefore, in 
order to complete the series, the 6,5,5- and 6,5,7-substituted ring systems were prepared. 
The substrates for the radic.al cycIisation were 4-benzyloxy-I-(3-iodopropyJ)-5-
methoxyindoie-3-carboxaldehyde 259 and 4-benzyloxy-I-(5-iodopentyl)-5-
methoxyindole-3-carboxaIdehyde 260, respectively. Thus, alkylation of the indole with 
l-bromo-3-chloropropane using potassium hyd.roxide in DMSO gave the corresponding 
. 4-benzyJoxy-I-(3-chloropropyl)-5-methoxyindole-3-carboxaldehyde 258 as a yellow oil, 
in 74% yield. The iodide 260 was prepared directly from aldehyde by alkylation with 
1,5-diiodopentane, in 70% yield. Again the cyclisation were effected by slow addition 
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of tributyltin hydride and AIBN to the iodoalkJyindoles in boiling toluene. This resulted 
in the fonnation of indoles 261 and 262 in 47 and 29% yield, respectively. 
MeO 
·OBn 
eRO 
261 n = 1 (47%) 
262 n = 3 (29%) 
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258 n = 1 (74%) 
259 n = 1 (85%) 
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Chapter Five 
Biological Evaluation: Cyclopropamitosenes as Potential Anticancer 
Agents 
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Biological Evaluation: Cyclopropamitosenes as Potential Anticancer Agents 
S.11ntroduction to Bioreductive Drugs 
Bioreductive drugs are defined as compounds that are selectively toxic to hypoxic 
tumour cells. As described in Chapter 1, in vivo a significant difference between normal 
tissue and solid tumours is the presence of hypoxic cells, located in poorly vascularised 
regions of the tumour. Therefore, bioreductive drugs are capable of selectively targeting 
cells in hypoxia, causing death of solid tumour cells. This selective hypoxic cytotoxicity 
is partly due to the ability of an enzyme to metabolise these drugs to a toxic species 
under hypoxic conditions. Many enzymes have been implicated in this reaction, 
including NADPH cytochrome P450 reductase, xanthine dehydrogenase, xanthine 
oxidase and DT -diaphorase. 
Reductive activation of bioreductive drugs is dependent on the ability of the drug to act 
as a substrate for the intracellular reductase(s) and the expression of these enzyme(s) 
within the particular cell type. Furthermore, reducing enzyme(s) activate bioreductive 
drugs via a one or two electron reduction. One electron reduction (by enzymes such as 
cytochrome P450 reductase) leads to the formation of a semiquinone radical anion in a 
process that is potentially reversible by oxygen, as discussed in Chapter 1. However, 2-
electron reduction gives a hydroquinone in a process generally carried out by DT-
diaphorase in a process that is oxygen independent. These factors all contribute to the 
variability of cytotoxic efficiency observed in different cell types and also the variable 
magnitude of the hypoxic/oxic differential. 
5.2 Biological Activity 
The main objective of this study was to investigate the effect of oxygen on the 
cytotoxicity of cyclopropamitosenes (the synthesis of which had been previously 
discussed) by determining the antitumour activity in vitro. The biological experiments 
were carried out under the direction of Dr Ian Stratford at the MRC Radiobiology Unit. 
Initially, the in vitro activity of the cycloprop~itosenes was determined on V79 cell 
types both under oxic and hypoxic conditions, as shown in Table 5. The MTT assay was 
used to estimate toxicity in these experiments. The in vitro activities are represented as 
ICso value, indicating the concentration (!1M) of drug that inhibits survival by 50% 
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following exposure to cells for 3 hours at 37'C. The structure of the various novel 
cyclopropamitosenes are illustrated in Figure 8. 
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Table 6 Biological Activity of Cyclopropamitosenes 
1Cso(pmoldm·3) 
Compound No. Structure R Air N2 AirIN2 
MMCl 0.8 0.4 2 
136 A OCONH2 4.8 0.14 34 
150 A OH 100 50 2 
173 B OH 75 10 7.5 
230 C OCONH2 0.63 0.25 2.6 
223 D OCONH2 0.68 0.36 1.9 
228 C OH 31 15.8 2.0 
The results from Table 6 illustrate that even the small structural modifications resulted 
in very significant differences in in vitro activity of the cyclopropamitosenes. Some of 
these compounds showed better in vitro activity than the lead compound MMC. Under 
anaerobic conditions compound 136 became significantly more toxic than MMC. This 
possibly means that 1t is a better substrate for I-electron reductases than MMC or 
reflects the difference in the stability of the semiquinone radiCal anion (and hence the 
position of equilibrium between semiquinone and hydroquinone). 
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The results indicate that the cyclopropapyrido[1,2-a]indole homologue 173 is more 
potent than the parent cyclopropapyrrolo[1 ,2-a]indole 150 suggesting that alterations in 
the ring system from 6,5,5 to 6,5,6 increases the cytotoxicity. However, more 
information regarding other ring systems such as the 6,5,7 and their analogues is 
necessary before any correlation between ring systems and potency of these compounds 
can be confirmed. 
Clearly, from Table 6, cyclopropamitosenes which posses a carbamate group at the C-lO 
position are more potent than the comparative quinone alcohols. These results suggest 
that a good leaving group at the C-lO position is necessary for the potent antitumour 
activity. 
The higher potency of cyclopropamitosenes 230 and 223 over MMC and the 7-
methoxycycIopropamitosene 136 in air may be due to the fact that it is activated by DT-
diaphorase in V79 cells, and MMC/136 less so. The cyclopropamitosenes 230 and 223 
do not show greater specificity for hypoxic cells in comparison to the 7-
methoxycyclopropamitosene 136. This is illustrated by the fact that compound 136 is 
considerably more active than 230 and 223 under hypoxic conditions and the hypoxicl 
oxic differential of 34 for 135 is much greater than that of 230 and 223 which are 2.6 
and 1.9 respectively. Reductive activation of 230 and 223 by DT -diaphorase to give a 
hydroquinone contradicts the mechanistic issue of the semiquinone radical anion 
inducing ring opening of the cyclopropane. Formation of the hydroquinone eliminates 
the possibility of radical ring opening of the cyclopropane, in which the phenyl stabilises 
the developing radical centre. However, the fact that little difference is seen in the ICso 
values under aerobic and hypoxic conditions for compounds 230 and 223 may be 
attributed to the steric effects incurred by the presence of a phenyl group on the 
cyclopropane ring. 
In summary, 7-methoxycyclopropamitosene 136 appears to be more specific for hypoxic 
cells than MMC indicating that it is a better substrate for I-electron reductases. 
Compounds 230 and 223 are equally effective at killing aerobic and hypoxic cells 
suggesting they may be reductively activated by DT -diaphorase. This excludes the 
possibility of radical induced ring opening of the cyclopropane ring. Therefore, more 
information on the enzymatic activation of these compounds may be needed to allow 
prediction of these differentials. Also,. the potential steric effects from the phenyl 
substituent attached to the cyclopropane ring cannot be eliminated. Initial studies of the 
cytotoxic effects when modifying the cyclopropamitosene ring system indicate the 6,5,6 
to be more potent than the 6,5,5-ring system. However, more evidence to confirm this 
93 
correlation is needed. Finally. cyclopropamitosene analogues with the carbamate group 
at the C-lO position were more potent in vitro than the corresponding derivatives with 
the hydroxyl group. 
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Chapter Six 
Experimental Section 
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6.i General information 
Solvents and Reagents-Commercially available solvents were used throughout without 
further purification,' except those detailed below which were purified as described. 
'Light petroleum' refers to the fraction of petroleum ether boiling between 40'C and 
60'C and was distilled through a 36 cm Vigreux column before use. 'Ether' refers to 
diethyl ether, ether and xylene were dried by standing over sodium wire for several days. 
THF was distilled from sodium benzophenone ketyl under nitrogen, prior to use. 
Dichloromethane was distilled from phosphorus pentoxide. Acetonitrile was dried over 
anhydrous potassium carbonate and distilled from phosphorus pentoxide before storing 
over activated 4A molecular sieves under nitrogen. DMF and DMSO Was dried by 
stirring over calcium hydride for 15 h, decanted and disti!led under reduced pressure 
before storing over activated 4A molecular sieves under nitrogen. Pyridine and 
triethylamine were distilled from and stored over, potassium hydroxide pellets. 
Methanol and ethanol were distilled from magnesium turnings and iodine and stored 
over activated 4A molecular sieves under nitrogen. Aziridine was prepared according to 
literature procedure and distilled from potassium hydroxide pellets and stored over, 
sodium hydroxide pellets, under nitrogen, in the refrigerator. 
Chromatographic Procedures-Analytical thin layer chromatography (TLC) was carried 
out using aluminium backed plates coated with Merck Kieselgel 60 GF254. Plates were 
visualised under uv light (at 254 and/or 360 nm) or by staining with phosphomolybdic 
acid reagent, followed by heating. Flash chromatography was carried out using Merck 
Kieselgel 60 H silica or Sorbsil C 60 silica gel. Pressure was applied at the column head 
with hand bellows. Gravity" chromatography was carried out using Merck Kieselgel 60 
(70-230 mesh) silica. Samples were pre-adsorbed on silica or as a saturated solution in 
an appropriate solvent. 
Spectroscopic Techniques-Infra red spectra were recorded in the range 4000-600 cm" 
using a Nicolet Ff-250 spectrometer, with internal calibration. Spectra were recorded as 
solutions in chloroform, thin films or as a nujol mull. Elemental analyses were carried 
out on a Perkin Elmer 2400 Elemental Analyser. 'H and 13C NMR spectra were 
recorded using Bruker AC-250 and Bruker WH-400 instruments. 'H NMR spectra are 
referenced against residual undeuterated solveIlt. in the case of deuterochloroforrn this is 
7.260 ppm. Signals are described as singlets (s), doublets (d), quartets (q), double 
doublets (dd) etc. High and low resolution mass spectra were recorded on a Kratos 
MS80 instrument or on a VG Analytical ZAB-F instrument (EPSRC mass spectrometry 
service Swansea). 
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Other Data and lnstrumentation- Melting points were measured on a Reichert-Kofler 
hot stage apparatus or an Electrothermal digital melting point apparatus and. are 
uncorrected. 
All of the following experimental reactions were carried out under an atmosphere of 
nitrogen except in cases where it was obviously unnecessary. 
Synthesis or Preparation of General Reagents 
Methyl Azidoacetate 
Methyl chloroacetate (50.0 g, 0.461 mmol) was added followed by sodium azide (37.65 
g, 0.579 mmol) to a stirred mixture of water (50 cm3) and acetone (75 cm3). The stirred 
mixture was refluxed for 16 h. After this time, the mixture was cooled to room 
temperature and the acetone removed in vacuo to afford a yellow liquid/white solid 
(sodium chloride). The mixture of liquid and solid was then extracted with ether (3 x 
150 cm3). The ethereal extracts were washed with water (3 x 100 cm3), brine (150 
cm3), dried (MgS04) and then condensed in vacuo to give the azide (44.6 g, 82%) as a 
pale yellow liquid, llH (250 MHz; CDCh) 4.95 (2H, s, CH2) and 3.96 (3H, s, Me). 
Note: Care was taken at all times when handling this compound. Methyl azidoacetate is 
potentially explosive. Hence, this compound was not purified by distillation. 
Fremy's Salt [KzON ( S03) if 
A solution of sodium nitrite (5.8 g, 0.08 mmol) in water (15 cm3) was well cooled in an 
ice bath and crushed ice (35 g) stirred in, with continuous stirring. A solution of sodium 
metabisulphite (7.3 g, 0.04 mmol) in water (15 cm3) was added next, followed by glacial 
acetic acid (3.5 cm3). The mixture was rendered alkaline by adding ammonia (0.88, 2.5 
cm3) and was then continously stirred in the ice bath during addition of an ice cold 
solution of potassium permanganate (2.1 g, 0.013 mmol) in water (65 cm3). The 
precipitate of manganese dioxide was filtered off through a bed of Celite. To the cooled 
violet filtrate was added a saturated solution (85 cm3) of potassium chloride (33 gllOO 
cm3 water). An orange solid precipitated out, which was filtered under suction. The 
orange solid was washed several times with 5%. potassium hydroxide, then twice with 
ethanol containing approximately 5% v/v 0.88 ammonia and finally with acetone. Air 
was not drawn through the solid but it was spread on a watch glass and the acetone 
allowed to evaporate over 10-15 min. The product was dried in a desiccator over 
ammonium carbonate and calcium oxide. 
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6.2 Experimental/or Chapter Two (2.2) 
OBn 
MeO~CHO 
U 
139 
2-Benzyloxy-3-methoxybenzaldehyde 139 
Potassium hydroxide pellets (16.0 g, 286 mmol) were added to a stirred solution of 0-
vanillin 138 (40.0 g, 264 mmol) in ethanol (98%, 240 cm3), followed by benzyl chloride 
(32.8 ml, 286 mmol). The stirred mixture was refluxed for 12 h, then water (200 cm3) 
was added and the mixture extracted with diethyl ether (3 x 300 cm3). The ethereal 
extracts were washed with water (2 x 100 cm3), potassium hydroxide solution (2M, 5 x 
200 cm3), water (2 x 200 cm3) and brine (200 cm3). The organic layer was dried 
(MgS04), then condensed in vacuo, to give the title compound 139 (60.7 g, 95%) as a 
colourless solid on trituration with hexane, m.p. 45-47'C (lit.SS 44-45'C); 'Umax (Nujol) 
1695, 1584, 1367, 1266, 1247 and 1222 cm-I; OH (250 MHz; CDCI3) 10.23 (1 H, s, 
CHO), 7.40-7.09 (8 H, m, Ar-H), 5.17 (2 H, s, OCH2Ph) and 3.94 (3 H, s, OMe); Oc 
(62.9 MHz; CDCi3) 190.00 (CHO), 153.04, 136.38, 130.28, 128.65, 128.57, 128.50, 
124.25, 118.97, 118.00,76.29 (OCH2Ph) and 56.05 (OMe). 
OBn 
MeO 
140 
MethyI2-azido-3-(2 '-benzyloxy-3 '-methoxyphenyl)propenoate 140 
Sodium metal (7.60 g, 330 mmol) was added to dry methanol (150 cm3). The solution 
was cooled to _15°C and a solution of methyl.azidoacetate (38.02 g, 330 mmol) and 2-
benzyloxy-3-methoxybenzaldehyde 139 (-20.00' g, 82.0 mmol) in dry methanol (15 cm3) 
was introduced, dropwise, by means of a pressure equalising dropping funnel. The 
mixture was stirred at _10°C for 3h then at 4°C for 12 h. Water (50 cm3) was cautiously 
added to the mixture, which was then extracted with ethyl acetate (2 x 250 cm3). The 
98 
combined extracts were washed with water (500 cm3), brine (250 cm3) and dried 
(MgS04). Removal of the solvent in vacuo gave a pale yellow residue, which was 
triturated with a small quantity of diethyl ether and the resulting precipitate filtered off. 
The remaining oily residue was purified by column chromatography (50% light 
petroleuml50% diethyl ether) to give the title compound 140 (20.35 g, 72%) as pale 
yellow rhomboids, m.p. 66-67·C; 'Umax (film) 2120, 1712, 1457, 1260 and 1218 cm-I; 
BH (250 MHz; CDC!3) 7.79 (1 H, d, J 8.0, 6'-H), 7.44-7.27 (5 H, m, Ar-H), 7.13 (1 H, s, 
3-H), 6.96 (1 H, t, J 8.0, 5'-H), 6.93 (1 H, d, J 8.0, 4'-H), 4.99 (2 H, s, OCH2Ph), 3.89 (3 
H, s, C02CH3) and 3.85 (3 H, s, OMe); Bc (62.9 MHz; CDCI3) 164.04 (C02CH3), 
152.66, 146.77, 137.08, 128.76, 128.68, 128.33, 128.14, 127.85, 125.59, 123.93, 122.05, 
120.05,119.65,113.52,75.86 (OCH2Ph), 55.88 (OMe) and 52.77 (C02CH3). 
OBn 
MeO 
" 
C02Me 
N 
I 
141 H 
Methy14-benzyloxy-S-methoxyindole-2-carboxylate 141 
A solution of methyl 2-azido-3-(2' -benzyloxy-3' -methoxyphenyl)propenoate 140 (5.00 
g, 14.8 mmol) in dry xylene (200 cm3) was introduced, dropwise, by means of a 
pressure equalising dropping funnel, to refluxing dry xylene (800 cm3). After the 
addition was complete (ca. 1 h), the solution was refluxed for a further 45 min. 
Removal of solvent in vacuo gave a yellow solid residue. The residue was triturated 
with a small quantity of diethyl ether and the resulting precipitate was filtered off. The 
remaining oily residue was purified by column chromatography (dichloromethane) to 
give the title compound 141 (3.14 g, 84%) as pale yellow needles, m.p. 97-100·C; 'Umax 
(Nujol) 3342, 3031,1697,1528,1453 and 1257 cm-I; BH (250MHz; CDC!3) 8.82 (1 H, 
s, NH), 7.53 (2 H, m, Ar-H), 7.52-7.34 (3 H, m, Ar-H), 7.33 (1 H, s, 3-H), 7.08 (2 H, s, 
6n-H), 5.26 (2 H, s, CH2), 3.92 (3 H, s, C02Me) and 3.91 (3 H, s, OMe); Bc (62.9 . 
MHz; CDCI3) 162.55 (C02CH3), 145.12, 141.78, 137.89, 134.20, 128.35, 128.0, 
127.88, 127.31, 123.13, 116.26, 107.21, lOtUS, 75.04 (OCH2Ph), 58.45 (OMe) and 
52.03 (C02CH3)' 
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OBn 
MeO 
" 
CH20H 
N 
I 
142 H 
4-Benzsloxy-S-methoxyindole-2-methanol142 
A solution of methyl-4-benzyloxy-5-methoxyindole-2-carboxylate 141 (10.0 g, 32.15 
mmol) in dry THF (200 cm3) was addeddropwise to a stirred suspension of lithium 
aluminium hydride' (1.22 g,32.15 mmol) in dry THF (100 cm3), such that the mixture 
achieved gentle reflux. After 30 min, water (1.2 cm3), sodium hydroxide (15%, 1.2 
'. cm3) arid water (3.6 cm3), were added to the mixture and the resultant precipitate 
removed by filtration (through a bed of Celite). The filtrate was dried (MgS04), then 
condensed in vacuo to give the title compound 142 (8.55 g, 94%) as a colourless 
crystalline solid; in.p. 91"C; 'Ilmax{Nujol) 3479, 3282, 1506, 1324, 1283, 1244, 1091 and 
701 cm-I; IlR (250 MHz; CDCI3) 8.24 (1 H, s, NH), 7.49 (2 H, m, Ar-H), 7.33-7.29 (3 
H, m, Ar-H), 6.97 (2 H, AB, J 9.0, 7/6-H), 6.39 (1 H, s, 3-H), 5.21 (2 H, s, OCH2Ph), 
4.74 (2 H, s, CH20H), 3.88 (3 H, s, OMe) and 1.67 (1 H, s, OH); /le (62.9 MHz; CDCI3) 
---144.94,140.00,138.36,138.07, 133.57, 128.33, 128.10, 127.84, 123.10, 111.63, 106.45, 
97.56,75.05 (OCH2Ph), 58.29 (OMe) and 58.22 (CH20H); mlz 283 (M+, 27%), 192 
(100),174 (28) and 91 (38). 
OBn 
MeO 
CHO 
4-Benzsloxy-S-methoxyindole-2-carboxaldehyde 143 
Manganese dioxide (14.0 g, 160 mmol) was added to a stirred solution of 4-benzyloxy-
5-methoxyindole-2-methanoI142 (9.0 g, 32.0.mmol) in dichloromethane (1000 cm3). 
The suspension was refluxed for 12 h, then the mixture .was filtered and the residue 
washed with dichloromethane. (3 x 500 crn3). The combined filtrate and washings were 
evaporated to give an oil, which was purified by column chromatography (diethyl ether) 
to give the title compound 143 (5:96 g, 66%) as a yellow crystalline solid, m.p. 143~ 
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145'C; 'Umax (Nujol) 3188, 1667, 1446, 1148 and 1094 cm-I; IiH (250 MHz; CDCI3) 
9.75 (1 H, s, CHO), 9.05 (1 H, s, NH), 7.52-7.21 (5 H, m, Ar-H), 7.15 (1 H, d, J 8.8, 7/6-
H), 7.12 (1 H, d, J 8.8, 6n-H), 5.28 (2 H, s, CH2) and 3.91 (3 H, s, OMe); lie (62.9 
MHz; CDCI3) 182.08 (CHO), 145.23, 142.20, 137.78, 136.20, 135.11, 128.42, 128.13, 
128.02, 123.43, 118.33, 112.47, 107.61,75.22 (OCH2Ph) and 58.42 (OMe). 
OBn 
MeO 
CHO 
N 
144 V 
1-Allyl-4-benzyloxy-S-methoxyindole-2-carboxaldehyde 144 
To a flask charged with sodium hydride (80%; 0.475 g, 15.8 mmol) was added dry light 
petroleum (10 cm3). The mixture was stirred for 10 min, the petroleum removed by 
syringe and the flask contents dried under reduced pressure. 4-Benzyloxy-5-
methoxyindole-2-carboxaldehyde 143 (3.56 g, 12.7 mmol) in DMF (51 cm3) was added 
dropwise and the mixture was stirred at room temperature for 30 min. Allyl bromide 
(1.36 cm3, 15.8 mmol) was added and the mixture was stirred at room temperature. 
After 1 h, water (150 cm3) was cautiously added and the mixture was extracted with 
diethyl ether (4 x 250 cm3). The combined ethereal extracts were washed with water (8 
x 200 cm3), brine (200 cm3), dried (MgS04) and evaporated to give the title compound 
144 (4.03 g, 99%) as a yellow solid, m.p. 69-70°C; 'Umax (Nujol) 1670, 1490, 1407, 1248 
and 1141 cm-I; IiH (250 MHz; CDCh) 9.77 (1 H, s, CHO), 7.51 (2 H, m, Ar-H), 7.25 (3 
H, m,Ar-H), 7.20 (1 H, s, 3-H), 7.17 (1 H, d, J 9.0,.7/6-H), 7.14 (1 H, d, J 9.0, 6n-H), 
5.97 (1 H, m, CH2CH=CH2), 5.28 (2 H, s, OCH2Ph), 5.16 (3 H, m, CH2CH=CH2 and 
CH2CH=CHH), 4.94 (1 H, d, J 18.0, CH2CH=CHH) and 3.91 (3 H, s, OMe); lie (62.9 
MHz; CDCI3) 182.00 (CHO), 145.17, 137.83, 137.44, 135.33, 133.45, 128.43, 128.11, 
122.00, 118.15, 116.33, 115.23, 105.90, 75.23 (OCH2Ph), 58.49 (OMe) and 46.98 
(NCH2)· 
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OBn 
MeO 
.&NNHTs 
145 
1-Allyl-4-benzyloxy-S-methoxyindole-2-carboxaldehyde tosylhydrazone 14S 
1-Allyl-4-benzyloxy-5-methoxyindole-2-carboxaldehyde 144 (2.43 g, 7.57 mmol) was 
added to a stirred solution of 4-toluenesulfonyl hydrazide (1.69 g, 9.08 mmol) in 
methanol (20 ml). The mixture was stirred at 40·C for 45 min. Removal of the solvent 
in vacuo, gave a dark green residue which was recrystallised from diethyl ether and the 
resulting precipitate filtered off. The remaining mother liquors were purified by column 
chromatography (50% light petroleuml50% diethyl ether) to give the title compound 
145 (3.29 g, 89%) as a colourless solid, m.p. 49-50°C (dec.); 'Ilmax (Nujol) 2956,1718, 
1492, 1456, 1358 and 1166 cm-I; 3H (250 MHz; CDCI3) 7.83 (2 H, m, Ar-H), 7.81 (2 H, 
m, NH and CH=N), 7.47 (2 H, m, Ar-H), 7.38-7.30 (5 H, m, Ar-H), 7.04 (1 H, d, J 7.5, 
7/6-H), 6.95 (1 H, d, J 7.5, 6n-H), 6.67 (1 H, s, 3-H), 5.85 (1 H, m, CH=CH2), 5.20 (2 
H, s, OCH2Ph), 5.04 (3 H, m, CH2CH=CH2 and CH2CH=CHH), 4.85 (1 H, d, J 17.5, 
CH2CH=CHH), 3.87 (3 H, s, OMe) and 2.42 (3 H, s, Ts-Me); 3c (62.9 MHz; CDCI3) 
144.33,141.15,138.08,136.78,135.25,133.68,131.74, 129.86, 129.68, 128.36, 128.09, 
128.05, 127.89, 116.14, 114.79, 107.34, 105.23,75.10 (OCH2Ph), 58.38 (OMe), 47.41 
(NCH2) and 21.58 (Ts-CH3). 
OBn 
MeO 
8-Benzyloxy-7-methoxy-1,2-dihydro-3H-1,2-cyclopropapyrrolo[1,2-ajindole 146 
Sodium hydride (50%, 0.291 g, 6.07 mmol)."\vas added to a stirred solution of the 
tosylhydrazone 145 (1.98 g, 4.05 mmol) in dry THF (60 cm3). After 10 min the solution 
was filtered and the filtrate evaporated. The residue was dissolved in dry chlorobenzene 
(600 cm3) and the solution refluxed for 3 h. The solvent was evaporated and the residue 
purified by column chromatography (50% light petroleurnl50% diethyl ether) to give the 
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title compound 146 (1.16 g, 94%) as a pale yellow oil; 'Ilmax (film) 1500, 1495, 1288, 
1234 and 750 cm-I; BH (250 MHz; CDCI3) 7.53 (2 H, m, Ar-H), 7.41-7.23 (3 H, m, Ar-
H), 6.82 (1 H, d, J 7.5, 615-H) 6.78 (1 H, d, J 7.5, 516-H), 5.27 (2 H, s, OCH2Ph), 4.06 (2 
H, m, 3-H), 3.86 (3 H, s, OMe), 2.37 (2 H, m, 1,2-H), 1.25 and 0.65 (each 1 H, m, 1a-
H). 
OBn 
CHO 
MeO 
147 
8-Benz;yloxy-7-methoxy-l,2-dihydro-3H-l,2-cyclopropapyrrolo[1,2-ajindole-9-
carboxaldehyde 147 
DMF (10 cm3) and phosphorus oxychloride (0.15 ml, 1.61 mmol) were stirred under 
nitrogen for 30 min. The resulting yellow solution was cooled to O°C and 8-benzyloxy-
7-methoxy-l,2-dihydro-3H-l ,2-cyclopropapyrrolo[1 ,2-aJindole 146 (0.250 g, 0.819 
mmol) in DMF (2 cm3) was added and the mixture stirred for 45 min. Sodium acetate 
(1M, 6 cm3) was added and the mixture was extracted with diethyl ether (6 x 20 cm3). 
The combined ethereal extracts were washed with brine (6 x 50 cm3) and dried 
(MgS04). Removal of the solvent in vacuo gave a green oily residue which was 
recrystallised with a small quantity of diethyl ether and the resulting precipitate filtered 
off. The mother liquors were purified by column chromatography (diethyl ether) to give 
the title compound 147 (0.145 g, 53%) as a colourless solid, m.p. 128-130'C; 'Ilmax 
(Nujol) 1648, 1536,757 and 702 cm-I; BH (250 MHz; CDCI3) 10.32 (1 H, s, CHO), 7.49 
(2 H, m, Ar-H), 7.40-7.26 (3 H, m, Ar-H), 6.90 and 6.85 (each 1 H, d, J 8.7, 615-H), 5.18 
(2 H, s, OCH2Ph), 4.10 (2 H, m, 3-H), 4.03 (3 H, s, OMe), 2.99 (1 H, m, I-H), 2.46 (l 
H, m, 2-H), 1.48 and 0.72 (each 1 H, m, la-H); Bc (62.9 MHz; CDCh) 186.57 (CHO), 
154.56, 147.97 (4a-C), 141.49, 137.50 (8-C), 129.49 (9a18a-C), 125.28 (8/9a-C), 110.49 
(615-C), 110.06 (9-C), 105.31 (5/6-C), 74.86 (OCH2Ph), 57.72 (OMe), 47.57 (3-C), 
21.59 (1-C), 18.06 (2-C) and 17.50 (la-C). 
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OH 
CHO 
MeO 
148 
8-Hydroxy-7-methoxy-l,2-dihydro-3H-l,2-cyclopropapyrrolo[1,2-aJindole-9-
carboxaldehyde 148 
To a solution of 8-benzyloxy-7-methoxy-I,2-dihydro-3H-I ,2-cycJopropapyrrolo[I,2-
a]indole-9-carboxaldehyde 147 (0.200 g, 0.601 mrnol) in ethyl acetate (lOO cm3) was 
. added 10% palladium on carbon (0.04 g) and dilute sulfuric acid (4 drops). The mixture 
was stirred under an atmosphere of hydrogen for 12 h. After this time, the suspension 
was filtered and washed with dichloromethane. The combined filtrate and washings 
were washed with water (3 x 50 cm3), brine (40 cm3) and dried (MgS04). The organic 
layer was evaporated to dryness to give a brown solid. Purification of the residue by 
column chromatography (ethyl acetate) gave the title compound 148 (0.133 g, 91 %) as a 
colourless solid, m.p. 146-147°C; 'Ilmax 1606, 1304, 1252 and 825 cm-I; SH (250 MHz; 
CDCI3) 10.87 (I H, s, OH), 9.58 (I H, s, CHO), 6.82 (I H, d, J 8.5, 6/5-H), 6.46 (I H, d, 
J 8.5, 5/6-H), 4.04 (2 H, m, 3-H), 3.88 (3 H, s, OMe), 2.56 (2 H, m, 1,2-H), 1.45 and 
0.72 (each I H, m, la-m; Se (62.9 MHz; CDCI3) 183.20 (CHO), 159.64, 142.62, 141.15 
129.70, 118.84, 111.95 (6/5-C), 110.69,99.94 (5/6-C), 57.55 (OMe), 47.91 (3-C),21.88 
(I-C), 17.28 (la-C) and 15.93 (2-C). 
o 
CHO 
MeO 
o 149 
9.Formyl-7-methoxy·l,2.dihydro.3H.l,2.cyclopropapyrrolo[1,2.aJindole·S,8.dione 
149 
Potassium nitrosodisulfonate (0.607 g, 2.26 mmol) was added to a solution of 8-
hydroxy-7 -methoxy-I ,2-dihydro-3H-l ,2-cyclopropapyrrolo[ 1 ,2-a ]indole-9-
carboxaldehyde 148 (0.250 g, 1.03 mmol) in acetone (lOO cm3), sodium dihydrogen 
phosphate solution (0.167M, 30 cm3) and water (30 cm3) and the resulting suspension 
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stirred at room temperature for 12 h. The mixture was extracted with dichloromethane 
(3 x 50 cm3) and the combined organic extracts were dried (Na2S04) and evaporated. 
Purification of the residue by column chromatography (ethyl acetate) gave the title 
compound 149 (0.232 g, 82%) as orange needles, m.p. 217-218°C; Amax (MeOH) 447 
(Jog E 3.75), 329 (4.42),280 (4.99) and 219 nm (5.03); 'Umax (Nujol) 1684, 1666, 1637, 
1588, 1502, 1242 and 1212 cm-I; OH (250 MHz; CDCI3) 10.37 (I H, s, CHO), 5.68 (1 
H, s, 6-H), 4.32 (2 H, m, 3-H), 3.85 (3 H, s, OMe), 2.86 (I H, m, I-H), 2.47 (1 H, m, 2-
H), 1.47 and 0.65 (each I H, m, la-H); oe (62.9 MHz; CDCI3) 187.84, 186.58 (CHO), 
177.98,160.64, 150.77, 115.78, 106.47, 105.29 (6-C), 56.65 (OMe), 50.46 (3-C), 22.07 
(I-C), 16.74 (2-C) and 16.53 (la-C). 
o 
MeO 
o 150 
9-Hydroxymethyl.7.methoxy.l,2.dihydro.3H.l,2.cyclopropapyrrolo[I,2·aJindole·S,8· 
dione 150 
Sodium borohydride (0.200 g, 5.26 mmol) was added to a stirred solution of 9-forrnyl-
7-methoxy-1 ,2-dihydro-3H-I ,2-cycJopropapyrrolo[ I ,2-a]indole-5,8-dione 149 (0.200 g, 
0.778 mmol) in methanol (150 cm3). After stirring for I h at room temperature, air was 
blown rapidly through the solution and the mixture was extracted with dichloromethane 
(3 x 200 cm3). The combined extracts were washed with water (2 x 200 cm3), brine (2 x 
200 cm3) and dried (Na2S04). The solvent was evaporated and the residue purified by 
column chromatography (ethyl acetate) to give the title compound 150 (0.149 g, 74%) as 
an orange solid, m.p. 150-151·C; Amax (MeOH) 471 (log E 3.95), 348 (4.30), 290 (4.96) 
and 238 nm (4.99); 'Umax (Nujol) 3312,1668,1630,1586 and 722 cm-I; OH (250 MHz; 
CDCI3) 5.61 (1 H, s, 6-H), 4.68 (2 H, m, IO-H), 4.26 (2 H, m, 3-H), 3.89 (1 H, t, J 7.1, 
OH), 3.82 (3 H, s, OMe), 2.36 (2 H, rn, 1,2-H), 1.30 and 0.60 (each 1 H, rn, la-H); oe 
(62.9 MHz; CDCI3) 177.65, 160.85 143:81, 11.1.08, 117.36 (6-C), 56.63 (OMe), 56.52 
(IO-C), 50.04 (3-C), 26.90 (I-C), 16.42 (la-C) and 14.23 (2-C). 
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o 
OCOOPh 
MeO 
o 151 
9-Hydroxymethyl-7-methoxy-l,2-dihydro-3H-l,2-cyclopropapyrrolo[I,2-ajindole-5,S-
dione phenyl carbonate 151 .. . 
Phenyl chlorofonnate (0.03 cm3, 0.232 rnrnol) was added dropwise to a stirred, ice cold 
solution of the alcohol 150 (0.040 g, 0.153 mmol) indry pyridine (10 cm3). The 
mixture was stirred at room temperature for 2 h, then water (4 cm3) was added. The 
mixture was extracted with diethyl ether (3 x 25 cm3) and the combined organic extracts 
were washed with brine (6 x 25 cm3), water (2 x 25 cm3), saturated aqueous copper 
sulfate solution (2 x 25 cm3), water (2 x 25 cm3) and dried (Na2S04). The solvent was 
evaporated and the residue purified by column chromatography (ethyl acetate) to give 
the title compound 151 (O.054g, 92%) as an orange solid, m.p. 40-43°C (dec.); Am.x 
(MeOH) 475 (log e 3.00), 348 (3.29), 271 (4.61) and 213 nm (4.68); 'Umax (Nujol) 1785, 
1758 and 1592 cm-I; OH (250 MHz; CDCh) 7.27 (5 H, rn, Ar-H), 5.60 (1 H, S, 6-H), 
5.28 (2 H, m, lO-H), 4.28 (2 H, rn, 3-H), 3.80 (3 H, s, OMe), 2.35 (1 H, m, I-H), 2.17 (1 
H, m, 2-H), 1.26 and 0.57 (each 1 H, m, la-H). 
MeO 
o 136 
9-Hydroxymethyl-7-methoxy-l,2-dihydro-3H-l,2-cyclopropyrrolo[I,2-ajindole-5,S-
. dione carbamate 136 
A solution of phenyl carbonate 151 (0.110 g, 0.290 mmol) in dry dichloromethane (80 
cm3) was cooled to -78'C. Ammol}ia g·a~ was bubbled into the solution for. 
approximately 45 min, afte~ which time the contents were allowed to warm to room 
temperature and the solvent ·removed in vacuo. Trituration of the residue with h·ot 
dichloromethane gave the title compound 136 (0.071 g, 81 %) as red needles; m.p. 175-
177°C; Am.x (MeOH, qualitative) 234, 293, 346 and 459 nm; 'Umax (Nujol) 3408, 3212, 
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1764, 1668, 1620, 1584, 1350, 1306 and 1242 cm-I; OH (250 MHz; CDCI3IDMSO) 5.56 
(1 H, s, 6-H), 4.92 (2 H, m, IO-H), 4.42 (2 H, br s, NH2), 3.55 (2 H, m, 3-H), 3.06 (3 H, 
s, OMe), 1.83 (l H, m, I-H), 1.65 (I H, m, 2-H), 0.58 and 0.03 (each 1 H, m, la-H); oc 
(62.9 MHz; CDCI3) 177.68 (8-C), 177.20 (5-C), 160.44 (7-CICONH2), 156.77 
(CONH2n-C), 146.31 (4a-C), 129.24 (9a18a-C), 123.90 (8a19a-C), I I 1.33 (9-C), 105.35 
(6-C), 57.87 (IO-H), 56.38 (OMe), 50.00 (3-C), 20.63 (I-C), 16.17 (Ia-C) and 14.69 (2-
C). 
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6.3 Experimental/or Chapter Two (2.3) 
OBn 
MeO 
CHO 
152 
4.Benzyloxy.l.(but.3.enyl).5.methoxyindole.2.carboxaldehyde 152 
To a flask charged with sodium hydride (60%; 0.282 g, 11.73 mmol) was added dry 
light petroleum (10 cm3). The mixture was stirred for 10 min, the petroleum removed 
by syringe and the flask contents dried under vacuum. 4·Benzyloxy·5·methoxyindole· 
2-carboxaldehyde 143 (2.20 g, 7.82 mmol) in DMF (150 cm3) was added dropwise and 
the mixture was stirred at room temperature for 30 min. 4-Bromo-l-butene (4.22 g, 
31.38 mmol) was added and the mixture was stirred at room temperature. After 15 h, 
water (100 cm3) was cautiously added and the mixture was extracted with ethyl acetate 
(3 x 200 cm3). The combined extracts were washed with water (3 x 200 cm3), brine (6 x 
150 cm3), dried (MgS04)· and evaporated to give the title compound 152 (1.83 g, 70%) 
as a yellow oil; (Found: C, 75.19; H, 6.12; N, 4.14. C2IH21N03 requires C, 75.20; H, 
6.31; N, 4.18%); 'Umax (Nujol) 1714, 1673, 1614, 1520, 1467, 1417, 1355 and 1121 cm-
I; llH (250 MHz; CDCI3) 9.80 (lH, s, CHO), 7.49 (2H, m, Ar-H), 7.36 (3H, m, Ar-H), 
7.25 (IH, s, 3-H), 7.19 (lH, d, J 8.66, 7/6-H), 7.06 (lH, d, J 8.66, 6n-H), 5.77 (lH, m, 
CH2CH2CH= CH2), 5.28 (2H, s, OCH2Ph) , 4.99 (2H, m, NCH2), 4.55 (2H, m, 
CH2CH2CH= CH2), 3.91 (3H, s, OMe) and 2.50 (2H, m, CH2CH2CH= CH2); llc (69.2 
MHz; CDCI3) 182.00 (CHO), 144.92, 137.31, 135.37, 134.51 (CH2CH2CH=CH2, 
128.35, 128.01, 127.93, 122.26, 117.99 (7/6-C), 117.22 (CH2CH2CH=CH2), 115.14 (3-
C), 105.70 (6n-C), 75.11 (OCH2Ph), 58.45 (OMe), 44.30 (NCH2), 34.70 
(CH2CH2CH=CH2); mlz 335 (M+, 18%),244 (53), 204 (15), 91 (100), and 55 (31). 
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OBn 
MeO 
,&NNHTs 
153 
4-Benzyloxy-1-(but-3-enyl)-5-methoxyindole-Z-carboxaldehyde tosylhydrazone 153 
4-Benzyloxy-l-(but-3-enyl)-5-methoxyindole-2-carboxaldehyde 152 (1.824 g, 5.44 
mmol) was added to a stirred solution of 4-toluene sulfonyl hydrazide (1.640 g, 8.81 
mmol) in methanol (50 cm3). After stirring at 40'C for 15 h, the solvent was removed in 
vacuo and the residue was purified by column chromatography (50% light 
petroleuml50% diethyl ether) to give the title compound 153 (2.446 g, 89%) as a pale 
yellow oil; (Found: M+H+, 504.1960. C2SH29N304S requires M+H, 504.1957); 'Ilmax 
(film) 2935, 1598, 1492, 1463, 1434, 1345, 1249 and 1166 cm-I; OH (8.52 (lH, br s, 
NH), 7.82 (2H, d, J 8.5, Ts-H), 7.76 (lH, s, HC=N), 7.46 (2H, m, Ar-H), 7.36-7.16 (5H, 
m, Ar-H), 6.97 (2H, AB, J 8.75, 617-H), 6.60 (lH, s, 3-H), 5.73 (lH, m, 
CH2CH2CH=CH2), 5.18 (2H, s, OCH2Ph), 5.00 (2H, m, NCH2), 4.34 (2H, m, 
CH2CH2CH=CH2), 3.85 (3H, s, OMe) and 2.34 (5H, m, CH2CH2CH=CH2 and Ar-
Me); oc 144.96, 144.24, 141.30 (HC=N), 141.10, 138.04, 136.66, 135.39, 134.85 
(CH2CH2CH=CH2)131.90, 129.92, 128.45, 128.35, 128.04, 127.98, 122.45, 116.91 
(CH2CH2CH=CH2), 114.52 (7/6-C), 107.13 (3-C), 105.07 (617-C), 75.06 (OCH2Ph), 
58.37 (OMe), 44.55 (NCH2), 34.26 (CH2CH2CH=CH2) and 21.51 (Me); mlz (FAB, 3-
NBA Matrix) 504 (M + H+, 65%),412 (lOO), 348 (8), 258 (13), 228 (25),216 (25), 201 
(9), 185 (8), 115 (5) and 105 (7). 
OBn 
MeO 
9-Benzyloxy-8-methoxy-l,Z-dihydro-3H,4H-1,Z-cyclopropapyrido[l,Z-ajindole 154 
Sodium hydride (60%; 0.152 g, 6.34 mmol) was added to a stirred solution of the 
tosylhydrazone 153 in dry THF (20 cm3). After 20 min, the solution was filtered and 
the filtrate evaporated. The residue was dissolved in dry chlorobenzene (250 cm3) and 
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the solution refluxed for 3 h. The solvent was evaporated and the residue purified by 
column chromatography (50% light petroleum: 50% diethyl ether) to give the title 
compound 154 (1.179 g, 76%) as a pale yellow oil; (Found: C, 78.33; H, 6.74; N, 4.28. 
C21H21N02 requires C, 78.97; H, 6.63; N, 4.39); llmax (film) 1556, 1495, 1326 and 
1271 cm-I; OH (400 MHz; CDCI3) 7.59 (2H, m, Ar-H), 7.43-7.28 (3H, m, Ar-H), 6.88 
(2H, s, 7/6-H), 6.42 (IH, br s, IO-H), 5.25 (2H, s, OCH2Ph), 4.17 (JH, m, 4-CHH), 3.90 
(3H, s, OMe), 3.55 (lH, ddd, J 3 and 8, 4-CHH), 2.31-2.19 (3H, m, 3-CH2 and I-H), 
1.69 (lH, m, 2-H), 1.07 and 0.92 (each lH, m, la-H); oe (100.6 MHz; CDCI3) 145.57, 
140.80, 139.15, 139.01, 133.72, 128.66, 128.32, 127.99, 123.26, 110.37 (7/6-C), 103.58 
(6n-C), 95.05 (IO-C), 75.21 (OCH2Ph), 59.03 (OMe), 37.52 (4-C), 21.64 (3-C), 12.42 
(2-C), 10.91 (J-C) and 9.96 (la-C); mlz 319 (M+, 13%),228 (100),185(18) and 91 (43). 
MeO 
9-Benzyloxy-8-methoxy-1,2-dihydro-3H,4H-1,2-cyclopropapyridol,2-aJindole-10-
carboxaldehyde 165 
DMF (0.51 cm3; 0.481 g, 6.52 mmol) and phosphorus oxychloride (0.14 cm3; 0.226 g, 
1.48 mmol) were stirred at -5'C for 30 min. A solution of9-benzyloxy-8-methoxy-l,2-
dihydro-3H,4H-l,2-cyc1opropapyrrolo[I,2-a]indole 154 (0.421 g, 1.32 mmol) in DMF 
(3 cm3) was added slowly dropwise maintaining the temperature below 10·C. After the 
addition was complete the mixture was stirred at 35'C for 1 h. Ice water (10 cm3) 
followed by sodium hydroxide solution (37%; 10 cm3) was added and the mixture 
extracted with diethyl ether (3 x 100 cm3). The ether layer was dried (MgS04) and 
concentrated in vacuo. The crude mixture was columned (diethyl ether) giving the title 
compound 165 (0.263 g, 57%) as a pale yellow solid; m.p. 135.9·C (Found C, 75.89; H, 
5.80; N, 4.08. C22H21N03 requires C, 76.~6; H, 6.09; N, 4.03.); llmax (Nujol) 1634, 
1523,1255 and 742 cm- l ;oH (250 MHz; CDCI3) 10.52 (lH, s, CHO), 7.41-7.26 (5H, m, 
Ar-H), 6.91 (2H, s, 7/6-H), 5.17 (2H, s, OCHiPh), 4.17 (JH, m, 4-CHH), 3.84 (3H, s, 
OMe), 3.52 (lH, ddd, J 13 and 5.25 4-CI:IH), 3.39 (JH, ddd, J 8.75 and 4.25, I-H), 2.33 
(lH, rn, 3-CHH), 2.13 (lH, m, 3-CHH), 1.77 (JH, m, 2-H), 1.30 and 1.08 (each lH, m, 
la-H); oe (69.2 MHz; CDCI3) 187.68 (CHO), 148.19, 147.94, 137.44, 132.43, 128.38, 
127.96, 113.19, 109.97 (7/6-C), 104.29 (6n-C), 74.71 (OCH2Ph), 57.63 (OMe),37.43 
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(4-C), 20.13 (3-C), 13.45 (2-C), 10.88 (la-C) and 10.59 (1-C); mlz 347 (M+, 8%), 267 
(31),256 (66),155 (60), 186 (30),113 (57),91 (53),51 (lOO) and 28 (88). 
OH 
MeO 
9-Hydroxy-8-methoxy-1,2-dihydro-3H,4H-1,2-cyclopropapyrido[1,2-ajindole-10-
carboxaldehyde 167 
To a solution of 9-benzyloxy-8-methoxy-l ,2-dihydro-3H,4H-l ,2-cyclopropapyrrido[1 ,2-
alindole-IO-carboxaldehyde 165 (0.263 g, 0.76 mmol) in ethanol (200 cm3) was added 
10% palladium on carbon (0.097 g). The mixture was stirred under an atmosphere of 
hydrogen (60psi) for 12 h. After this time the suspension was filtered and washed with 
dichloromethane (250 cm3). The combined filtrate and washings were washed with 
water (3 x 100 cm3, brine (75 cm3) and dried (MgS04). The organic layer was 
condensed in vacuo to give a yellow solid. Purification of the residue by column 
chromatography (50% ethyl acetate: 50% light petroleum) gave the title compound 167 
(0.134 g, 69%) a pale yellow solid, m.p. 183'C (Found: M+H+, 258.1130. ClSHlSN03 
requires M+H, 258.1130); 'Ilmax (film) 1733, 1645, 1602,865 and 779 cm-I; liB (250 
MHz; CDCI3) 11.24 (lH, s, OH), 9.69 (lH, s, CHO), 6.91 (lH, d, J 8.75, 7/6-H), 6.58 
(IH, d, J 8.75, 6n-H), 4.15 (IH, m, 4-CHH), 3.91 (3H, s, OMe), 3.49 (IH, ddd, J 13 and 
5.25, 4-CHH), 2.59 (lH, ddd, J 8.4 and 4.25, I-H), 2.36 (lH, m, 3-CHH), 2.18 (lH, m, 
3-CHH), 1.93 (lH, m, 2-H), 1.35 and 1.17 (each IH, m, la-H); lie (100.6 MHz; CDCI3) 
182.74 (CHO), 152.65, 143.11, 141.37, 133.21, 115.55, 114.98, 112.14 (7/6-C), 98.84 
(6n-C), 57.76 (OMe), 37.55 (4-C), 19.95 (3-C), 13.69 (2-C), 11.37 (la-C) and 8.58 (1-
C); mlz 257 (M+, 24%), 217 (15), 186 (14), 155 (26), 124 (15), 113 (26),70 (13), 51 
(55) and 28 (100). 
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o 
CHO 
MeO 
10-Formyl-8-methoxy-1,2-dihydro-3H,4H-1,2-cyclopropapyrido[1,2-aj-6,9-dione 168 
Potassium nitrosodisulfonate (0.223 g, 0.83 mmol) was added to a: solution of 9-
hydroxy"8-methoxy~ 1 ,2-dihydro~3H,4H-l,2-cyclopropapyrrido[1 ,2-a lindole~ 1 0-
carboxaldehyde 167 (0.097 g, 0.38 mmol) in acetone (65 cm3), sodium dihydrogen 
phosphate solution (0.167M; 25cm3) and water (25 cm3) and the resulting suspension 
stirred at room temperature for 12 h. The mixture was extracted with ethyl acetate (3 x 
75 cm3) and the combined organics were dried and evaporated. Purification of the 
residue by column chromatography (ethyl acetate) gave the title compound 168 (0.091 
g, 89%) as orange crystals, m.p. 168'C, (Found:M+, 271.0853. CI5HI3N04 requires 
271.08445); A.max (MeOH) 458 (log E 2.99), 331 (3.58),282 (4.27) and 227 nm (4.30); 
umax (Film) 1678, 1663, 1637, 1603, 1512, 1486, 1237, 1219, 1152 and 834 cm-I; OH 
(250 MHz; CDCi3) 10.54 (lH, s, CHO), 5.66 (IH, s, 6-H), 5.11 (lH, m, 4-CHH), 3.84 
(3H, s, OMe), 3.57 (lH, ddd, J 14.8 and 5.25, 4-CHH), 3.14 OH, ddd, J 8.75 and 4.5, 1-
H), 2.27 (IH, m, 3-CHH), 2.08 (IH, m, 3-CHH), 1.79 OH, m, 2-H), 1.27 and 1.13 (each 
IH, m, la-H); oe (100.6 MHz; CDCI3) 188.06 (CHO), 179.04 (9-C), 177.77 (6-C), 
159.65, 145.34, 128.01, 122.55, 119.33, 106.44 (7-C), 56.65 (OMe), 40.42 (4-C), 19.94 
(3-C), 13.58 (2-C), 10.24 (la-C) and 9.97 (I-C); mJz 271 (M+, 100%),228 (15), 200 
(17),186 (23),155 (29), 132 (19), 113 (27), 77 (18), 51 (59) and 28(97). 
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MeO 
10-Hydroxymethyl-8-methoxy-1,2-dihydro-3H,4H-1,2-cyclopropapyrido[1,2-ajindole-
6,9-dione 173 
Sodium borohydride (0.039 g, 1.02 mmol) was added to a stirred solution of 10-formyl-
8-methoxy-l,2-dihydro-3H,4H-l,2-cyclopropapyrrido[I,2-alindole-6,9-dione 168 
(0.034 g, 0.13 mmol) in methanol (30 cm3). After stirring for 1 h at room temperature, 
air was blown rapidly through the solution and the mixture was extracted with 
. dichloromethane (3 x 50 cm3). The combined extracts were washed with water (2 x 50 
cm3), brine (2 x 50 cm3) and dried (MgS04). The solvent was removed and the residue 
purified by column chromatography to give the title compound 173 (0.012 g, 36%) as 
an orange solid, m.p. 175·C (Found: M+, 273.0991. CISHISN04 requires M, 273.1001); 
Amax (MeOH) 483 (log e 3.35), 354 (3.54), 292 (4.30) and 245 nm (4.38); 'l>max (film) 
3409, 1667, 1627, 1594 and 1153 cm-I; OH (400 MHz; CDCI3) 5.52 (lH, s, 7-H), 4.92 
(lH, m,4-CHH), 4.62 (2H, m, ll-H), 3.88 (lH, br s, OH), 3.74 (3H, s, OMe), 3.49 (lH, 
m, 4-CHH), 2.06 (3H, m, 3-H and 1-H), 1.61 (lH, m, 2-H), 0.88 and 0.80 (each lH, m, 
la-H); oe (62.9 MHz; CDCI3) 179.82 (9-C), 178.82 (6-C), 159.89, 136.65, 128.21, 
122.53,122.21,107.49,56.94 (OMe), 55.80 (l1-C), 4Q.43 (4-C), 20.92 (3-C), 12.47 (2-
C), 9.80 (la-C) and 8.43 (l-C); mlz 273 (M+, 13%),212 (11),163 (8), 155 (15), 132 (9), 
113 (17), 69 (14), 51 (18),28 (lOO). 
MeO 
10-Hydroxymethyl-8-methoxy-1H,3H,4H-2-methylpyrido[1,2-ajindole-6,9-dione 174 
The title compound 174 was isolated in (OmO g, 30%) as an orange solid, m.p. 173·C 
(Found: M+, 275.1157. CISH17N04 requires M, 275.11575); 'l>max (film) 3419, 1670, 
113 
1634, 1596, 1219, 1149 and 1054 cm·l ; liB (250 MHz; CDCh) 5.63 OH, s, 7-H), 4.68 
(IH, m, 4-CHH), 4.58 (2H, m, II-H), 4.02 (2H, m, 4-CHH) and OH), 3.82 (3H, s, 
OMe), 2.95 (IH, m, l-CHH), 2.27 (lH, m, l-CHH), 2.03 (2H, m, 3-CHH and 2-H), 1.62 
(lH, m, 3-CHH) and 1.14 (3H, d, J 6.5, Me); lie (100.6 MHz; CDCh) 179.45 (9-C), 
178.29 (6-C), 159.77, 134.41, 128.74, 122.39, 121.61, 107.09,56.53 (OMe), 55.39 (11-
C), 45.44 (4-C), 30.62 (3-C), 29.97 (l-C), 26.30 (2-C) and 21.20 (Me); m/z 275 (M+, 
18%),217 (16),163 (16),151 (31), 124 (19),113 (33), 57 (29), 51 (100),40 (29), 31 
(51). 
MeO 
10-Hydroxymethyl-8-methoxy-l,2-dihydro-3H,4H-1,2-cyclopropapyrido[I,2-aJindole-
6,9-dione phenyl carbonate 137 
Phenyl chlorofonnate (0.009 cm3; 0.011 g, 0.07 mmol) was added dropwise to a stirred, 
ice cold solution of alcohol 173 (0.012 g, 0.04 mmol) in dry THF (10 cm3) and pyridine 
(5 drops). The mixture was stirred at room temperature for 2 h then water (5 cm3) was 
added. The mixture was extracted with dichloromethane (3 x 25 cm3). The combined 
extracts were washed with water (3 x 25 cm3), brine (50 cm3) and dried (Na2S04). The 
solvent was evaporated and the residue purified by column chromatography (diethyl 
ether) to give the phenyl carbonate 137 (0.013 g, 75%) as an orange gummy solid; m.p. 
54'C (dec.); Amax (MeOH) 480 (log £ 3.11), 346 (3.29), 292 (4.09), 244 (4.14) and 223 
nm (4.20); 'Ilmax (film) 1669, 1630 and 1597 cm· l ; liB (400 MHz; CDCI3) 7.29-6.94 
(5H, m, Ar-H), 5.57 (IH, s, 7-H), 5.36 (2H, AB, J 12, H-H), 5.01 (lH, m, 4-CHH), 3.79 
(3H, s, OMe), 3.56 OH, m, 4-CHH), 2.32-2.16 (3H, m, 3-CH2 and I-H), 1.61 OH, m, 2-
H) and 0.97 (2H, m, la-CH2); lie 000.6 MHz; CDCI3) 178.64 (9-C), 178.22 (6-C), 
159.61 (8-ClOCOOPh), 158.75 (OCOOPhl8-C), 139.47 (4a-C), 129.43, 127.29, 121.46, 
120.91,116.48, 115.18, 106.73 (7-C), 60.60(11-C), 56.41 (OMe), 40.08 (4-C), 20.55 
(3-C), 12.11 (2-C), 9.42 (la-C) and 8.37 (l-C) ... 
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. 6.4 Experimental for Chapter Three 
MeO 
OBn 
CHO 
N 
213 I .." ~Ph 
4-Benzyloxy-S-methoxy-l-(l-phenyl-l-propenyl)indole-2-carboxaldehyde 213 
To a flask charged with sodium hydride (80%; 0.202 g, 8.41 mmol) was added dry light 
petroleum (10 cm3). The mixture was stirred for 10 min, the petroleum removed by 
syringe and the flask contents dried under reduced pressure. 4-Benzyloxy-5-
methoxyindole-2-carboxaldehyde 143 (1.873 g, 6.66 mmol) in DMF (150 cm3) was 
added dropwise and the mixture was stirred at room temperature for 1 h. Cinnamyl 
bromide (2.625 g, 13.32 mmol) was added and the mixture was stirred at room 
temperature. After 12 h, water (85 cm3) was cautiously added and the mixture was 
extracted with diethyl ether (4 x 150 cm3). The combined ethereal extracts were washed 
with water (8 x 100 cm3), brine (lOO cm3), dried (MgS04) and evaporated to give the 
title compound 213 (1.746 g, 66%) as a yellow solid, m.p. 105· C; (Found: C, 78.7; H, 
5.9; N, 3.3 C26H23N03 requires C, 78.6; H, 5.8; N, 3.5%); '\)max (Nujol) 1666, 1519, 
1488,1377 and 1142 cm-I; 8H (250 MHz; CDCI) 9.81 (lH, s, CHO), 7.49 (2H, m, Ar-
H), 7.38-7.25 (4H, m, Ar-H), 7.22 (4H, m, Ar-H), 7.17 (2H, m, 7/6-H), 7.12 (!H, s, 3-
H), 6.34 (2H, m, N-CH2), 5.32 (2H, m, CH2CH=CHPh), 5.29 (2H, s, OCH2Ph) and 3.91 
(3H, s, OMe); 8c (69.2 MHz; CDCI3) 182.45 (CHO) 145.19, 137.82, 137.40, 136.31, 
135.28,131.85,128.83,128.46, 128.41,128.07,127.99,127.69, 126.43, 126.20, 124.87, 
118.17, 115.33, 105.93,75.19 (OCH2Ph), 58.43 (OMe) and 46.55 (NCH2); m/z 397 
(MH+, 8%),155 (14), 117 (88), 91 (100) and 51 (56). 
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4-Benzyloxy-S-methoxy-l-(l-phenyl-l-propenyl)indole-2-carboxaldehyde 
tosylhydrazone 214 
4-Benzyloxy-5-methoxy-l-(I-phenyl-l-propenyl)indole-2-carboxaldehyde 213 (0.842 g, 
2.12 rnrnol) was added to a stirred solution of toluenesulfonyl hydrazide (0.510 g, 2.74 
mmol) in dry methanol (25 cm3). After stirring the mixture at 40'C for 3 h, the solvent 
was removed in vacuo and the dark green residue was purified by column 
chromatography (50% diethyl ether: 50% light petroleum) to give a cream foam. 
Recrytallisation of this foam from ethyl acetate and light petroleum gave the title 
compound 214 (0.731 g, 61%) as a colourless solid; m.p. 142'C, (Found: C, 70.2; H, 
5.2; N, 7.7. C33H31N304S requires C, 70.1; H, 5.5; N, 7.4%); '\)max (Nujol) 3209, 3185, 
1711,1517,1317 and 1162 cm-I; OH (250 MHz; CDCh) 7.75 (3H, rn, Ar-H), 7.46 (2H, 
rn, NH and CH=N), 7.25-7.22 (8H, rn, Ar-H), 7.00 (4H, m, 7/6-H and Ar-H), 6.66 (lH, 
s, 3-H), 6.23 (2H, m, CH2CH=CHPh), 5.20 (2H, s, OCH2Ph), 5.19 (2H, rn, N-CH2), 
3.86 (3H, s, OMe) and 2.18 (3H, s, Ar-Me); oe (62.9 MHz; CDCI3) 145.19, 144.20, 
140.93, 136.72,136.58,135.05,131.81,131.26,129.67,128.49, 128.38, 128.07, 127.90, 
127.88, 127.58, 126.49, 125.25, 122.62, 114.66, 107.39 (7/6-C), 105.32 (617-C), 75.11 
(OClhPh), 58.30 (OMe). 46.96 (NCH2) and 21.41 (Ar-Me); mlz (FAB, 3-NBA Matrix) 
566 (MH+, 63%), 474 (54). 290 (18) and 117 (100). 
OBn 
MeO 
H 
Ph 
8-Benzyloxy-7-methoxy-l,2-dihydro-la-phenyl-3H-l,2-cyclopropapyrrolo[1,2-ajindole 
215 
, 
Sodium hydride (80%; 0.069 g. 2.85 mmol) was added to a stirred solution of the 
tosylhydrazone 214 (0.253 g. 0.45 mmol) in dry THF (10 cm3). After 2 h the solution 
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was filtered and the filtrate evaporated. The residue was dissolved in dry chlorobenzene 
(100 cm3) and the solution refluxed for 12 h. The solvent was evaporated and the 
residue purified by column chromatography (50% diethyl ether/50% light petroleum) to 
give the title compound 215 (0.144 g, 84%) as a pale yellow oil (Found: M+, 381.1735. 
C26H23N02 requires M, 381.1729); "Ilmax (film) 1602, 1577, 1570, 1561, 1491, 1454, 
1434 and 1254 cm-I; OH (250 MHz; CDCh) 7.53 (2H, m, Ar-H), 7.36-7.19 (6H, m, Ar-
H), 7.07-7.04 (2H, m, Ar-H), 6.83 (2H, m, 6/5-H), 6.25 (lH, s, 9-H), 5.21 (2H, s, 
OCH2Ph), 4.17 (2H, m, NCH2), 3.86 (3H, s, OMe), 2.66 (2H, m, I-H and 2-H) and 2.06 
(lH, m, la-H); oe (62.9 MHz; CDCI3) 145.94, 145.25, 139.99, 131.01, 130.55, 129.53, 
128.53,128.29, 127.96, 127.67, 126.26, 126.12, 125.52, 110.44 (6/5-C), 104.24 (5/6-C), 
89.81,74.93 (OCH2Ph), 58.50 (OMe), 47.17, 34.62 (la-C), 31.51 (2-C) and 27.05 (1-
C); mlz 381 (M+, 10%),290 (41),247 (7), 200 (9),170 (8),117(14) and (lOO). 
OBn 
MeO 
216 
CHO 
H 
Ph 
8-Benzyloxy-7-methoxy.l,2.dihydro.la·phenyl.3H.l,2.cyclopropapy"olo[1,2. 
aJindole.9.carboxaldehyde 216 
DMF (0.58 cm3) and phosphorus oxychloride (0.70 cm3) were stirred under a calcium 
oxide drying tube for 10 min. The resulting yellow precipitate was cooled to O·C and an 
amount of this yellow precipitate (0.212 g; 0.069 g, 0.94 mmol DMF and 0.144 g, 0.94 
mmol phosphorus oxychloride) was added to 8-benzyloxy-7-methoxy-l,2-dihydro-la-
phenyl-3H·l,2-cycIopropapyrrolo[I,2-a]indole 215 (0.298 g, 0.78 mmol) in DMF (20 
cm3). The mixture was stirred at room temperature for 2 h. Sodium acetate (lM, 5 cm3) 
was added to the mixture which was then extracted with ethyl acetate (3 x 20 cm3). The 
combined extracts were washed with water (6 x 20 cm3), brine (50 cm3) and dried 
(MgS04). Removal of the solvent in vacuo gave a brown solid which was triturated 
with a small quantity of ethyl acetate and the resulting precipitate filtered off. The 
mother liquors were purified by column chromatography (diethyl ether) to give the title 
compound 216 (0.188 g, 59%) as pale yellow solid, m.p.144·C (Found: M+, 409.1723. 
C27H23N03 requires M,409.1678); "Ilmax (Nujol) 1648, 1529 and 1491 cm-I; OH (250 
MHz; CDCI3) 10.34 (lH, s, CHO), 7.51-7.47 (2H, m, Ar-H), 7.40-7.22 (6H, m, Ar-H), 
\ 
7.14-7.10 (2H, m, Ar-H), 6.91 (2H, m, 5-H and 6-H), 5.19 (2H, s, OCH2Ph), 4.26 (2H, 
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m, NCH2), 3.92 (3H, s, OMe), 3.30 (!H, m, I-H), 2.73 (1H, m, 2-H) and 2.13 (!H, t, J 
3.44, la-H); lie (62.9 MHz; CDCIJ) 186.30 (CHO), 153.07, 148.01, 141.57, 138.78, 
137.47, 129.61, 128.59, 128.47, 128.45, 128.07, 126.75, 126.05, 125.32, 110.63 (6/5-C), 
110.09, 105.37 (5/6-C), 74.90 (OCH2Ph), 57.69 (OMe), 48.13 (3-C), 34.78 (la-C); 
31.07 (2-C) and 28.18 (1-C); m/z 409 (M+, 15%), 318 (64), 91(77), 51(100). 
OH 
MeO 
224 
CHO. 
H 
Ph 
8-Hydoxy-7-methoxy-l,2-dihydro~la~phenyl-3H-l,2-cyclopropapyrrolo[1,2-a]indole-
9-carboxaldehyde 224 
To a solution of 8-benzyloxy-7-methoxy-I,2-dihydro-la-phenyl-3H -1,2-
cycJopropapyrrolo[I,2-aJindole-9-carboxaldehyde 216 (0.131 g, 0.32 mmol) in ethanol 
(150 cm3) was added 10% palladium on carbon (0.093 g). The mixture was stirred 
under an atmosphere of hydrogen for 12 h. After this time, the suspension was filtered 
and washed with dichloromethane (150 cm3). The combined filtrate and washings were 
washed with water (3 x 50 cm3), brine (50 cm3) and dried (MgS04). The organic layer 
was evaporated to dryness to give a brown residue. Purification of the residue by 
colunm chromatography (diethyl ether) gave the title compound 224 (0.093 g, 87%) as 
a colourless solid, m.p. 176"C, (Found: M+, 318.1135. C20HI6N03 requires M, 
318.1130); umax (film) 1603, 1298, 1252 and732 cm-I; IiH (400 MHz; CDCI3) 10.84 
(IH, s, OH), 9.24 (!H, s, CHO), 7.34-7.23 (5H, m, Ar-H), 6.84 (!H, d, J 8.5, 6/5-H); . 
6.50 (1H, d, J 8.5, 5/6-H), 4.08-4.01 (2H, m, 3NCH2), (3H, s, OMe), 2.97 (!H, m, I-H), 
2.89 (!H, m, 2-H) and 2.23 (!H, t, J 3.6, la-H); lie (100.6 MHz; CDCI3) 183.32 (CHO), 
157.72, 143.23, 141.85, 138.08, 130.26, 128.88, 128.69, 127.18, 125.76, 119.22, 112.86 
(6/5-C), 111.14,99.93 (5/6-C), 57.87 (OMe), 48.59 (3-C), 34.71 (Ia-C), 31.09 (2-C) and 
26.57 (1-C); m/z 318 (M+, 3%), 267 (15),186 (23),155 (39), 91 (30),51 (67) and 31 
(100). 
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9-Fonnyl-7-methoxy-I,2-dihydro-Ia-phenyl-3H-I,2-cyclopropapyrrolo[l,2-aJindole-
5,8-dione 225 
Potassium nitrosodisulfonate (0.089 g, 0.33 mmol) was added to a solution of 8-
hydroxy-7 -methoxy-l,2-dihydro-l a-phenyl-3H-l,2-cyclopropapyrrolo[ 1,2-a lindole-9-
carboxaldehyde 224 (0.048 g, 0.15 mmol) in acetone (17 cm3), sodium dihydrogen 
phosphate (0. 167M, 17 cm3) solution and water (6 cm3) and the resulting suspension 
stirred at room temperature for 12 h. The mixture was extracted with ethyl acetate (3 x 
50 cm3) and the combined organics were dried (Na2S04) and evaporated. Purification 
of the residue by column chromatography (ethyl acetate) gave the title compound 225 
(0.085 g, 94%) as orange crystals, m.p. 185·C, (Found: M+, 333.0991. C20HISN04 
requires M, 333.1001); Amax (MeOH) 455 (log £ 2.36), 283 (3.74) and 223 nm (3.81); 
'Ilmax (Nujol) 1678, 1671, 1666, 1639, 1594 and 1508 cm-I; OH (250 MHz; CDCI3) 
10.36 (!H, s, CHO), 7.37-7.18 (5H, m, Ar-H), 5.70 (!H, s, 6-H), 4.39 (IH, m, 3-CHH), 
3.96 (1H, m, 3-CHH), 3.85 (3H, s, OMe), 3.33 (2H, m, IH and 2-H) and 2.91 (!H, m, 
la-H); Oc (100.6 MHz; CDCI3) 186.41 (CHO), 178.10 (8-C), 177.21 (5-C), 160.83 (7-
C), 149.56 (4a-C), 138.37 (9aJ8a-C), 138.00 (8aJ9a-C), 128.70, 127.05, 126.10, 115.90 
(9-C), 105.56, 105.43 (6-C), 56.77 (OMe), 51.07 (3-C), 33.93 (la-C), 30.77 (2-C) and 
26.66 (1-C); mlz 333 (M+. 16%),267 (24), 217 (30), 186 (28), 155 (56), 113 (51) and 
51 (100). 
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9-Hydroxymethyl-7-methoxy-I,2-dihydro-Ia-phenyl-3H-I,2-cyclopropapyrrolo[1,2-
aJindole-S,8-dione 228 
Sodium borohydride (0.051 g, 1.34 mmol) was added to a stirred solution of the quinone 
aldehyde 225 (0.063 g, 0.19 mmol) in methanol (43 cm3). After stirring for I h at room 
temperature, air was blown rapidly through the solution and the mixture was extracted 
with dichloromethane (3 x 75 cm3). The combined extracts were washed with water, (3 
x 75 cm3), brine (75 cm3) and dried (Na2S04). The solvent was evaporated and the 
residue purified by column chromatography (ethyl acetate) to give the title compound 
228 (0.049 g, 78%) as a red solid, m.p. 157'C, (Found: M+ 335.1160. C20H17N04 
requires M, 335.1158); Amax (MeOH) 474 (log e 1.99),346 (2.31), 285 (3.06), 244 
(3.23) and 205 nm (3.27); 'Ilmax (Film) 3400,1669,1635, 1586 and 1492 cm-I; OH (250 
MHz; CDCh) 7.36-7.06 (5H, m, Ar-H), 5.64 (lH, s, 6-H), 4.68 (2H, m, 10-H),4.43 
(2H, m, 3-CH2), 3.90 (lH, m, OH), 3.84 (3H, s, OMe), 2.66 (2H, m, lH and 2-H) and 
2.04 (lH, m, la-H); oc (100.6 MHz) 178.85 (8-C), 177.68 (5-C), 160.70 (7-C), 142.81, 
138.76, 128.72, 127.35, 126.78, 125.59, 125.01, 117.51, 105.90 (6-C), 56.69 (l0-C), 
56.49 (OMe), 50.51 (3-C), 33.65 (la-C), 30.69 (2-C) and 24.83 (I-C); m/z 335 (M+, 
19%),317 (15), 267 (17), 236 (14), 217 (21), 186 (21), 155 (45),124 (27),113 (40), 91 
(37),70 (23), 51 (lOO) and 31 (73). 
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9.Hydroxymethyl.7.methoxy.I,2.dihydro.la.phenyl.3H.I,2.cyclopropapyrrolo[I,2. 
ajindole·5,8·dione carbamate 230 
Phenyl chlorofonnate (0.018 cm3; 0.022 g, 0.14 mmol) was added dropwise to a stirred, 
ice cold solution of the alcohol 228 (0.0296 g, 0.09 mmol) in dry THF (10 cm3) and 
pyridine (10 drops). The mixture was stirred at room temperature for 2 h, then water (5 
cm3) was added. The mixture was extracted with dichloromethane (3 x 25 cm3) and the 
combined extracts were washed with water (3 x 25 cm3), CUS04 (25 cm3), brine (50 
cm3) and dried (Na2S04). The solvent was evaporated and the residue purified by 
column chromatography (diethyl ether) to give the phenyl carbonate as an orange 
gummy solid. 
A solution of phenyl carbonate in dry dichloromethane (25 cm3) was cooled to ·78"C. 
Ammonia gas was bubbled into the solution for approximately 45 min (150 cm3), after 
which time the contents were allowed to wann to room temperature and the solvent 
removed in vacuo. Purification of the residue by column chromatography (diethyl ether) 
gave the title compound 230 (0.0298 g, 89%) as an orange crystalline solid, m.p. 144"C, 
(Found: PegH, 415.2545. C21HlSN20S requires PegH, 415.2543), Amax (MeOH) 462 
(log e 2.04), 345 (2.22), 289 (3.17) and (233 (3.19), 1lmax (Film) 3379, 3211, 1767, 
1671,1636,1631,1590,1498,1401,1347 and 1237 cm-I, (iH (400 MHz; CDCI3) 7.30-
7.09 (5H, m, Ar-H), 5.62 (lH, s, 6-H), 5.26 (2H, m, 10-H), 4.58 (2H, br s, NH2), 4.43 
(2H, m, 3-H), 3.80 (3H, s, OMe), 2.82 (lH, m, I-H or la-H), 2.63 (lH, m, I-H or la-H) 
and 2.02 (2H, m, 2-H); (ic (100.6 MHz; CDCI3) 177.87 (8-C), 177.63 (5-C), 160.56 (7-
CICONH2), 156.79 (CONH2n-C), 146.38 (4a-C), 129.35 (9a18a-C), 123.90 (8a19a-C), 
117.53 (9-C), 105.94 (6-C), 56.72 (IO-C), 56.53 (OMe), 50,62 (2-C), 33.89 (Ia-C), 
30.74 (2-C) and 25.03 (I-C); mlz 379 (M + H+, 11 %),330 (15),308 (15),290 (12), 179 
(15), 156 (23) and 140 (20). 
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OBn 
Meo~ 
VLN' 
I 
242 H 
4-Benzyloxy-S-methoxyindole 242 
Bis (triphenylphosphine) carbonylrhodium chloride (0.197 g, 0.29 mmol) was suspended 
in dry degassed mesitylene (20 cm3) and warmed to 80'C. After 10 min, 1,3-bis 
(diphenylphosphino)propane (0.344 g, 0.84 mmol) was added and a yellow precipitate 
formed. After a further 10 min 4-benzyloxy-5-methoxyindole-2-carboxaldehyde 143 
(0.750 g, 2.67 mmol) was added and the flask plunged into a woods metal bath at 190'C. 
The mixture was refluxed for 2 h. The crude mixture was concentrated and purified by 
column chromatography (50% diethyl ether! 50% light petroleum) to give the title 
compound 242 (0.608 g, 90%) as a brown solid; m.p. 83-84' C (lit. 83-84'C); 'Ilmax 
(Nujol) 3327, 3024 and 1490 cm-I; BH (250 MHz; CDCI3) 8.09 (IH, br s, NH), 7.54-
7.51 (2H, m, Ar-H), 7.40-7.26 (3H, m, Ar-H), 7.03 (3H, m, 7!6-H and 2-H), 6.55 (IH, 
m, 3-H), 5.24 (2H, s, OCH2Ph) and 3.88 (3H, s, OMe); Bc (69.2 MHz; CDCb) 145.11, 
138.35, 132.80, 128.31, 128.06, 127.75, 124.55, 118.40, 112.13, 107.40, 106.22, 100,02, 
74.99 (OCH2Ph), 58.54 (OMe). 
'6joBn CHO MeO If? I ' ~ N 
I 
243 H 
4-BenzyloxY-S-methoxyindole-3-carboxaldehyde 243 
DMF (0.68 cm3; 0.652 g, 8.92 mmol) and phosphorus oxychloride (0.19 cm3; 0.316 g, 
." ." 
2.06 mmol) were stirred at -5'C for 30 min. A solution of 4-benzyloxy-5-
methoxyindole 242 (0.466 g, 1.84 mmol) in DMF (3 cm3) was added slowly dropwise 
maintaining the temperature below IO'C. After the addition was completed the mixture 
was stirred at 35'C for 1 h. Ice water (10 cm3) followed by sodium hydroxide solution 
122 
(37%; 10 cm3) was added and the mixture extracted with diethyl ether (3 x 100 cm3). 
The ether layer was dried (MgS04) and concentrated in vacuo. The crude mixture was 
columned (50% diethyl etherl 50% light petroleum) giving the title compound 243 
(0.269 g, 57%) as a colourless solid, mp. 113-114· C (lit.113-114"C); U max (Nujol) 
3033,2964, 1712 and 1634 cm-I; BH (250 MHz; CDCb) 10.26 OH, s, CHO), 10.25 
(lH, br s, NH), 7.75 (IH, d, J 3.23, 2-H), 7.49-7.28 (5H, m, Ar-H), 7.04 OH, d, J 8.75, 
7/6-H),.6.93 (lH, d, J 8.75, 6n-H), 5.20 (2H, s, OCH2Ph), 3.90 (3H, s, OMe); Bc (69.2 
MHz; CDC13) 187.28, 147.82, 140.80, 137.36, 133.40, 132.43, 128.65, 128.47, 128.19, 
120.95, 118.28, 111.94 (7/6-C), 108.28 (6n-C), 75.42 (OCH2Ph), 57.63 (OMe). 
m
OBn 
CHO 
MeO ~ 
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258 I ~CI 
4-Benzyloxy-l-(3-chloropropyl)-5-methoxyindole-3-carboxaldehyde 258 
A mixture of 4-benzyloxy-5-methoxyindole-5-carboxaldehyde 243 (0.122 g, 0.43 
mmol), powdered 87% potassium hydroxide (0.033 g, 0.59 mmol) and DMSO (3 
cm3)was sonicated for 10 min, and then cooled to O·C. I-Bromo-3-chloropropane (0.16 
cm3, 0.252 g, 1.60 mmol) was added at O"C, and the mixture was stirred at room 
temperature. Mter 4 h, water (15 cm3) was added and the mixture was extracted with 
ethyl acetate (3 x 75 cm3). The combined extracts were washed with water (6 x 50 
cm3), brine (2 x 25 cm3) and dried (Na2S04)' The solvent was removed in vacuo and 
the residue was purified by column chromatography (50% light petroleurnl50% ethyl 
acetate) to give the title compound 258 (0.115 g, 74%) as a yellow oil, (Found: M+, 
357.1132. C20H20ClN03fequires M, 357.1132); umax (film) 1651, 1517, 1497, 1260, 
1175 and 1122 cm-I; BH (400 MHz; CDCI3) 10.35 (lH, s, CHO), 7.86 (lH, s, 2-H), 7.49 
(2H, m, Ar-H), 7.40-7.33 (3H, m, Ar-H), 7.15 (1H, d, J 8.4, 7/6-H), 7.06 (1H, d, J 8.4, 
6n-H), 5.26 (2H, s, OCH2Ph), 4.35 (2H, t, J 6.8, NCH2), 3.98 (3H, s, OMe), 3.50 (2H, t, 
J 6.0, CH2Cl) and 2.32 (2H, q, J 6.4, CH2); 0<;: (100.6 MHz; CDCI3) 188.81 (CHO), 
149.77, 143.71, 139.32, 135.34,134.96 (2-C);130.38, 130.05, 129.98, 123.92, 119.61, 
113.99 (7/6-C), 107.75 (6n-C), 76.98 (OCH2Ph), 59.74 (OMe), 45.86 (NCH2), 43 16 
(CH2) and 34.04 (CH2Cl); mlz 357(M+, 6%), 329 (6), 266 (38),251 (12),91 (100),77 
(12) and 65 (29). 
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4-Benzyloxy-1-(3-iodopropyl)-5-methoxyindole-3-carboxaldehyde 259 
A solution of 4-benzyloxy-l-(3-chloropropyl)-5-methoxyindole-3-carboxaldehyde 258 
(0.092 g, 0.26 mmol) in acetonitrile (8 cm3) containing sodium iodide (0.218 g, 1.45 
mmol) was he~ted at reflux t~ni.perature for 12 h. Water (5 cm3) was added and the 
mixture extracted with dichloromethane (3 x50 cm3). The extract was washed with 
water (3 x 25 cm3), saturated aqueous sodium sulfite solution (50 cm3) and dried 
(Na2S04). The solvent was removed in vacuo and the residue purified by column 
chromatography (diethyl ether) to give the title compound 259 (0.098 g, 85%) as a 
yellow oil, (Found: M+, 449:0488. C2oH20IN03 requires M, 449.0488); 'Ilmax (film) 
1652, 1515, 1497, 1260, 1123 and 1060 cm-I; OH (400 MHz; CDCI3) 10.25 (lH, s, 
CHO), 7.77 (lH, s, 2-H), 7.39 (2H, m, Ar-H), 7.28-7.23 (3H, m, Ar-H), 7.05 (lH, d, J 
8.8, 7/6-H), 6.96 (IH, d, J 8.8, 6n-H), 5.15 (2H, s, OCH2Ph), 4.17 (2H, t, J 6.4, NCH2), 
3.87 (3H, s, OMe), 3.00 (2H, t, J 6.4, CH2I) and 2.25 (2H, q, J 6.8, CH2); Oc (100.6 
MHz; CDCI3) 186.86 (CHO), 147.85, 141.80, 137.37, 133.39,.132.90 (2-C), 128.44, 
128.11,128.35,122.00,117.68, 112.07.(7/6-C), 105.87 (6n-C), 75.05 (OClhPh), 57.81 
(OMe), 47.22 (NCH2), 32.82 (CH2) and 1.64 (CH2I); m/z 449 (M+, 11 %),421 (8),358 
(34),91 (100),51 (15) and 28 (21). 
OBn 
MeO 
·261 
a-Benzyloxy-7-methoxy-1,2-dihydro-3H-pyrrolo[l,2-a]indole-9-carboxaldehyde 261 
A solution of tri-n-butyltin hydride (0.10cm3;0.109 g, 0.38 mmol) and AIBN (0.038 g, 
0.23 mmol) in toluene (2 cm3) was added to 4-benzyloxy-l-(3-iodopropyl)-5-. 
methoxyindole-3-carboxaldehyde 259 (0.0841 g, 0.19 mmol) in toluene (1;65 cm3) at 
. ' . , 
reflux over 15 min. The reaction was stirred at reflux for 3 h and a further portion of tri" 
124 
n-butyltin hydride (0.03 cm3)/AIBN (0.013 g) was added over 5 min. After a further 20 
min at reflux the mixture was allowed to cool to room temperature and the solvent 
removed in vacuo. Water (0.25 cm3), ethyl acetate (3 cm3) and potassium fluoride 
(0. ISO g) were added and the mixture stirred at room temperature. After 12 h, a further 
portion of water, ethyl acetate and potassium fluoride were added and the mixture stirred 
for 2 h. Potassium carbonate was added, the mixture filtered and the solvent removed in 
vacuo. The residue was purified by column chromatography (diethyl ether) to give the 
title compound 261 (0.028 g, 47%) as a pale yellow oil; (Found: M+, 321.1365. 
C20HI9N03 requires M, 321.1365); umax (film) 1645, 1490, 1388, 1256, 1099 and 700 
cm-I; OH (400 MHz; CDCI3) 10.32 (IH, s, CHO), 7.47 (2H, m, Ar-H), 7.38-7.30 (3H, m, 
Ar-H), 6.95 (2H, AB, J 8.4, 615-H), 5.20 (2H, s, OCH2Ph), 4.07 (2H, t, J 7.2, NCH2), 
3.93 (3H, s, OMe), 3.31 (2H, t, J 7.2, I-H) and 2.66 (2H, m, 2-H); Oc (100.6 MHz; 
CDCI3) 186_81, 153.22, 148.02, 142.50, 137.58, 129.58, 128.46, 128.07,125.90, 110.96 
(615-C), 109.96, 105.86 (516-C), 74.87 (OC1I2Ph), 57.77 (OMe), 44.57 (NC1I2), 26.69 
(2-C) and 26.66 (I-H); m/z 321 (M+, 21 %),230 (100), 215 (40), 91 (40),77 (10),65 
(26) and 51 (8). 
4-Benzyloxy-l-( 4-chlorobutyl)-S-methoxyindole-3-carboxaldehyde 244 
A mixture of 4-benzyloxy-5-methoxyindole-3-carboxaldehyde 243 (0.357 g, 1.27 
mmol), powdered 87% potassium hydroxide (0.089 g, 1.59 mmol) and DMSO (7 cm3) 
was sonicated for 10 min, and then cooled to O'C. I-Bromo-4-chlorobutane (0.44 cm3; 
0.653 g, 4.81 mmol) was added at O'C, and the mixture was then stirred at room 
temperature for 4 h. The reaction mixture was poured into water (15 cm3), and the 
product was extracted into ethyl acetate (3 x 150 cm3). The extract was washed with 
water ( 6 x 100 cm3), brine (2 x 75 cm3) and dri~d (Na2S04). The solvent was removed 
in vacuo and the residue was purified by column chromatography (diethyl ether) to give 
the title compound 244 (0.395 g, 84%) asa colourless solid, m.p. 82'C; (Found: C, 67.5; 
H, 6.0; N, 4.0. C21H22ClN03 requires C, 67.8; H, 6.0; N, 3.8%); umax (Nujol) 1709, 
1645, 1517, 1496, 1255 and 1120 cm-I; OH (400 MHz; CDCh) 10.33 (1H, s, CHO), 
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7.82 (lH, s, 2-H), 7.49-7.46 (2H, m, Ar-H), 7.37-7.32 (3H, m, Ar-H), 7.06 (2H, AB, J 
8.81, 7/6-H), 5.24 (2H, s, OCH2Ph), 4.15 (2H, t, J6.8, NCH2), 3.96 (3H, s; OMe), 3.54 
(2H, t, J 6.0, CH2Cl), 2.06 (2H, m, 2-CH2) and 1.80 (2H, m, 3-CH2); oe (100.6 MHz; 
CDCI3) 186.93 (CHO), 147.82, 141.83, 137.46, 133.49, 132.77 (2-C), 128.35, 128.48, 
128.14,122.06, 117.51, 112.04 (7/6-C), 105.88 (6n-C), 75.07 (OCH2Ph), 57.86 (OMe), 
46.72 (NCH2), 44.07 (2-C), 29.57 (3-C), 27.03 (CH2CI); mlz 371 (M+, 45%), 373 (17), 
280 (lOO), 245 (17), 190 (11) and 91 (70). 
MeO'6joBn CHO 
I ' ~ N 
245 ~I 
4-Benzyloxy-l-( 4-iodobutyl)-s-methoxyindole-3-carboxaldehyde 245 
A solution of the chloride 244 (0.359 g, 0.97 mmol) in acetonitrile (12 cm3) containing 
sodium iodide (0.599 g, 4.00 mmol) was heated at reflux temperature for 12 h. The 
solution was poured into water (15 cm3) and extracted with dichloromethane (3 x 100 
cm3). The extract was washed with water (3 x 75 cm3), saturated aqueous sodium 
sulfite solution (50 cm3) and dried (Na2S04). The solvent was removed in vacuo and 
the residue purified by column chromatography (diethyl ether) to give the title 
compound 245 (0.322 g, 72%) as a colourless solid, m.p. 96"C; (Found: M+, 463.0650. 
C21H22IN03 requires M, 463.0646); 'Ilmax (Nujol) 1651, 1511, 1494, 1254, 1120 and 
1052 cm-I; OH (400 MHz; CDCI3) 10.32 (IH, s, CHO), 7.79 (lH, s, 2-H), 7.46 (2H, m, 
Ar-H), 7.37-7.30 (3H, m, Ar-H), 7.05 (2H, AB, J 9.6, 7/6-H), 5.23 (2H, s, OCH2Ph), 
4.12 (2H, t, J 7.2, NCH2), 3.95 (3H, s, OMe), 3.16 (2H, t, J 6.8, CH2I), 2.00 (2H, m, 2-
CH2) and 1.82 (2H, m; 3-CH2); lie (100.6 MHz; CDCh) 186.91 (CHO), 147.82, 141.82, 
137.45,133.47,132.74 (2-C), 128.47, 128.13, 122.04, 117.51, 112.03 (7/6-C), 105.89 
(6n-C), 75.06 (OCH2Ph), 57.86 (OMe), 46.36 (NCH2), 30.50 (2-C), 30.30 (3-C), 4.99 
(CH21); mlz 463 (M+, 15%),435 (13), 372 (57), 244 (22), 202 (15),174 (17),155 (13), 
113 (10), 91 (100), 65 (21), 55 (31) and 28 (85): 
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OBn 
CHO 
MeO 
246 
9-Benzyloxy-S-methoxy-l,2,3,4-tetrahydropyrido[1,2-ajindole-lO-carboxaldehyde 246 
(a) To an ultrasonically irradiated solution ofiron(II)sulfate heptahydrate (0.041 g, 0.15 
mmol) and the iodide 245 (0.054 g, 0.12 mmol) in DMSO (4 cm3) was added 30% 
hydrogen peroxide (0.13 cm3; 0.040 g, 1.16 mmol) dropwise as rapidly as was feasible 
so that the reaction temperature did not exceed 40'C. This addition never required more 
than 30 min. When the peroxide addition was completed, the reaction was poured into 
water (15 cm3) and extracted with dichloromethane (3 x 75 cm3). The extract was 
washed with water (3 x 50 cm3), 10% aqueous sodium sulfite solution (5 x 25 cm3) and 
dried (Na2S04). Removal of the solvent in vacuo gave a brown solid which was 
purified by column chromatography (diethyl ether) to give the title compound 246(0.013 
g, 33%) as a colourless oil, (Found: M+, 335.1524. C2!H2!N03 requires M, 335.1521); 
'\)max (film) 1642, 1491, 1392, 1287, 1093 and 735 cm-!; OH (400 MHz; CDCh) 10.49 
(lH, s, CHO), 7.51-7.48 (2H, m, Ar-H), 7.39-7.32 (3H, m, Ar-H), 6.98 (2H, AB, J 8.8, 
7/6-H), 5.19 (2H, s, OCH2Ph), 4.04 (2H, t, J 6.0, NCH2), 3.94 (3H, s, OMe), 3.35 (2H, t, 
J 6.4, I-H), 2.09 (2H, m, 3/2-H) and 1.94 (2H, m, 2/3-H); Oc (100.6 MHz; CDCI3) 
187.56 (CHO), 148.23, 146.43, 141.26, 137.59, 133.03, 128.47, 128.04, 121.86, 112.76, 
110.34 (7/6-C), 105.21 (6n-C), 74.82 (OCH2Ph), 57.96 (OMe), 42.59 (NCH2), 25.29 
(I-C), 22.31 (3-C) and 19.54 (2-C); mJz 335 (M+, 14%),267 (13), 244 (100), 186 (15), 
155 (29), 91 (43),51 (50) and 28 (41). 
(b) A solution of tri-n-butyltin hydride (0.50 cm3; 0.550 g, 1.19 mmol) and AmN 
(0.157 g, 0.96 mmol) in toluene (16 cm3) was added to 4-benzyloxy-l-(4-iodobutyl)-5-
methoxyindole-3-carboxaldehyde (0.438 g, 0.95 mmol) in toluene (12 cm3) at reflux 
over 15 min. The reaction was stirred at reflux for 3 h and a further portion of tri-n-
butyltin hydride (0.20 cm3)/AmN (0.053 g) was added over 5 min. After a further 20 
min at reflux the mixture was allowed to cool to room temperature and the solvent 
removed in vacuo. Water (0.25 cm3) ethyl acetate (3 cm3) and potassium fluoride 
(0.150 g) were added and the mixture stirred atroom temperature. After 12 h, a further 
portion of water, ethyl acetate and potassium fluoride were added and the mixture stirred 
for 2 h. Potassium carbonate was added, the mixture filtered and the solvent removed in 
vacuo. The residue was purified by column chromatography (diethyl ether) to give the 
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title compound 246 ( 0.231 g, 73%) as a colourless solid; spectroscopic data identical to 
the sample prepared by the above route. 
MeO 
9-Hydroxy-8-methoxy-1,2,3,4-tetrahydropyrido[1,2-aJindole-1O-carboxaldehyde 166 
To a solution of 9-benzyloxy-8-methoxy-1 ,2,3,4-tetrahydropyrido[1,2-alindole-1 0-
carboxaldehyde 246 (0.018 g, 0.054 mmol) in ethanol (50 cm3) was added 10% 
palladium on carbon (0.04 g). The mixture was stirred under an atmosphere of hydrogen 
(60psi) for 12 h. After this time, the suspension was filtered and washed with 
dichloromethane. The combined filtrate and washings were washed with water (3 x 25 
cm3), brine (20 cm3) and dried (Na2S04). The organic layer was evaporated to dryness 
to give a brown solid. Purification of the residue by column chromatography (diethyl 
ether) gave the title compound 166 (0.009 g, 69%) as a colourless solid, m.p. IIO"C; 
(Found: M+, 245.1044. CI4HI5N03 requires M, 245.1052); 'l>max (film) 1597, 1579, 
1506, 1434, 1314, 1254 and 1079 cm-I; IiH (250 MHz; CDCI3) I J.J I (lH, s, OH), 9.61 
(lH, s, CHO), 6.94 (IH, d, J 8.5, 7/6-H), 6.65 (lH, d, J 8.5, 617-H), 4.00 (2H, t, J 6.0, 
NCH2), 3.92 (3H, s, MeO), 3.23 (2H, t, J 6.25, I-H), 2.13 (2H, m, 3/2-H) and 1.99 (2H, 
m, 2/3-H); IiH (100.6 MHz; CDCI3) 182.92, 150.32, 143.34, 141.38, 133.77, 115.69, 
114.21, 112.51 (7/6-C), 107.55 (617-C). 57.83 (MeO), 42.59 (NCH2), 29.71 (1-C), 22.26 
(3-C) and 19.27 (2-C); mlz 245 (M+, 10%), 149 (29),71 (62),57 (100), 43 (51) and 28 
(13). 
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MeO 
10.Formyl-8-methoxy.1,2,3,4.tetrahydropyrido[1,2-a]indole.6,9.dione 241 
Potassium nitrosodisulfonate (0.022 g, ) was added to a solution of the phenol 166 
(0.009 g, 0.037 mmol) in acetone (5 cm3), sodium dihydrogen phosphate solution 
(0.167M, 2 cm3) and water (2 cm3) and the resulting suspension stirred at room 
temperature for 12 h. The mixture was extracted with dichloromethane (3 x 10 cm3) and 
the combined organic extracts were dried (Na2S04) and evaporated. Purification of the 
residue by column chromatography (ethyl acetate) gave the title compound 241(0.005 g, 
53%) as orange needles, m.p. (Found: M+, 259.0845. CI4H13N04 requires M, 
259.0845); Umax (400 MHz; CDCI3) 10.17 (lH, s, CHO), 5.62 (lH, s, 7-H), 4.32 (2H, t, 
J 6.4, NCHz), 3.77 (3H, s, MeO), 3.11 (2H, t, J 6.4, I-H), 1.95 (2H, m, 3/2-H) and 1.82 
(2H, m, 213-H); lie (100.6 MHz; CDCI3) 189.34 (CHO), 180.32 (9/6-C), 179.35 (6/9-C), 
161.33, 144.66, 120.48, 108.06 (7-C), 58.10 (MeO), 47.78 (NCH2), 26.02 (I-C), 23.70 
(3-C) and 20.23 (2-C); m/z 259 (M+, 100), 203 (47), 91 (18),77 (19), 69 (27) and 41 
(15). 
'OrjoBn CHO MeO ~ I " :::::.... N 
260 I ~I 
4.Benzyloxy.1-(S·iodopentyl)·S·methoxyindole-3-carboxaldehyde 260 
A mixture of 4-benzyloxy-5-methoxyindole-5-carboxaldehyde 243 (0.104 g, 0.37 
mmol), powdered 87% potassium hydroxide «),046 g, 0.83 mmol) and DMSO (4 cm3) 
was sonicated for 10 min, and then cooled to O·C. l,5-Diiodopentane (0.16 cm3; 0.346 
g, 1.07 mmol) was added at O'C, and the mixture was stirred at room temperature. After 
4 h, water (15 cm3) was added and the mixture was extracted with ethyl acetate (3 x 75 
cm3). The combined extracts were washed with water (6 x 50 cm3), brine (2 x 25 cm3) 
129 
---------------
and dried (Na2S04)' The solvent was removed in vacuo and the residue was purified by 
column chromatography (50% light petroleuml50% diethyl ether) to give the title 
compound 260 (0.124 g, 70%) as a yellow oil, (Found: M+, 477.0801. C22H24IN03 
requires M, 477.0803); umax (film) 1651, 1516, 1461, 1389, 1259, 1172, 1060 and 760 
cm-I; /)H (400 MHz; CDCI3) 10_33 (!H, s, CHO), 7.83 (IH, s, 2-H), 7.49 (2H, m, Ar-H), 
7.40-7.33 (3H, m, Ar-H), 7.07 (2H, AB, J 8.8,7/6-H), 5.25 (2H, s, OCH2Ph), 4.13 (2H, 
t, J 7.2, NCH2), 3.97 (3H, s, OMe), 3.16 (2H, t, J 7.2, CH2I), 1.89 (4H, m, 2 and 4-CH2) 
and 1.47 (2H, m, 3-CH2); /)c 187.15 (CHO), 148.04, 142.05, 137.71, 133.76 (2-C), 
133.13, 128.71, 128.36, 122.27, 117.62, 112.20 (7/6-C) , 106.16 (617-C), 75.29 
(OCH~Ph), 58.11 (OMe), 47.43 (Nci-I2), 33.02 (4-C), 28.83 (2-C), 28.59 (3~C)and 6.05 
(CH2I); mlz 477(M+, 12%),449(13),386 (71), 258 (17), 216 (28), 155 (29), 91 (100), 
51 (53) and 28 (63). 
OBn 
·MeO 
IO-Benulory-8-methoxy-I,2,3,4-tetrahydro-SH-azepino[1,2-aJindole-I 1-
carboxaldehyde 262 
A solution of tri-n-butyltin hydride (0.07 cm3; 0.081 g, 0_28 mmol) and AIBN (0.029 g, 
0.18 mmol) in toluene (2 cm3) was added to 4-benzyloxy-I-(5-iodopentyl)-5-
methoxYindole-3-carboxaldehYde 260 (0.067 g, 0.14 mmol) in toluene (1.65 cm3) ~t 
reflux over 15 min. The reaction was stirred at reflux for 3 h and a further portion of tri-· 
n-butyltin hydride (0.02 cm3)/AIBN (0.010 g) was added over 5 min. After a further 20 
min at reflux the mixture was allowed to cool to room temperature and the solvent 
removed in vacuo. Water (0.25 cm3) ethyl acetate (3 cm3) and potassium fluoride 
(0.150 g) were added and the mixture stirred at room temperature. After 12 h, a further 
portion of water, ethyl acetate and potassium fluoride were added and the mixture stirred 
for 2 h. Potassium carbonate was added; the mixture filtered and the solvent removed in 
vacuo. The residue was purified by column ch~omatography (diethyl ether) to give the. 
title compound 262 (0.014 g, 29%) asa colourless solid, m.p. 116°C; (Found: M+, 
349.1678. C22H23N03 requires M, 349.1678); 'Ilmax (Nujol) 1650, 1493, 1393, 1258, 
1104 and 774 cm-I; /)H (400 MHz; CDCI3) 9.69 (1H, s, CHO), 7.41 (2H,m, Ar-H), 
7.31-7.23 (3H, m, Ar-H), 6.92 (2H,AB, J 8.8, 817-H), 5.10 (2H, s, OCH2Ph), 4.08 (2H, 
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t, J 4.8, NCH2), 3.86 (3H, s, OMe), 3.46 (2H, t, J 4.8, I-H), 1.81 (2H, m, 3-H) and 1.71 
(4H, m, 2-H and 4-H); lie (100.6 MHz; CDCI3) 189.00 (CHO), 151.43, 147.96, 141.85, 
137.89, 133.35, 128.83, 128.77, 128.35, 122.33, 113.09, 111.06 (8n-C), 105.27 (7I8-C), 
75.16 (OCH2Ph), 58.17 (OMe), 45.34 (NCH2), 31.23 (3-C), 30.25 (4/2-C), 27.08 (2/4-
C) and 26.34 (1-C); mlz 349 (M+, 25%), 321 (14),258 (lOO), 243 (47), 159 (16), 130 
(14),91 (77) and 65 (18). 
(r)CHO , I ' . ~ N 
253 ~Cl 
1-(3-Chloropropyl)indole-3-carboxaldehyde 253 
A mixture of indole-3-carboxaldehyde 252 (0.503 g, 3.47 mmol), powdered 87% 
potassium hydroxide (0.254 g, 4.52 mmol) and DMSO (8 cm3) was sonicated for 10 
min, and then cooled to O"C. I-Bromo-3-chloropropane (1.02 cm3; 1.626 g, 10.33 
mmol) was added at O"C, and the mixture was stirred at room temperature. After 4 h, 
water (50 cm3) was added and the mixture was extracted with ethyl acetate (3 x 150 
cm3). The combined extracts were washed with water (6 x 100 cm3), brine (2 x 75 cm3) 
and dried (Na2S04). The solvent was removed in vacuo and the residue was purified by 
column chromatography (50% light petroleurnl50% diethyl ether) to give the title 
compound 253 (0.696 g, 91 %) as a colourless solid, m.p. 46"C (lit.96 47-48.5"C) (Found: 
M+, 221.0607. C12H12ClNO requires M, 221.0607); umax (Nujol) 1656, 1533 and 1401 
cm-I; liH (400 MHz; CDCI3) 10.00 (1H, s, CHO), 8.31 (lH, m, 4-H), 7.75 (lH, s, 2-H), 
7.42-7.30( 3H, m, Ar-H), 4.41 (2H, t, J 6.4, NCH2), 3.48 (2H, t, J 5.6, CH2Cl) and 2.33 
(2H, q, J 6.4, CH2); lie (100.6 MHz; CDCI3) 184.51 (CHO), 138.37 (2-C), 137.02, 
125.55, 124.21, 123.09, 122.33, 118.47,109.90,43.80 (NCH2), 41.30 (CH2) and 32.00 
(CH2Cl); mlz 221(M+, 51 %),158 (100),144 (12),130 (29),51 (9) and 28 (17). 
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CHO o ~i 
235 I 
............... 1 
1-(3-/odopropyl)indole-3-carboxaldehyde 235 
A solution of 1-(3-chloropropyl)-5-methoxyindole-3-carboxaldehyde 253 (0.621 g,2.80 
mmol) in acetonitrile (12 cm3) containing sodium iodide (0.1673 g, 11.16 mmol) was 
heated at reflux temperature for 12 h. The solution was poured into water (50 cm3) and 
extracted with dichloromethane (3 x 150 cm3). The extract was washed with water (3 x 
100 cm3), saturated aqueous sodium sulfite solution (50 cm3) and dried (Na2S04). The 
solvent was removed in vacuo and the residue purified by column chromatography 
(diethyl ether) to give the title compound 235 (0.694 g, 79%) as a colourless oil, (Found: 
M+,312.9964. CI2H12INO requires M, 312.9965); umax (film) 1647, 1530, 1261,1217, 
1166 and 1038 cm-I; OH (400 MHz; CDCI3) 10.05 (lH, s, CHO), 8.35 (lH, m, 4-H), 
7.81 (lH, s, 2-H), 7.46-7.34 (3H, m, Ar-H), 4.38 (2H, t, J 6.4, NCH2), 3.13 (2H, t, J 6.4, 
CH21), 2.39 (2H, q, J 6.4, CH2); Oc (100.6 MHz; CDCI3) 184.47 (CHO), 138.13 (2-C), 
136.99, 125.57, 124.19, 123.11, 122.36, 118.48, 109.90,47.04 (NCH2), 32.63 (CH2) and 
1.94 (CH21); mlz 313 (M+, 56%), 217 (9),186 (10),158 (100),130 (26), 77 (15), 51 (43) 
and 28 (56). 
1,2-Dihydro-3H-py"olo[1,2-ajindole-9-carboxaldehyde 236 
A solution oftri-n-butyltin hydride (0.29 cm3; 0.314 g, 1.08 mmol) and AIBN (0.089 g, 
0.54 mmol) in toluene (7 cm3) was added to 1-(3-iodopropyl)indole-3-carboxaldehyde 
235 (0.169 g, 0.54 mmol) in toluene (5 cm3) ·at. reflux over 15 min. The reaction was 
stirred at reflux for 3 h and a further portion of tri-n-butyltin hydride (0.10 cm3) IAIBN 
(0.030 g) was added over 5 min. After a further 20 min at reflux the mixture was 
allowed to cool to room temperature and the solvent removed in vacuo. Water (0.25 
cm3) ethyl acetate (3 cm3) and potassium fluoride (0.150 g) were added and the mixture 
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stirred at room temperature. After 12 h, a further portion of water, ethyl acetate and 
potassium fluoride were added and the mixture stirred for 2 h. Potassium carbonate was 
added, the mixture filtered and the solvent removed in vacuo. The residue was purified 
by column chromatography (diethyl ether) to give the title compound 236 (0.064 g, 
64%) as a colourless solid; m.p.136'C (lit.96 146-147'C); (Found: M+, 185.0841. 
CI2HllNO requires M, 185.0841); \lmax (Nujol) 1642, 1538, 1303, 1245, 1121, 1041, 
and 747 cm-I; OH (400 MHz; CDCb) 10.00 (lH, s, CHO), 8.19 (lH, m, 4-H), 7.29-7.22 
(3H, m, Ar-H), 4.12 (2H, t, J 6.8, NCH2), 3.28 (2H, t, J 7.2, I-H) and 2.71 (2H, m, 2-H); 
oe (100.6 MHz; CDCb) 183.44 (CHO), 155.45, 133.22, 130.00, 122.83, 122.75, 121.42, 
110.28, 110.00,44.53 (NCH2), 26.85 (2-C)and 24.55 (I-H); m/z 185 (M+, 85%), 156 
(29), 128(18),77 (12), 51 (11) and 28 (22). 
COCHO 17 I ' ~ N 
254 ~CI 
1-( 4-Chlorobutyl)indole-3-carboxaldehyde 254 
A mixture of indole-3-carboxaldehyde 252 (0.501 g, 3.45 mmol), powdered 87% 
potassium hydroxide (0.256 g, 4.56 mmol) and DMSO (8 cm3) was sonicated for 10 
min, and then cooled to O'C. I-Bromo-4-chlorobutane (1.19 cm3; 1.771 g, 10.33 mmol) 
was added at O'C, and the mixture was stirred at room temperature. After 4 h, water (50 
cm3) was added and the mixture was extracted with ethyl acetate (3 x 150 cm3). The 
combined extracts were washed with water (6 x 100 cm3), brine (2 x 75 cm3) and dried 
(Na2S04). The solvent was removed in vacuo and the residue was purified by column 
chromatography (50% light petroleurnl50% diethyl acetate) to give the title compound 
254 (0.785 g, 97%) as a colourless solid, m.p. 63'C (lit.96 62-64'C), (Found: M+, 
235.0764. C!3HI4CINO requires M, 235.0764); llmax (Nujol) 1659, 1523, 1378, 1319 
and 1171cm-l ; OH (400 MHz; CDCI3) 1O.oI (IH, s, CHO), 8.31 (lH, m, 4-H), 7.71 (lH, 
s, 2-H), 7.39-7.30 (3H, m, Ar-H), 4.23 (2H, t, J 7.2, NCH2), 3.55 (2H, t, J 6.4, CH2Cl), 
2.09 (2H, m, 2-CH2) and 1.82 (2H, m, 3-CH2);.Oc (100.6 MHz; CDCI3) 184.44 (CHO), 
137.80 (2-C), 137.16, 125.55, 124.12, 123.01, 122.26, 118.38, 109.93,46.57 (NCH2), 
44.08 (2-C), 29.63 (3-C) and 27.22 (CH2CI); m/z 235(M+, 44%), 158 (lOO), 144 (16), 
130 (24), 51 (27) and 28 (27). 
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CHO ~-( ~l 
237 ~I 
1-(4-1odobutyl)indole-3-carboxaldehyde 237 
A solution of 1-(4-chlorobutyl)-5-methoxyindole-3-carboxaldehyde 254 (0.499 g, 2.12 
mmol) in acetonitrile (12 cm3) containing sodium iodide (1.306 g, 8.71 mmol) was 
heated at reflux temperature for 12 h. The solution was poured into water (50 cm3) and 
extracted with dichloromethane (3 x 150 cm3). The extract was washed with water (3 x 
100 cm3), saturated aqueous sodiu~ sulfite solution (50 cm3) and dried (Na2S04). The 
solvent was removed in vacuo and the residue purified by column chromatography 
(diethyl ether) to give the title compound 237 (0.504 g, 73%) as a colourless solid; m.p 
57°C (lit.96 58-59°C); (Found: M+, 327.0120. C13HI4INO requires M, 327.0120.); urnax 
(Nujol) 1645, 1533, 1468, 1401, 1135 and 752 cm-I; liH (400 MHz; CDCI3) 10.04 OH, 
s, CHO), 8.34 OH, m, 4-H), 7.73 (IH, s, 2-H), 7.42-7.34 (3H, m, Ar-H), 4.42 (2H, t, J 
7.2, NCH2), 3.20 (2H, t, J 7.2, CH2I), 2.07 (2H, m, 2-CH2) and 1.88 (2H, m, 3-CH2); liH 
(100.6 MHz; CDCIJ) 186.67 (CHO), 139.99 (2-C), 139.38, 127.80, 126.36, 125.26, 
124.51, 120.63, 112.17,48.45 (NCH2), 32.93 (2-C), 32.61 (3-C) and 7.18 (CH2I); m/z 
327 (M+, 68%),170 (26),158 (91),130 (100),116 (45), 77 (46) and 55 (62). 
1,2,3,4-Tetrahydropyrido[1,2.ajindole-lO·carboxaldehyde 238 
A solution of tri-n-butyltin hydride (0.10 cm3; 0.107 g, 0.37mmol) and AIBN (0.030 g, ' 
0.18 mmol) in toluene (7 cm3) was added to 1-(4-iodobutyl)indole-3-carboxaIdehyde 
237 (0.060 g; 0.18 mmol) in toluene (5 cm3)'at reflux over 15 min. The reaction was 
stirred at reflux for 3 h and a further port.ion of tri-n-butyItin hydride (0.03 cm3) I AffiN 
(0.01 g) was added over 5 min. Mter a further 20 min at reflux the mixture was aIIowed 
to cool to room temperature and the solvent removed in vacuo. Water (0.25 cm3) ethyl 
acetate (3 cm3) and potassium fluoride (0.150 g) were added and the mixture stirred at 
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room temperature. After 12 h, a further portion of water, ethyl acetate and potassium 
fluoride were added and the mixture stirred for 2 h. Potassium carbonate was added, the 
mixture filtered and the solvent removed in vacuo. The residue was purified by column 
chromatography (diethyl ether) to give the title compound 238 (0.027 g, 75%) as a 
colourless solid, m.p. 124'C (lit.96 121-125'C); (Found: M+, 199.0997. C13H13NO 
requires M, 199.0997.); 'Ilmax (Nujol) 1640, 1519, 1313, 1249, 1169, 1061, and 748 cm-
I; SH (400 MHz; CDCI3) 10.16 (1H, s, CHO), 8.20 (IH, m, Ar-H), 7.31-7.23 (3H, m, 
Ar-H), 4.10 (2H, t, J 6.0, NCH2), 3.31 (2H, t, J 6.4, I-H), 2.15 (2H, m, 3-H) and 1.98 
(2H, m, 2-H); Se (100.6 MHz; CDCI3) 183.50 (CHO), 148.00, 136.50, 126.01, 123.13, 
122.74, 120.56 (9-C), 112.95, 109.12, 42.44 (NCH2), 22.84 (1-C), 22.49 (3-C) and 
19.69 (2-C); mlz 199 (M+, 100%), 170 (46),155 (27),113 (21),51 (51) and 28 (57). 
COCHO 17 I " ~ N 
255 ~a 
1-(5-Chloropentyl)indole-3-carboxaldehyde 255 
A mixture of indole-3-carboxaldehyde 252 (0.500 g, 3.44 mmol), powdered 87% 
potassium hydroxide (0.300 g, 5.34 mmol) and DMSO (8 cm3) was sonicated for 10 
min, and then cooled to O'C. 1-Bromo-5-chloropentane (1.36 cm3; 1.916 g, 10.33 
mmol) was added at O'C, and the mixture was stirred at room temperature. After 4 h, 
water (50 cm3) was added and the mixture was extracted with ethyl acetate (3 x 150 
cm3). The combined extracts were washed with water (6 x 100 cm3), brine (2 x 75 cm3) 
and dried (Na2S04). The solvent was removed in vacuo and the residue was purified by 
column chromatography (50% light petroleuml50% diethyl acetate) to give the title 
compound 255 (0.764 g, 86%) as a colourless solid, m.p. 64'C; (Found: M+, 249.0920. 
C14H16CJNO requires M, 249.0920.); 'Ilmax (NujoJ) 1655, 1525, 1243, 1311 and 1174 
cm-I; SH 10.00 (lH, s, CHO), 8.31 (1H, m, 4-H), 7.70 (IH, s, 2-H), 7.38-7.29 (3H, m, 
Ar-H), 4.18 (2H, t, J 7.2, NCH2), 3.51 (2H, t, J 6.8, CH2CI), 1.93 (2H, m, 2-CH2), 1.79 
(2H, m, 4-CH2) and 1.51 (2H, m, 3-CH2); SC;·(100.6 MHz; CDCI3) 184.44 (CHO), 
138.04 (2-C), 137.16, 125.53, 124.00, 122.93, 122.20, 118.22, 109.98,47.909 (NCH2), 
44.48 (4-C), 31.96 (2-C), 29.11 (3-C) and 24.20 (CH2CJ); mlz 249 (M+, 39%), 186 (7), 
158 (100), 144 (14), 130 (34), 77 (16) and 51 (9). 
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(X)CHO ~ I ~ ~ N 
256 ~I 
1-( S-Iodopentyl)-S-methoxyindole-3-carboxaldehyde 2S6 
A solution of 1-(5-chloropentyl)-5-methoxyindole-3-carboxaldehyde255 (0.545 g, 2.18 
mmol) in acetonitrile (12 cm3) containing sodium iodide (1.336 g, 8.9Immol) was 
heated at reflux temperature for 12 h. The solution was poured into water (50 cm3) and 
extracted with dichloromethane (3 x 150 cm3). The extract was washed with water (3 x 
100 cm3), saturated aqueous sodium sulfite solution (50 cm3) and dried (Na2S04). The 
solvent was removed in vacuo and the residue purified by column chromatography 
(diethyl ether) to give the title compound 256 (0.683 g, 92%) as a colourless solid; m.p. 
72-74'C; (Found: M+, 341.0277; C14HI6INO requires M, 341.0277.); 'llmax (Nujol) 
1646,1531,1260,1234,1169; 1137 and 1015 cm-I; OH (400 MHz;CDCI3) 10.04 (lH, s, 
CHO), 8.34 (lH, m, 4-H), 7.74 (IH, s, 2-H), 7.40-7.32 (3H, m, Ar-H), 4.22 (2H, t, J 6.8, 
NCH2), 3.18 (2H, t, J 6.8, CH21), 1.97-1.84 (4H, m, 2 and 4-CH2) and 1.51 (2H, m, 3-
CH2); oc (100.6 MHz; CDCI3) 184.79 (CHO), 138.33 (2-C), 137.51, 125.92, 124.38, 
123.31,122.59,118.61,110.33,47.42 (NClh), 33.10 (4-C), 29.11 (2-C), 28.12 (3-C) 
and 6.26 (C H2I); mlz 341 (M+, 54%), 186 (19), 158 (lOO), 130(47),77 (16) and 51 (6). 
CHO 
1,2,3,4-Tetrahydro-SH-azepino[I,2-ajindole-ll-carboxaldehyde 2S7 . 
A solution oftri-n-butyltin hydride ( 0.36 cm3; 0.388 g, 1.33 minol) and AIBN (0.110 g, 
0.67 mmol) in toluene (7 cm3) was added to 1-(5-iodopentyl)indole-3-carboxaldehyde 
256 (0.228 g, 0.67 mmol) in toluene (5 cm3) ·~t reflux over 15 min. The reaction was 
stirred at reflux for 3 h and a further portion oftri-n-butyltin hydride (0.10 cm3) IAmN 
(0.03 g) was added over 5 min. After a further 20 min at reflux the mixture was allo~ed 
to cool to room temperature and the solvent removed in vacuo. Water (0.25 ·cm3) ethyl 
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acetate (3 cm3) and potassium fluoride (0.150 g) were added and the mixture stirred at 
room temperature. After 12 h, a further portion of water, ethyl acetate and potassium 
fluoride were added and the mixture stirred for 2 h. Potassium carbonate was added, the 
mixture filtered and the solvent removed in vacuo. The residue was purified by column 
chromatography (diethyl ether) to give the title compound 257 (0.061 g, 43%) as a 
colourless solid, m.p. 114'C; (Found: M+, 213.1154. C14HlSNO requires M, 
213.1154.); "Ilmax (Nujol) 1645, 1576, 1533, 1376, 1203, 1047 and 743 cm-I; IiH (400 
MHz; CDCI3) 10.08 (lH, s, CHO), 8.24 (lH, m, Ar-H), 7.28-7.16 (3H, m, Ar-H), 4.12 
(2H, t, J 4.8, NCH2), 3.16 (2H, t, J 5.2, I-H), 1.84 (2H, m, 3-H) and 1.73 (4H, m, 2 and 
4-H); lie (100.6 MHz; CDC13) 184.44 (CHO), 153.98, 136.74, 126.05, 123.43, 122.93, 
121.63 (1O-C), 113.73, 109.38,45.20 (NCH2), 31.06 (3-C), 28.55 (4/2-C), 26.87 (2/4-
C), 25.41 (I-C); mJz 213 (M+, 100%), 184 (59),156 (21), 77 (11), 51 (10) and 28 (11). 
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Appendix 1 X-ray crystallographic data 
All measurements were made on a Rigaku AFC7S diffractometer with graphite 
monochromated Cu-Ka radiation. 
Structure Solution 
Refinement 
Function Minimised 
Least Squares Weights 
Anomalous Dispersion 
Figure 2 compound 165 
Empirical Formula 
Formula Weight 
Crystal System 
Lattice Parameters 
Space Group 
Z value 
Dcalc 
llCCuKa) 
Cu Radiation 
Scan Type 
, 
No. of Reflections Measured 
Corrections 
Direct Methods (SIR88) 
Full-matrix least squares 
l:co([Fo]- [Fc])2 
1/(02 (Fo)) = 4 Fo2/ (02 (Fo2)) 
All non-hydrogen atoms 
Crystal Data 
C22H2,N03 
347.41 
monoclinic 
a=9.29 (l)A 
b = 15.770 (7)A 
c = 12.21 (l)A 
~ = 104.3 (1)' 
P2,/a 
4 
1.330 glcm3 
7.11 cm-' 
Intensity Measurements 
143 
A. = 1.54178A 
co 
Total: 2895 
, .' 
Unique: 2711 (Rim = 0.059) 
Lorentz-polarisation 
Structure Solution and Refinement 
p-factor 
No. Observations (1)3.000- (I» 
No. Variables 
ReflectionlParameter Ratio 
Residuals: R, Rw 
Goodness of Fit Indicator 
Max ShiftlError in Final Cycle 
Maximum peak in Final Diff. Map 
Minimum peak in Final Diff. Map 
Figure 6 compound 216 
Empirical Formula 
Formula Weight 
Crystal SysteIIl . . 
Lattice Parameters 
Space Group 
Zvalue 
Dca/c 
11 (CuKa.) 
0.0090 
1330 
236 
5.64 
0.051: 0.047 
2.90 
0.09 
0.18 e-/A3 
-0.15 e-/A3 
Crystal Data 
C27H23N03 
409.48 
triclinic 
a = 10.485 (2) A 
b= 11.811 (l)A 
c = 9.161 (1) A 
. a. = 92.667 (9)" 
~ = 105.26 Cl)" 
'Y = 98.78 (1)" 
P21/a 
2 
1.262g1cm3 
6.19 cm·! 
Intensity Measurements 
Cu radiation 
Scan Type 
No. of Reflections Measured 
144 
"'';'1.54178 A 
ro-2~ 
Total: 3410 
Unique: 3208 (Rint = 0.038) 
;1 
Corrections Lorentz-polarisation 
i Structure Solution and Refinement 
',' 
p-factor 0.0030 
No. Observations (I > 3.00<1 (I)) 2425 
I No. Variables 281 , i 
, ReflectionIParameter Ratio 8.63 
Residuals: R; Rw 0.045; 0.038 
Goodness of Fit Indicator 4.25 
Max Shift! Error in Final Cycle 0.00 
Maximum peak in Final Diff. Map 0.22 e-/A3 
Minimum peak in Final Diff. Map -0.23 e-/A3 
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